The Energy Code

Every month there's an avalanche of new research — but very little of it actually changes how we think about health. In this episode of The Energy Code, Dr. Mike Belkowski breaks down the most important mitochondrial research published over the last month and separates genuine scientific progress from marketing hype. You'll learn why independent testing revealed that some commercial red light therapy devices don't emit the wavelengths they claim, why that matters far more than advertised power output, and what consumers should actually be looking for. Dr. Mike also explores the latest mechanistic research on methylene blue, the expanding clinical evidence behind Urolithin A, and a fascinating new body of mitochondrial science suggesting that dysfunctional mitochondria may actively drive inflammation and aging through cellular signaling — not simply by producing less energy. If the recent science is pointing in one direction, it's this: Mitochondrial quality may be one of the most important upstream regulators of health, resilience, and longevity. Whether you're interested in red light therapy, methylene blue, Urolithin A, or simply understanding where longevity science is headed next, this episode provides an evidence-based review of the month's biggest developments. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: "Wavelength is the identity of the treatment... Power output can often be compensated for. Wavelength cannot." "Consumers should care whether companies are willing to have their products independently tested." "Methylene blue is not a molecule where more automatically means better." "Healthy mitochondria don't just make energy. They help determine how your cells respond to stress, inflammation, and aging." "Every month, the science becomes a little clearer: mitochondrial health sits upstream of countless chronic diseases." "The best longevity interventions don't replace biology — they help restore how biology was designed to function." - Key Points ⚡ Independent researchers tested commercial red light therapy devices with laboratory spectrometers and found that some failed to emit the wavelengths they claimed. ⚡ Wavelength accuracy may be more important than raw power output because wavelength determines the biological target being stimulated. ⚡ FDA Registered, FDA Cleared, and FDA Approved are very different regulatory classifications—and understanding the distinction matters. ⚡ The red light industry is beginning to mature, with manufacturers focusing more on wavelength selection and engineering than simply increasing wattage. ⚡ New mechanistic research continues strengthening our understanding of how methylene blue influences mitochondrial redox biology. ⚡ Methylene blue appears to provide its greatest mitochondrial benefits at lower doses, reinforcing its biphasic dose-response. ⚡ Safety remains paramount with methylene blue, particularly regarding serotonergic medications, dosing, and product purity. ⚡ Urolithin A continues expanding beyond muscle health into immune aging, obesity, cognition, oncology, and metabolic health. ⚡ A new Nature Aging study explored how Urolithin A may support immune function by improving mitochondrial quality control through mitophagy. ⚡ Researchers are now investigating whether Urolithin A can help preserve lean muscle mass during weight loss, particularly alongside GLP-1 therapies. ⚡ Emerging mitochondrial research suggests damaged mitochondria actively communicate with the nucleus, influencing inflammatory gene expression and aging. ⚡ Mitochondria are increasingly being viewed as drivers of inflammation — not simply victims of aging. ⚡ New research highlights the importance of mitochondrial membranes, network dynamics, and respiratory supercomplex architecture in maintaining cellular energy production. ⚡ Controlled mitochondrial stress (hormesis) continues to emerge as one of the body's most powerful mechanisms for building resilience. ⚡ The month's research reinforces that mitochondrial quality—not simply mitochondrial quantity — may be one of the most important upstream regulators of healthspan and longevity. ⚡ While supplements and therapies continue to advance, the highest-leverage mitochondrial interventions remain the fundamentals: quality nutrition, exercise, sleep, metabolic health, and consistent healthy habits. ⚡ Red light therapy, methylene blue, and Urolithin A should be viewed as tools that amplify a strong biological foundation — not replace one. - Episode timeline 00:00 – Why This Month Actually Matters The biggest red light story wasn't a new device—it was independent testing. Overview of the month's biggest mitochondrial research. 02:00 – Red Light Therapy Under the Spectrometer Independent wavelength verification. Why wavelength accuracy matters more than marketing wattage. Devices that passed—and those that didn't. 05:05 – FDA Marketing vs Reality FDA Registered vs FDA Cleared vs FDA Approved. Why consumers should understand the difference. 09:20 – Methylene Blue Update New mitochondrial mechanisms. Redox biology. Why dose remains everything. 14:30 – Urolithin A's Research Explosion Nature Aging publication. Immune aging. Muscle preservation during weight loss. Obesity and cognition research. 20:08 – The Biggest Story of the Month Mitochondria communicate with the nucleus. Inflammation and aging may begin upstream in mitochondrial dysfunction. Why this changes how we think about longevity. 22:50 – Practical Takeaways Choosing red light devices. Methylene blue expectations. Why Urolithin A continues gaining momentum. The importance of foundational lifestyle interventions. 26:45 – What's Coming Next Future red light testing. Traumatic brain injury research. Urolithin A clinical expansion. Mitochondrial signaling and epigenetics. - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

David Horinek returns to The Energy Code to share the cutting-edge technologies he's developing at the intersection of light, frequency, biomaterials, regenerative health, and human performance.   In this wide-ranging conversation, David explains how infrared light, sound frequencies, grounding, nature, advanced textiles, bioactive materials, and emerging peptide technologies may shape the future of health optimization. He also shares the story behind BioCream and BioBlue, discusses new innovations in agriculture, construction materials, AI-driven plant optimization, and offers dozens of practical biohacks he personally uses every day.   Whether you're interested in mitochondria, red light therapy, peptides, longevity, or the future of biohacking, this episode is packed with ideas that challenge conventional thinking and explore where health technology may be headed next.   (Educational content only, not medical advice.) - Follow & Learn More From David Horinek: Social MediaIG: @Celliant Website & Other:Celliant Discount Code: DAVE20 for 20% offOriginal Source Collective (Coffee Company) Discount code: BIOLIGHT15 for 15% offVolap.io - Key Quotes From David Horinek “Good for people and good for the planet has always been my mantra.” “Nature is still one of the greatest technologies we’ve ever had.” “The future of wellness is frequencies, energies, and intuition.” “I don’t feel like I lived if I didn’t learn something new every day.” “I try to create one hero moment every single day.” Key Points ⚡ David Horinek returns to discuss the latest innovations he’s developing across biohacking, sustainable materials, and frequency-based health technologies. ⚡ Morning sunlight, grounding, and time in nature remain foundational health practices despite rapidly advancing wellness technologies. ⚡ Infrared-responsive materials continue expanding into clothing, bedding, topical products, agriculture, and construction materials. ⚡ Violet-light technologies may become a future tool for food preservation and biological applications. ⚡ David believes light, sound, and frequency therapies represent one of the next frontiers in health optimization. ⚡ The conversation explores how mitochondrial function and peptide production may be more closely connected than previously understood. ⚡ Emerging peptide delivery systems may reduce reliance on injectable therapies through improved absorption technologies. ⚡ AI and data centers present both opportunities and challenges, including concerns around energy use, noise pollution, infrastructure, and privacy. ⚡ David shares his philosophy on entrepreneurship, intellectual property, intuition, and developing inventions through collaboration. ⚡ Both David and Dr. Mike emphasize small daily habits, spending time outdoors, and continuous learning as long-term strategies for health and success. ⚡ The episode concludes with a rapid-fire Q&A covering David’s favorite inventions, biggest inspirations, and vision for the future of wellness. Timeline 00:00:00–00:02:47 — Mike introduces David Horinek and the evolution of BioBlue and BioCream 00:02:48–00:06:02 — Morning sunlight, circadian biology, infrared energy, and David’s early influences 00:06:03–00:10:58 — Frequency agriculture, sustainable textiles, AI-assisted farming, and NASA-inspired research 00:10:59–00:15:00 — Building cellular homeostasis with light, sound, and mitochondrial support 00:15:01–00:18:00 — Red light therapy, eye health, nutrition, and daily longevity practices 00:18:01–00:22:48 — Grounding, forest immersion, and reconnecting with nature 00:22:49–00:25:50 — Chaga, sea buckthorn, functional nutrition, and BioCream 00:25:51–00:35:45 — Cold exposure, active building materials, BioLight innovations, and longevity technologies 00:35:46–00:45:56 — Functional beverages, women’s health products, future inventions, and entrepreneurial updates 00:45:57–00:49:10 — Intellectual property strategies, collaborative innovation, and violet-light food preservation technologies 00:49:11–00:54:30 — The future of peptides, blockchain applications, digital ownership, and decentralized technologies 00:54:31–01:04:38 — AI, data centers, sustainable infrastructure, meditation, float therapy, and creativity 01:04:39–01:12:17 — Mitochondria, peptide signaling, bioenergetics, photonic amino acids, and the future of frequency medicine 01:12:18–01:19:58 — Practitioner philosophy, resilience, daily habits, Kaizen, grounding, and peptide delivery innovations 01:19:59–01:23:31 — Rapid-fire questions: favorite inventions, wellness technologies, inspiration, and the future of health 01:23:32–End — Where to follow David, upcoming projects, final thoughts, and closing remarks - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

What does one of the world's most respected transformation coaches do to stay healthy while constantly traveling, competing, and pushing the limits of performance? In this wide-ranging conversation, Dr. Mike Belkowski sits down with Kris Gethin to explore the practical side of biohacking — from travel optimization and circadian health to grounding, light exposure, peptides, longevity, and why intuition may be just as important as technology. Chris shares his personal peptide journey, including how BPC-157, TB-500, GHK-Cu, and cartilage-targeting peptides dramatically accelerated his recovery after major injuries. He also discusses the current peptide landscape, how to identify reputable sources, and where he believes the industry is headed. The conversation ultimately comes back to a simple but powerful message: the greatest health interventions are often the foundational ones — movement, sunlight, nature, sleep, and consistency. (Educational content only, not medical advice.) - Articles & Books Discussed in Episode: Books by Kris Gethin: 12-Week Daily Video Trainer, The Bodybuilding.com Guide to Your Best Body, and Man of Iron Research & References: Peptide Signaling and Tissue Bioregulators Study, Environmental Psychology of View Angles and Cortisol Reduction, Methylene Blue Cellular Energy Research - Key Quotes From Kris: “Health optimization requires continuous daily mobility, not just an intense hour in the gym.” “If you over-quantify every single biological metric, you end up inducing the very stress you're trying to eliminate.” “Grounding and nature offer a biological reset that no expensive technology can replicate.” “Peptides provide the body with precise cellular directions, but sourcing and third-party testing are non-negotiable.” “Sleep quality will always trump sleep duration if your environment isn't dialed in.” - Follow & Learn From Kris Gethin   Social Media:InstagramFacebookTikTokLinkedInXYouTube Website & Other:Unmatched SuppsKris Gethin Coaching The Kris Gethin Podcast - Key Points ⚡ Kris Gethin joins Dr. Mike Belkowski for a treadmill-desk session focused on practical health optimization and high-performance recovery. ⚡ Continuous daily movement and mobility take precedence over isolated workout sessions for long-term metabolic health. ⚡ Combatting travel-induced oxidative stress requires proactive pre-, during-, and post-flight protocols. ⚡ Key travel non-negotiables include Faraday shielding, blue-light blocking glasses, and grounding techniques to maintain circadian balance. ⚡ Earth grounding and spending time in natural settings trigger immediate stress reduction and biological recovery. ⚡ Over-reliance on health tracking devices can cause "shiny object syndrome" and distract from listening to internal body cues. ⚡ Tissue-specific bioregulator peptides like BPC-157 and TB-500 aid in targeted cell signaling for injury recovery and repair. ⚡ The peptide industry faces significant hurdles with FDA scrutiny, payment processing issues, and gray-market quality concerns. ⚡ Independent, third-party lab testing is essential for consumers looking to verify peptide purity and authenticity. ⚡ Methylene blue serves as an effective intervention for enhancing cellular energy and mitochondrial function. ⚡ Optimizing sleep architecture relies on environmental controls like total blackout light elimination, air filtration, and active cooling. ⚡ Sleep duration matters far less than sleep quality and uninterrupted deep/REM cycles tailored to individual needs. - Episode Timeline 00:00:02–00:00:34 — Show Intro: Unlocking the Mitochondrial Matrix 00:00:35–00:03:00 — Welcome back Kris Gethin & treadmill desk catch-up 00:03:01–00:04:09 — The importance of continuous daily movement over isolated workouts 00:04:10–00:07:10 — Authenticity and mentorship in the health and wellness industry 00:07:11–00:13:14 — Pre-, during-, and post-travel protocols to mitigate oxidative stress and jet lag 00:13:15–00:16:48 — Mid-episode spotlight: Methylene blue and cellular energy boost 00:16:49–00:17:59 — Top 3 travel non-negotiables: Faraday blankets, grounding footwear, and blue-blocking glasses 00:18:00–00:22:24 — The overlooked biological power of earthing and grounding 00:22:25–00:28:16 — Nature as nurturing medicine: Environmental psychology and view angles 00:28:17–00:32:14 — Sifting through biohacking noise: Fraud, over-testing, and shiny object syndrome 00:32:15–00:37:59 — Balancing data quantification with intuitive bodily awareness 00:38:00–00:43:42 — Deep dive into peptides: Origins, injury recovery, and tissue regeneration 00:43:43–00:47:31 — Industry challenges: Payment processing, FDA scrutiny, and gray market quality control 00:47:32–00:52:11 — Consumer advice for sourcing peptides and performing independent lab testing 00:52:12–01:02:44 — Comparing peptides to traditional pharmaceuticals and life-extending signaling 01:02:45–01:04:59 — Emerging peptides: Klotho proteins, myostatin inhibitors, and new delivery methods 01:05:00–01:12:01 — Analysis of extreme health tracking and avoiding performance anxiety in biohacking 01:12:02–01:17:22 — Upgrading sleep architecture: Blackout shades, Chilly Pad temperature control, and air filtration 01:17:23–01:20:06 — Sleep hours vs. sleep quality: Individualized sleep architecture 01:20:07–01:25:30 — Unmatched Longevity Sleep: Ingredient synergies and supporting natural sleep hygiene - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

Something significant just happened in the world of peptides. On July 23–24, the FDA’s Pharmacy Compounding Advisory Committee considered seven widely discussed peptides and voted in favor of six: BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax, while rejecting DSIP (emideltide). But these votes are widely misunderstood. In this Energy Code Deep Dive, Dr. Mike Belkowski breaks down what the committee actually voted on, why a YES vote is not FDA drug approval, and the debate that divided the committee: should promising but under-studied peptides remain largely in the gray market, or could regulated pharmacy compounding provide a safer path? We explore the harm-reduction argument behind the YES votes, the FDA scientists’ objections, concerns surrounding human evidence, product consistency and immunogenicity, why DSIP failed to clear the bar, and what happens next. This isn't the finish line for peptides. But it could represent a major turning point in how peptide medicine is researched, regulated, and ultimately accessed. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: “Six of the seven (peptides) got a thumbs up. One got rejected.” “A yes vote didn't mean the FDA is declaring the peptide safe and effective.” “The yes side is saying, ‘Meet people where they are and add safety guardrails.’” “The no side says, ‘Thin evidence is thin evidence, and a regulatory blessing shouldn't get ahead of the science.’” “The single best thing that could come out of this moment is that the mainstreaming of peptides drives real rigorous clinical research.” - Key Points ⚡ An FDA advisory committee voted favorably on 6 of 7 peptides considered for the 503A compounding pathway. ⚡ BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax received favorable recommendations; DSIP did not. ⚡ These votes do not constitute FDA drug approval and are non-binding recommendations. ⚡ One of the strongest arguments for inclusion was harm reduction: moving peptide use away from unregulated gray-market sources and toward clinicians and licensed pharmacies. ⚡ FDA scientists opposed inclusion, citing limited human evidence, product-characterization issues, immunogenicity concerns, and the possibility of creating false perceptions of FDA endorsement. ⚡ The BPC-157 vote was particularly close: 8–6 with one abstention. ⚡ DSIP was rejected amid especially limited evidence and questions surrounding the proposed route of administration. ⚡ The composition of the advisory committee and potential industry conflicts became another source of controversy. ⚡ Even if ultimately permitted for compounding, these products would remain fundamentally different from FDA-approved drugs. ⚡ The larger opportunity may be increased legitimacy driving better human clinical research into peptides. - Episode timeline 00:00 — A major moment for peptide medicine Why the July FDA advisory committee meeting deserves attention. 01:28 — What the FDA actually voted on The crucial difference between FDA drug approval and inclusion on the compounding bulks list. 04:20 — Nothing changed overnight Why the committee's recommendations are non-binding and what happens next. 04:55 — Peptides 101 & the gray-market problem Why peptide popularity has outpaced human clinical evidence and regulation. 06:27 — The final tally: 6 YES, 1 NO BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax versus DSIP. 08:12 — Breaking down the six peptides What each peptide is commonly associated with and why they're attracting attention. 10:05 — Why the YES side won The central harm-reduction argument: people are already using peptides, so would regulated access be safer? 12:17 — Why FDA scientists opposed all seven Human evidence, consistency, immunogenicity and the danger of perceived regulatory endorsement. 15:15 — Why DSIP failed What the committee's lone rejection reveals about its evidentiary threshold. 16:45 — Politics & conflicts of interest The political environment surrounding the meeting and questions about the panel's composition. 18:52 — What this means for consumers right now Why these votes do not suddenly make the peptides FDA-approved or broadly legal. 20:39 — A legitimacy inflection point Why peptide medicine may be transitioning from a fringe conversation toward the mainstream. 21:15 — The research opportunity Why regulatory momentum still cannot substitute for rigorous human clinical trials. 22:19 — Final takeaways Why this is the beginning of the peptide conversation—not the finish line. - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

What happens when one of the world's leading experts in Ayurveda sits down with one of the leading voices in mitochondrial health? In this episode of The Energy Code, Dr. Mike Belkowski welcomes Dr. John Douillard for a wide-ranging conversation connecting ancient Ayurvedic medicine with modern physiology, mitochondria, circadian biology, digestion, lymphatic health, breathing, seasonal nutrition, and longevity. Dr. Douillard explains why digestion may be one of the true foundations of health, how the diaphragm powers the body's lymphatic system, why modern lifestyles disconnect us from natural biological rhythms, and why whole foods often outperform isolated compounds. Together they explore the science behind seasonal eating, breathing techniques, microbiome diversity, infrared light, melatonin, circadian medicine, and how aligning with nature may optimize energy production at the cellular level. Whether you're interested in mitochondria, performance, longevity, nutrition, or foundational health, this conversation bridges thousands of years of traditional wisdom with emerging scientific research. (Educational content only, not medical advice.) Articles & Books Discussed in Episode: Books by Dr. John Douillard: Eat Wheat, The 3-Season Diet, and Body, Mind, and Sport Research & References: Stanford Mummy Microbiome Diversity Study, International Journal of Neuroscience Nose-Breathing Study, Breath by James Nestor Key Quotes From Dr. John Douillard: “Rasa is the word for lymph. The study of the lymphatic system for Ayurveda was the study of longevity.” “If you can’t get the trash out of this body, you’re not going to be able to get the good stuff in.” “80% of your immune response is linked to these foods that create an immune response. If you bubblewrap your diet, you don't have a reason for gut immunity.” “When you add the plant and its natural microbiome, there’s nothing more potent than that, because it has the intelligence along with the biochemistry.” “The bigger the calm you have on the inside, the more powerful the winds you have on the outside.” “Melatonin is a 3-billion-year-old molecule. It isn’t a hormone... It tells your body when nighttime and winter are coming.” - Follow & Learn From Dr. John Douillard   Social Media:InstagramFacebookTikTokLinkedInXYouTube Website & Other:LifeSpa.com Newsletter Sign Uphttps://lifespa.com/appearances/  - Key Points ⚡ Dr. John Douillard shares his origin story from competitive triathlon training to studying ancient Ayurvedic medicine at a hospital in India. ⚡ In Ayurveda, Rasayana (longevity) is fundamentally tied to the study and health of the lymphatic system. ⚡ The lymphatic system handles waste removal, immune cell transportation, and baseline delivery of dietary fatty acid precursors for hormone production. ⚡ The diaphragm is the primary mechanical pump for both the body's lymphatics and the brain’s glymphatic waste-clearance system. ⚡ Studies reveal that 91% of elite athletes tested do not possess fully contracting and relaxing diaphragms due to chronic stress patterns. ⚡ Incompletely digested proteins and fats escape into the intestinal lymphatic collecting ducts, triggering systemic inflammation, brain fog, and skin eruptions. ⚡ "Bubble-wrapping" the diet by completely eliminating slightly irritating foods (like gluten, lectins, or nightshades) starves the gut of the hormetic irritation required for robust gut immunity. ⚡ Long-term continuous ketogenic diets bypass seasonal evolutionary biological cues, whereas seasonal fat-burning aligns with natural spring scarcity. ⚡ Dr. John demonstrates a step-by-step Maximum Inspiratory Breathing technique to break up rib cage scar tissue and reactivate full diaphragmatic movement. ⚡ Five key spices—ginger, cumin, coriander, fennel, and cardamom—naturally stimulate stomach acid, bile flow, pancreatic enzymes, and healthy gut microbes. ⚡ Cooking meat and foods with whole spices mitigates the free radical damage and carcinogenic compounds produced by high heat. ⚡ Whole turmeric root outperforms isolated curcumin extracts because isolated extracts can block stem cell production, whereas the full plant supports it. ⚡ Early morning sunlight exposures balance daytime and nighttime biological clocks while fueling mitochondrial cytochrome c oxidase and ATP production. ⚡ Front-loading food intake into breakfast and lunch matches human biological digestive clocks better than eating large late-night dinners. ⚡ Only 10% of total body melatonin originates in the pineal gland for sleep; 90% is produced within cellular mitochondria via infrared light exposure to neutralize metabolic free radicals. ⚡ DNA releases ultra-weak biophoton emissions that become coherent during calm, meditative states, carrying cellular information and systemic intention. ⚡ Microdosing melatonin supports cellular waste cleanup without suppressing the body's natural endogenous production. ⚡ Pushing energy production (e.g., via high-dose NAD+ precursors) without first clearing cellular trash and supporting lymphatic drainage can exacerbate systemic stress. ⚡ Nasal breathing during physical exertion shifts the brain into a calm alpha state, permitting parasympathetic recovery to coexist alongside high physical output. Episode Timeline 00:00–02:14 — Introduction: Dr. John Douillard's background in sports medicine, Ayurveda, and chiropractic care 02:15–06:50 — Origin story: Ironman triathlons, meditation retreats, and studying medicine in India 06:51–09:33 — Longevity and Rasayana: The vital role of the lymphatic system 09:34–13:50 — Diaphragm as the lymph pump, brain waste clearance, and systemic consequences of poor digestion 13:51–18:42 — The "bubble-wrapped diet" trap vs. seasonal eating and circadian alignment 18:43–21:11 — BioLight sponsorship spot 21:12–25:22 — Diaphragmatic weakness, chronic stress, and restoring digestive strength 25:23–28:37 — Live Demonstration: Maximum Inspiratory Breathing technique 28:38–32:10 — The 5 digestive spices that reboot stomach acid and protect against cooking toxins 32:11–36:35 — Plant micro-intelligence vs. sterile extracts, and soil microbiome changes across 3 seasons 36:36–41:00 — Fixing the root cause of digestion instead of blaming food 41:01–45:06 — Ayurvedic seasonal grocery lists (Vata, Pitta, Kapha balancing) 45:07–48:40 — Whole turmeric root vs. isolated curcumin extracts 48:41–53:29 — Circadian light habits, morning UV/infrared rays, and meal timing 53:30–57:10 — Seasonal sleep dynamics, activity cycles, and ancient alignment 57:11–01:05:14 — Quantum Ayurveda: Biophoton light emissions, sub-cellular melatonin, and creating inner stillness 01:05:15–01:13:38 — Mitochondrial waste removal, microdosing melatonin, and systemic anti-inflammation 01:13:39–01:16:58 — Practical lymphatic hacks: Exfoliation, static electricity, hydration, and movement 01:16:59–01:25:28 — Coaching the NBA's New Jersey Nets: Nasal breathing research vs. mouth breathing in elite athletics 01:25:29–01:27:08 — Peptide therapy perspectives, regulation, and closing quick-fire thoughts - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

In this Deep Dive, Dr. Mike Belkowski examines two new studies exploring transcranial photobiomodulation from completely different angles: protecting collegiate football players from the cumulative effects of repetitive head impacts and improving impulse control in adults with ADHD. The first study followed Division I football players across a full season and found that athletes using 810-nanometer transcranial and intranasal light maintained greater stability in MRI markers associated with neuroinflammation and axonal stress. The second study used 1,064-nanometer light over the right prefrontal cortex and reported improved impulse control, increased prefrontal oxygenation, and a 51% improvement in correct response inhibition among participants with ADHD after a single session. Although both studies are early and carry important limitations, they point toward the same underlying principle: brain health, resilience, and cognitive performance are deeply dependent on bioenergetics. Whether the goal is protecting the brain from repeated trauma or improving executive function, supporting mitochondrial energy production, oxygenation, and inflammatory balance may be the common lever. (Educational content only, not medical advice.) - Articles Discussed in Episode: Transcranial Photobiomodulation Promotes Neurological Resilience in Current Collegiate American Football Players Exposed to Repetitive Head Acceleration Events Transcranial photobiomodulation improves prefrontal oxygenation and impulse control in adults with ADHD: a randomized controlled trial - Key Quotes From Dr. Mike: “So much of brain health traces back to whether cells and mitochondria can make and utilize energy efficiently. “For every diagnosed concussion, hundreds of additional head-acceleration events may be occurring.” “Can we build resilience into the brain (via red light therapy) before the symptoms ever show up?” “The (near-infrared) light appeared to help precisely in the areas that needed it most.” “That improvement brought the ADHD group’s performance up to a level comparable with the non-ADHD participants.” “A brain with more energy and better oxygen delivery is both more resilient to insult and more capable of performing.” “Whether the goal is resilience or focus, the same lever keeps showing up: energy production, oxygenation, and inflammation control.” - Key Points ⚡ Two new studies examined transcranial photobiomodulation for two very different goals: neuroprotection in football players and cognitive enhancement in adults with ADHD. ⚡ The common mechanism connecting both studies is brain bioenergetics—how efficiently brain cells produce and use energy. ⚡ Red and near-infrared light interact with mitochondrial cytochrome c oxidase, supporting ATP production, oxygen utilization, blood flow, and cellular repair. ⚡ The football study evaluated whether near-infrared light could proactively build neurological resilience across a season of repetitive head impacts. ⚡ For every diagnosed concussion, football players may experience hundreds of additional subconcussive head-acceleration events. ⚡ These repetitive impacts may contribute to neuroinflammation, reduced white-matter integrity, altered brain activation, and cognitive decline. ⚡ The football study included 26 Division I athletes in a randomized, double-blind, sham-controlled design. ⚡ The active protocol used 810-nanometer light pulsed at 40 hertz for 20 minutes, three times weekly across a 16-week season. ⚡ The device targeted nodes of the default mode network and included an intranasal LED for deeper light delivery. ⚡ Diffusion MRI markers associated with neuroinflammation and axonal stress increased across the season in the sham group. ⚡ Players receiving active PBM showed greater stability in those markers and, in some brain regions, measurable reductions. ⚡ The areas showing the strongest protective effects closely matched the brain’s known “cone of vulnerability” to mechanical trauma. ⚡ The football study suggests PBM may help build resilience before cumulative damage becomes symptomatic. ⚡ The ADHD study explored whether near-infrared light could improve function in an underactivated and metabolically underfueled prefrontal cortex. ⚡ The study used 1,064-nanometer laser light over the right prefrontal cortex during a single eight-minute treatment. ⚡ In participants with ADHD, active PBM produced a 51% improvement in correct response inhibition compared with sham treatment. ⚡ Performance improved to a level comparable with participants who did not have ADHD. ⚡ The intervention did not significantly improve performance in the non-ADHD group, suggesting the greatest benefit may occur where a functional deficit exists. ⚡ Functional near-infrared spectroscopy showed increased oxygenated and total hemoglobin in the targeted prefrontal region. ⚡ The behavioral improvements and the biological oxygenation changes occurred in the same targeted area. ⚡ Both studies were early, with small to moderate samples, short timelines, and important methodological limitations. ⚡ The evidence is promising, but larger studies, repeated-session protocols, longer follow-up, and multi-season data are still needed. ⚡ Neuroprotection and cognitive enhancement may be two expressions of the same principle: a better-fueled brain is both more resilient and more capable. - Episode timeline 00:00–02:30 — Introduction: two different brain problems, one underlying bioenergetic mechanism 02:32–04:37 — How photobiomodulation affects cytochrome c oxidase, ATP, oxygenation, blood flow, oxidative stress, and inflammation 04:38–06:55 — Study 1 introduction: repetitive head impacts and the need for proactive brain protection in football 06:56–08:35 — Football study design: randomized sham control, 810-nanometer light, 40-hertz pulsing, transcranial and intranasal delivery 08:36–10:09 — Measuring neurological resilience with diffusion MRI, RDI, QA, inflammation, and white-matter integrity 10:10–11:12 — Football study results: rising damage markers in the sham group and relative stability in the active PBM group 11:13–12:11 — The “cone of vulnerability” and why the anatomical pattern of protection matters 12:12–14:00 — Study limitations and why the findings represent an early signal rather than a closed case 14:01–16:55 — Study 2 introduction: adult ADHD, prefrontal hypometabolism, impulse control, and the need for non-drug options 16:56–18:31 — ADHD study stage 1: 1,064-nanometer light, right prefrontal targeting, and the continuous performance task 18:32–19:17 — ADHD study stage 2: working memory testing and real-time measurement of prefrontal oxygenation 19:18–20:30 — Behavioral results: 51% improvement in impulse control after one eight-minute session 20:31–21:47 — Mechanistic results: increased oxygenated blood in the targeted prefrontal cortex 21:48–22:38 — ADHD study limitations, exploratory medication findings, and the need for repeated-session trials 22:39–24:53 — Two populations, two wavelengths, two goals—and the shared mechanism of brain energy 24:54–26:21 — Final takeaways: stronger study designs, calibrated expectations, and brain bioenergetics as the foundation 26:22–27:08 — Closing message and future research to watch - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

In this foundational episode of The Energy Code, Dr. Mike Belkowski challenges the conventional multivitamin and introduces Vitamin M, BioLight’s most advanced mitochondrial supplement to date. Traditional multivitamins were designed to prevent deficiency diseases — not to optimize energy, cognition, resilience, or longevity. Dr. Mike explains why many formulas rely on inexpensive nutrient forms, token doses, competing ingredients, and labels with no unifying biological purpose. Vitamin M takes the opposite approach, beginning with one central question: What does a mitochondrion actually need to produce energy and remain resilient? The episode walks through the formula ingredient by ingredient, organizing Vitamin M into four coordinated systems: replenishing NAD and cellular energy currency, supplying the cofactors required to produce ATP, reinforcing antioxidant defenses, and supporting methylation, DNA repair, and homocysteine management. Featuring NMN, niacinamide, ubiquinol, active B vitamins, alpha-lipoic acid, taurine, glycine, trace minerals, TMG, and folinic acid, Vitamin M is designed to support sustained cellular energy without caffeine or stimulants. This is not another kitchen-sink multivitamin — it is a coordinated mitochondrial system built from the ground up. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: “Americans spend somewhere north of eight billion dollars a year on multivitamins.” “Calling these multivitamins expensive urine might actually be too generous.” “You are only as young as your mitochondria.” "Mitochondrial health isn't another wellness trend — it's the foundation beneath every wellness trend." “What does a mitochondrion actually need to make energy and stay resilient? Vitamin M starts with a single question and works backward to the ingredients, forms, and doses.” "Every ingredient should have a job. Every job should support the same mission." "Every ingredient in Vitamin M was selected because the mitochondria actually need it — not because the label needed it." "Mitochondrial health isn't another wellness trend—it's the foundation beneath every wellness trend." - Key Points ⚡ Conventional multivitamins were created to prevent deficiency diseases such as scurvy, beriberi, pellagra, and rickets—not to optimize energy or longevity. ⚡ Recommended daily allowances represent minimum deficiency-prevention levels, not necessarily optimal amounts for cellular performance. ⚡ Many traditional multivitamins use inexpensive or inactive forms that the body must convert before they can be utilized. ⚡ Common examples include folic acid instead of bioactive folate, cyanocobalamin instead of active B12, and poorly absorbed mineral oxides. ⚡ Kitchen-sink formulas often contain dozens of ingredients at doses too small to produce meaningful biochemical effects. ⚡ Certain nutrients may also compete for absorption when packed together without an intentional design. ⚡ The central problem with most multivitamins is that they lack a biological thesis or clearly defined system they are built to support. ⚡ Physical energy is fundamentally ATP, and approximately 90–95% of ATP is produced by the mitochondria. ⚡ Mitochondria also regulate hormones, calcium signaling, cellular cleanup, heat production, redox signaling, and programmed cell death. ⚡ Caffeine does not create energy; it temporarily blocks the brain’s perception of fatigue. ⚡ Vitamin M is stimulant-free and is designed to support the machinery that actually produces cellular energy. ⚡ The formula addresses four age-related mitochondrial challenges: declining NAD, inefficient electron transport, weakened mitochondrial quality control, and disrupted methylation. ⚡ Team 1 supports cellular energy currency with NMN and niacinamide to replenish and recycle NAD. ⚡ Team 2 supports ATP production with ubiquinol, active riboflavin, thiamine, pantothenic acid, and mitochondrial adenosylcobalamin. ⚡ Ubiquinol acts both as an electron carrier in the respiratory chain and as a membrane-protective antioxidant. ⚡ Riboflavin supports FAD and FMN, molecules physically required by complexes I and II of the electron transport chain. ⚡ Thiamine helps convert pyruvate into acetyl-CoA, allowing carbohydrate-derived fuel to enter the Krebs cycle. ⚡ Pantothenic acid is required to produce coenzyme A, the carrier that transports fuel from carbohydrates, fats, and proteins. ⚡ Adenosylcobalamin is the mitochondrial form of B12 and helps additional fats and amino acids enter cellular energy pathways. ⚡ Team 3 protects the mitochondrial machinery with alpha-lipoic acid, taurine, glycine, selenium, manganese, and copper. ⚡ Alpha-lipoic acid helps regenerate other antioxidants while also supporting critical Krebs-cycle enzymes. ⚡ Taurine supports mitochondrial membranes, electron-transport proteins, cellular resilience, and healthy aging pathways. ⚡ Glycine supplies a frequently limiting building block for glutathione, the body’s master endogenous antioxidant. ⚡ Selenium, manganese, and copper are required for antioxidant enzymes and mitochondrial respiratory function. ⚡ Team 4 supports methylation and cellular maintenance with TMG, folinic acid, P5P, B12, and glycine. ⚡ Supporting NAD increases methylation demand, so Vitamin M intentionally includes methyl donors and cofactors to replenish that system. ⚡ The formula uses bioavailable forms — including ubiquinol, folinic acid, P5P, adenosylcobalamin, and chelated minerals — rather than inexpensive precursors. ⚡ Vitamin M is designed as two capsules twice daily to provide smoother availability throughout the day. ⚡ Vitamin M pairs naturally with urolithin A for mitophagy and with red light therapy for complementary internal and external mitochondrial support. - Episode timeline 00:00–02:25 — Introduction to the launch of Vitamin M and why mitochondrial wellness is foundational to health and longevity 02:27–04:10 — The multivitamin paradox: billions spent annually with underwhelming long-term results 04:11–06:25 — Why multivitamins were created to prevent deficiency diseases—not to optimize vitality, cognition, or aging 06:26–07:34 — The “expensive urine” problem and why wasted nutrients are only part of the issue 07:35–08:56 — Failure 1: Cheap, inactive, or poorly absorbed nutrient forms 08:57–09:37 — Failure 2: Kitchen-sink formulas with token doses and competing nutrients 09:38–10:50 — Failure 3: No biological thesis, target, blueprint, or coordinated system 10:51–13:49 — Why the mitochondria are the correct target for energy, resilience, signaling, and longevity 13:51–15:32 — Caffeine is a loan; ATP is income: stimulation versus genuine cellular energy production 15:33–16:39 — What declines with age: NAD, electron-transport efficiency, mitochondrial cleanup, and methylation 16:40–18:21 — Introduction to Vitamin M and its four coordinated ingredient teams 18:22–21:30 — Team 1: NMN, NAD production, sirtuins, DNA repair, insulin sensitivity, and cellular energy currency 21:32–23:17 — Niacinamide and the NAD salvage pathway: recycling the energy currency already spent 23:19–26:35 — Team 2 begins: ubiquinol, electron transfer, ATP synthase, membrane protection, and CoQ10 biology 26:36–28:01 — Active vitamin B2, FAD, FMN, complexes I and II, and glutathione regeneration 28:03–29:13 — Vitamin B1 as the gateway that allows carbohydrate fuel to enter the Krebs cycle 29:14–30:18 — Vitamin B5 and coenzyme A as the universal fuel-delivery system 30:18–31:29 — Adenosylcobalamin: the mitochondrial form of B12 and expanded fuel utilization 31:31–34:01 — Team 3 begins: oxidative stress, alpha-lipoic acid, antioxidant recycling, and Krebs-cycle support 34:02–35:59 — Taurine, mitochondrial stability, healthy aging, exercise, and cellular resilience 36:01–37:29 — Glycine, glutathione production, oxidative stress, sleep, collagen, and aging 37:31–39:19 — Selenium, manganese, copper, antioxidant enzymes, complex IV, and chelated mineral forms 39:21–41:09 — Team 4: methylation, gene regulation, neurotransmitters, homocysteine, and increased demand from NAD support 41:10–42:00 — TMG as a methyl donor and its role in SAM-e and homocysteine metabolism 42:02–43:00 — Folinic acid, bioactive folate, DNA synthesis, repair, and the one-carbon cycle 43:01–44:23 — P5P, trans-sulfuration, neurotransmitters, glutathione, and the complete methylation system 44:25–47:09 — The full formula: four coordinated teams, synergy, bioavailable forms, and why Vitamin M differs from a conventional multivitamin 47:10–48:51 — Practical use, split dosing, stimulant-free energy, expected experience, and stacking with BioLithin 48:52–49:36 — Vitamin M and red light therapy: “light from the outside, fuel from the inside” 49:37–50:44 — Closing message: moving beyond deficiency prevention toward intentional mitochondrial optimization - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

In this Deep Dive, Dr. Mike Belkowski examines the darker side of the rapidly growing peptide movement: unregulated sourcing, research-use-only products, online dosing communities, peptide stacking, questionable testing, and the widening gap between consumer experimentation and medical oversight. The episode begins with a recent review exploring how the success of GLP-1 drugs helped normalize self-injection and created an “Ozempic halo” around experimental peptides. Dr. Mike breaks down the digital peptide exposure pathway, the legal fiction of research-use-only labels, the risks of informal titration, and why a certificate of analysis may not confirm sterility, endotoxin safety, potency, or the quality of the vial actually being used. The second half turns to the FDA Pharmacy Compounding Advisory Committee’s July 23–24 review of BPC-157, KPV, TB-500, MOTS-c, DSIP, Semax, and Epitalon for possible inclusion on the Section 503A Bulks List. Dr. Mike explains what the proceeding does — and does not — mean, the FDA staff’s preliminary opposition, and three possible outcomes: favorable inclusion, rejection, or a substance-by-substance split decision. Ultimately, the central question is not whether peptide experimentation will continue. It is whether it will occur through accountable medical systems that improve testing and surveillance — or move further into an anonymous gray market operating beyond meaningful oversight. (Educational content only, not medical advice.) - Article Discussed in Episode: Unregulated Peptide Use in the Age of Biohacking: Digital Promotion, Gray-Market Access, and Emerging Public Health Risks - Key Quotes From Dr. Mike: “(Peptides) are relatively safe in the right hands — but can you really trust the sourcing and the quality?” “A certificate of analysis may be a veneer of professional legitimacy that lacks depth.” “A high purity percentage does not necessarily tell you about endotoxins, sterility, degradation, or the specific vial in your refrigerator.” “This (upcoming FDA approval hearing) not an FDA approval hearing for these peptides.” “What it could mean is that certain peptides gain a pathway into a more regulated, clinician-directed compounding environment.” “The committee must navigate the uncomfortable space between promising but incomplete science and the responsibility to protect patients.” “A restrictive decision may reduce access through licensed pharmacies without eliminating consumer demand.” “The organizations most likely to follow the rules could leave the market, while the organizations least concerned with the rules remain.” “The committee’s recommendations may determine whether the next chapter takes place inside the healthcare system—or even deeper inside the shadows.” - Key Points ⚡ The success of semaglutide, tirzepatide, and other injectable drugs has helped normalize self-injection and increased public interest in experimental peptides. ⚡ The “Ozempic halo” can cause consumers to assume that the word peptide automatically implies legitimacy, sophistication, and safety. ⚡ Approved peptide drugs and unapproved research peptides do not share the same level of clinical evidence, manufacturing oversight, or safety validation. ⚡ Research-use-only and “not for human consumption” labels often function as legal disclaimers while consumers use the products for self-administration. ⚡ Reddit, Discord, forums, and social media communities frequently provide reconstitution, dosing, stacking, and titration instructions outside clinical supervision. ⚡ Stacking several active peptides makes it difficult to determine which compound caused a benefit, side effect, laboratory change, or delayed complication. ⚡ Subjective dose adjustments based on appetite, sleep, recovery, or appearance create an informal and poorly monitored experimentation system. ⚡ A certificate of analysis may confirm identity or purity in a tested sample without establishing sterility, endotoxin burden, stability, potency, or quality of every vial sold. ⚡ Gray-market risks include mislabeling, contamination, non-sterility, inconsistent potency, degradation, infections, abscesses, and unidentified impurities. ⚡ Many peptide users do not disclose their use to physicians, creating a major gap in clinical surveillance and adverse-event reporting. ⚡ The July FDA meeting is not an approval hearing for BPC-157, MOTS-c, or the other reviewed peptides. ⚡ The committee will consider whether seven peptide-related bulk substances should be placed on the Section 503A Bulks List for potential patient-specific compounding. ⚡ On July 23, the committee is scheduled to review BPC-157, KPV, TB-500, and MOTS-c for specific nominated indications. ⚡ On July 24, it is scheduled to review DSIP, Semax, and Epitalon for selected neurological or sleep-related indications. ⚡ The FDA’s evaluation is limited to the nominated indications, formulations, and routes — not every benefit promoted online. ⚡ FDA staff preliminarily recommended against including all seven substances, citing insufficient human evidence, safety uncertainties, immunogenicity, impurities, and characterization concerns. ⚡ A favorable recommendation could create a more accountable pathway involving clinicians, prescriptions, licensed pharmacies, registered ingredient sources, testing, and medical records. ⚡ Inclusion on the 503A list would not make a peptide FDA-approved or legalize direct-to-consumer research-vial sales. ⚡ A negative decision could restrict legitimate compounding without eliminating demand, potentially pushing consumers further toward offshore or anonymous vendors. ⚡ A split decision may be the most realistic outcome because peptide substances differ significantly in structure, pharmacology, manufacturing complexity, evidence, and risk. ⚡ Advisory committee recommendations are non-binding, and any practical regulatory changes may take months through rulemaking and public-comment processes. ⚡ The core policy challenge is not simply access versus safety — it is determining where peptide use will occur and whether it can be tracked. ⚡ Regulation must acknowledge uncertainty without treating incomplete evidence as either proof of safety or proof of danger. ⚡ The peptide marketplace is evolving faster than the traditional drug-development system can respond. ⚡ The final outcome may determine whether peptide experimentation moves toward the healthcare system or deeper into the shadows. - Episode timeline 00:00–02:44 — Introduction to the gray-market peptide review and the upcoming FDA compounding discussion 02:45–04:00 — The normalization of the needle and the rise of the digital peptide exposure pathway 04:00–05:55 — Takeaway 1: The “Ozempic halo” and how approved peptide drugs lend perceived legitimacy to experimental compounds 05:56–07:08 — Takeaway 2: Research-use-only labeling, online communities, DIY reconstitution, and the legal-disclaimer loophole 07:09–08:29 — Takeaway 3: Peptide stacking, informal titration, and the surveillance gap created by self-experimentation 08:30–10:19 — Takeaway 4: The false security of third-party testing and the limits of certificates of analysis 10:21–11:43 — Takeaway 5: Non-disclosure, physician blind spots, retatrutide hype, and failures in adverse-event surveillance 11:44–13:23 — Review conclusion: distinguishing legitimate peptide medicine from opaque online supply chains 13:24–15:17 — The FDA’s July 23–24 peptide discussion and what the Section 503A Bulks List actually means 15:18–16:19 — The seven substances and the specific indications scheduled for committee review 16:20–17:39 — Why the FDA’s narrow indication-based framing could shape the outcome 17:40–20:15 — FDA staff’s preliminary opposition and the major evidence, safety, impurity, and characterization concerns 20:17–23:21 — Outcome 1: Favorable recommendation and the possible shift toward supervised pharmacy compounding 23:22–26:12 — Outcome 2: Rejection, reduced pharmacy access, gray-market displacement, and the evidence-financing gap 26:13–27:54 — Outcome 3: A split decision based on each peptide, formulation, indication, and route of administration 27:56–30:17 — What the meeting will not change: non-binding recommendations, delayed rulemaking, no FDA approval, and no legalization of research vending 30:18–32:19 — Potential effects on the gray market and the regulatory asymmetry between compliant and noncompliant sellers 32:21–33:51 — Questions the committee should ask about purity, aggregation, endotoxins, sterility, routes, registries, and evidence collection 33:52–35:00 — Why peptide innovation is moving faster than conventional regulation and drug development 35:01–37:11 — Closing argument: the decision is ultimately about what kind of peptide marketplace society chooses to create - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

In this Peptides 101 episode of The Energy Code, Dr. Mike Belkowski explains why peptides belong in a mitochondria-centered conversation. Rather than treating peptides as a separate wellness trend, he frames them as one of the body’s primary communication systems — molecular messages that instruct cells, influence mitochondrial function, regulate repair, modulate inflammation, and help coordinate energy production, adaptation, and longevity. Dr. Mike walks through the basics of peptide structure, origin, function, receptor activity, and biological location, showing how peptides can be classified as natural or synthetic, linear or cyclic, hormonal or regulatory, GPCR-targeting or intracellular, and much more. The episode also explains why mitochondrial-derived peptides like MOTS-c, Humanin, and SHLPs are especially important for the future of mitochondrial medicine. Ultimately, this episode presents peptides as the molecular language of life itself: tiny chains of amino acids that may help medicine shift from overriding biology to collaborating with it. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: “Individual amino acids are like letters. Peptides are words. Proteins are complete sentences or even entire chapters.” “Peptides are the molecular language of life itself.” “You cannot fully understand peptides without understanding mitochondria, and you cannot fully optimize mitochondria without understanding peptides.” “Peptides influence every one of these (Six Pillars of Mitochondrial Wellness).” “Peptides don’t replace mitochondria, of course, but they instruct mitochondria.” “Aging itself, in one way, shape, or form, is really a communication problem.” “One of the most exciting aspects of peptide science is the possibility of restoring healthier cellular communication.” “Light and peptides are partners in cellular communication.” - Key Points ⚡ Peptides and mitochondria are not separate conversations; they are deeply connected through cellular communication, energy production, repair, and aging. ⚡ Mitochondria are environmental sensors that respond to hormones, nutrients, inflammation, stress, circadian signals, exercise, and gut-derived inputs. ⚡ Peptides are one of the primary languages through which cells communicate with mitochondria. ⚡ Peptides can influence all six pillars of mitochondrial wellness: ATP production, mitogenesis, mitophagy, dynamics, redox balance, and light-driven signaling. ⚡ Hormonal peptides such as insulin, GLP-1, GIP, and glucagon regulate nutrient entry into cells and influence oxidative phosphorylation. ⚡ Mitochondrial-derived peptides such as MOTS-c can support metabolic flexibility, insulin sensitivity, and cellular stress adaptation. ⚡ Some peptide pathways help activate PGC-1α, the master regulator of mitochondrial biogenesis. ⚡ Peptide signaling can support mitophagy by helping cells recycle damaged mitochondria before they become dysfunctional. ⚡ Peptides can indirectly regulate mitochondrial fusion and fission through cellular stress-response networks. ⚡ Glutathione is technically a peptide and plays a major role in redox balance and antioxidant defense. ⚡ Red and near-infrared light can influence peptide production, growth factors, inflammatory mediators, and cellular repair pathways. ⚡ Aging can be viewed not only as accumulated damage, but also as a breakdown in cellular communication. ⚡ Mitochondrial-derived peptides show that mitochondria do not merely receive peptide signals — they also produce their own. ⚡ Humanin, MOTS-c, and SHLPs are mitochondrial-derived peptides that influence metabolism, inflammation, insulin sensitivity, stress resistance, and longevity. ⚡ Peptides are short chains of amino acids linked together by peptide bonds. ⚡ Amino acids are like letters, peptides are like words, and proteins are like sentences or chapters. ⚡ Natural peptides are produced by the body and are often short-lived because the body rapidly breaks them down after they deliver their message. ⚡ Synthetic peptides may copy or modify natural peptides to improve stability, receptor specificity, half-life, and dosing convenience. ⚡ Peptides can be structurally classified as linear, cyclic, branched, or stapled. ⚡ Functionally, peptides can be classified as hormonal, regulatory, structural, signaling, or enzymatic. ⚡ Receptor-based classifications include GPCR-targeting peptides, tyrosine kinase receptor peptides, cytokine receptor peptides, ion channel-modulating peptides, and peptides that indirectly influence nuclear gene expression. ⚡ Biologically, peptides can act in endocrine, paracrine, autocrine, neurocrine, or intracellular ways. ⚡ Peptide science has exploded because of advances in synthesis, chemical engineering, AI drug discovery, receptor biology, delivery systems, and mitochondrial signaling research. ⚡ The future of medicine may be less about stronger drugs and more about smarter biological signals. - Episode timeline 00:00–01:08 — Introduction to the Peptides 101 episode and why The Energy Code is dedicating time to peptide basics 01:09–02:57 — Why peptides belong in a mitochondria-centered conversation and why peptides and mitochondria are part of the same biological story 02:58–04:44 — Mitochondria as environmental sensors and peptides as one of the body’s primary communication languages 04:46–06:28 — The six pillars of mitochondrial wellness and how peptides influence each one 06:29–07:18 — ATP production and mitogenesis: insulin, GLP-1, GIP, glucagon, MOTS-c, AMPK, and PGC-1α 07:19–08:24 — Mitophagy and mitochondrial dynamics: peptide signaling, quality control, fusion, fission, and mitochondrial network health 08:25–10:04 — Redox balance and light: glutathione as a peptide, ROS regulation, PBM signaling, and light-peptide communication 10:05–11:41 — Aging as a communication problem and peptides as central players in restoring cellular signaling 11:42–14:03 — Mitochondrial-derived peptides: Humanin, MOTS-c, SHLPs, and mitochondria as endocrine-like signaling organelles 14:05–16:28 — Medicine shifting from chemistry to communication and why mitochondria and peptides must be understood together 16:30–18:47 — Peptide architecture: amino acids, peptide bonds, oligopeptides, polypeptides, proteins, and the “language of biology” analogy 18:48–19:28 — Peptides as biological managers that tell cells what to do 19:29–22:52 — Classification by origin: natural/endogenous peptides versus synthetic peptides and modern peptide engineering 22:55–24:37 — Structural classification: linear, cyclic, branched, and stapled peptides 24:37–28:42 — Functional classification: hormonal, regulatory, structural, signaling, and enzymatic peptides 28:43–33:33 — Classification by receptor: GPCRs, tyrosine kinase receptors, cytokine receptors, ion channel-modulating peptides, and nuclear gene-expression effects 33:35–34:35 — Classification by biological location: endocrine, paracrine, autocrine, neurocrine, and intracellular peptides 34:36–36:09 — Why peptide science has exploded: synthesis, engineering, AI, delivery technologies, receptor biology, and mitochondrial research 36:11–37:24 — Closing thoughts: peptides as the molecular language of life and the future of smarter biological signaling 37:25–37:58 — Final message: upcoming peptide deep dives and mitochondrial medicine - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

In this Deep Dive, Dr. Mike Belkowski explores the rapidly expanding world of therapeutic peptides and why these highly specific signaling molecules may represent one of the most important frontiers in modern medicine. Drawing from a 2026 review in the International Journal of Molecular Sciences, the episode explains how peptides function as the body’s “biological software,” delivering precise molecular instructions that influence metabolism, tissue repair, inflammation, collagen production, cognitive function, mitochondrial health, and cellular resilience. Dr. Mike breaks down major peptide categories, including GLP-1 agonists such as semaglutide, tirzepatide, and retatrutide; regenerative peptides such as BPC-157 and TB-500; growth hormone secretagogues; GHK-Cu; Semax, Selank, and DSIP; mitochondrial peptides such as MOTS-c, Humanin, SHLP-2, and SS-31; and topical aesthetic peptides including Argireline and Matrixyl 3000. The episode also addresses the critical distinction between FDA-approved therapies and investigational compounds, emphasizing that peptide enthusiasm must be balanced with clinical evidence, product quality, regulatory awareness, and appropriate medical supervision. The emerging vision is not simply better drugs, but a future of personalized biological programming that works with the body’s own molecular language. (Educational content only, not medical advice.) - Article Discussed in Episode: Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives - Key Quotes From Dr. Mike: “Each peptide binds to highly specific receptors like a key fitting into a lock.” “Peptide medicine represents a shift toward restoring biological communication before irreversible dysfunction occurs." "Unlike traditional stimulants or sedatives, (Semax & Selank) aim to optimize normal brain function without producing significant sedation or overstimulation.” “One of the newest frontiers in peptide science targets the very engines that power every cell — the mitochondria.” “Enthusiasm should always be balanced with scientific rigor, product quality, and appropriate medical supervision.” “The real revolution isn’t simply that we can create new peptides. It’s that we’re beginning to understand and speak the molecular language that has guided human biology for millions of years.” - Key Points Key Points ⚡ Peptides are short chains of amino acids that primarily function as highly specific biological signaling molecules. ⚡ Peptides can be thought of as the body’s “biological software,” delivering instructions that regulate repair, metabolism, inflammation, collagen production, mitochondrial function, and cellular survival. ⚡ Unlike many conventional drugs, therapeutic peptides often mimic or amplify signaling pathways that already exist naturally within the body. ⚡ Peptide medicine represents a shift from suppressing symptoms toward restoring healthier biological communication. ⚡ GLP-1 receptor agonists such as Semaglutide transformed obesity treatment by improving satiety, glucose regulation, insulin sensitivity, and caloric control. ⚡ Tirzepatide activates both GLP-1 and GIP receptors, while Retatrutide adds glucagon-receptor activation as a triple agonist. ⚡ Early Retatrutide trials produced average weight reductions exceeding 22% after approximately one year. ⚡ Metabolic peptides may eventually influence cardiovascular disease, fatty liver disease, kidney health, inflammation, and neurodegenerative processes — not merely weight loss. ⚡ Regenerative peptides such as BPC-157 and TB-500 are being investigated for tissue repair, angiogenesis, wound healing, muscle recovery, and inflammation modulation. ⚡ Growth hormone secretagogues such as Tesamorelin, Ipamorelin, and CJC-1295 stimulate the body’s own pulsatile growth hormone release. ⚡ GHK-Cu may influence thousands of genes related to collagen production, wound repair, antioxidant defense, inflammation, and extracellular matrix remodeling. ⚡ Semax and Selank are being studied for cognition, stress resilience, neuroprotection, neurotransmitter balance, and anxiety-related effects. ⚡ DSIP remains under investigation for its potential role in sleep quality and recovery. ⚡ Mitochondrial-derived peptides such as MOTS-c, Humanin, and SHLP-2 help coordinate cellular responses to metabolic stress. ⚡ SS-31 targets cardiolipin in the inner mitochondrial membrane, helping stabilize mitochondrial structure and support electron transport and ATP production. ⚡ Topical peptides such as Argireline and Matrixyl 3000 demonstrate that peptide signaling can also support healthy skin aging. ⚡ Some peptides have extensive clinical evidence and FDA approval, while many popular biohacking peptides remain investigational. ⚡ Long-term safety, optimal dosing, purity, manufacturing quality, and regulatory status vary widely between peptide therapies. ⚡ Competitive athletes must consider WADA restrictions because many performance-related peptides are prohibited. ⚡ The future of peptide medicine may include tissue-specific therapies, mitochondrial-targeted compounds, and AI-designed peptide sequences. ⚡ Peptides are not miracle cures; they are powerful biological messengers that may help medicine work with human physiology rather than against it. - Episode timeline 00:00–01:10 — Introduction to the 2026 therapeutic-peptide review and the accelerating interest in peptide medicine 01:12–03:21 — Dr. Mike’s personal interest in peptides, their relationship to mitochondrial health, and upcoming peptide master classes 03:22–04:18 — The molecular messenger revolution: how peptides moved from background therapies to precision medicine and longevity science 04:20–05:47 — What peptides are and why they function like the body’s biological software 05:49–06:57 — Why peptide medicine may shift healthcare from symptom suppression toward healthier physiological programming 06:59–09:50 — Metabolic peptides: semaglutide, tirzepatide, retatrutide, triple agonism, weight loss, and whole-body metabolic signaling 09:52–11:58 — Regenerative medicine: BPC-157, TB-500, tissue repair, angiogenesis, inflammation, and growth hormone secretagogues 11:59–13:26 — GHK-Cu and the biology of aging: collagen, elastin, wound healing, gene expression, and regenerative potential 13:28–15:12 — Brain health and cognitive performance: Semax, Selank, DSIP, BDNF, GABA signaling, and neuroprotection 15:15–16:59 — The mitochondrial revolution: MOTS-c, Humanin, SHLP peptides, SS-31, cardiolipin, and cellular energy restoration 17:00–18:01 — Peptides in aesthetic medicine: Argireline, Matrixyl 3000, wrinkle reduction, collagen, and skin elasticity 18:03–19:20 — The safety question: FDA approval, investigational use, long-term evidence, product quality, supervision, and anti-doping rules 19:22–20:31 — The future of precision medicine: tissue-specific peptides, mitochondrial targeting, and AI-designed sequences 20:32–22:34 — Final synthesis: peptides as powerful molecular messengers — not miracle cures — and their role in the future of The Energy Code - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

Dr. Mike unveils BioShilajit — a “trio stack” built for mitochondrial performance: shilajit for ionic minerals + fulvic/humic support, PQQ to signal mitochondrial biogenesis (PGC-1α), and pharmaceutical-grade methylene blue as a low-dose electron-cycling “failsafe” for the respiratory chain. Along the way, he breaks down why chronic fatigue and brain fog often evade standard labs, walks through the origin story and chemistry of shilajit, highlights ATP and endurance data, explains PQQ’s unique role in building new “cellular engines,” and tells the bizarre history of methylene blue — from textile dye to essential emergency medicine — before tying it all together as structure + supply + backup mechanics for cellular energy. He closes with launch details, the first-week discount code, and where to find the full resource library on the BioLight product page. (Educational content only, not medical advice.) - Article Discussed in Episode: Fullerenes as Anti-Aging Antioxidants - Key Quotes From Dr. Mike: Regarding BioShilajit: "A mountain resin, a bacterium, and a clothing dye… sounds like quite the trio.” “Shilajit roughly translates to: the conqueror of mountains and destroyer of weakness.” “Shilajit contains over 85 distinct trace minerals — and the key word is bioavailable.” “Shilajit is the pharmacological opposite of a stimulant — it doesn’t tape over the check-engine light; it helps the cell produce more of its own ATP.” “A microscopic picomolar concentration of PQQ can execute thousands — sometimes tens of thousands — of redox cycles without breaking down.” “PQQ triggers this exact same genetic alarm bell (PGC-1α -> mitogenesis) — but without the ten-mile run.” “Inside damaged mitochondria, methylene blue’s mechanism is bypassing the blockade (blockages in the ETC).” - Key Points Two BioLight events + one roadmap: Beyond Conference (Austin, May 27–29), Return to Nature (Franklin, June 11–12), and a tentative A4M plan (December). Core thesis: chronic fatigue/brain fog often reflects micro-level mitochondrial “power grid” failure, not a single broken marker on standard labs. BioShilajit = “unlikely trio”: shilajit + PQQ + methylene blue designed as a closed-loop energy system. Shilajit basics: paleo-humus resin rich in fulvic/humic acids, DBP-like compounds, and ionic trace minerals for high absorption. ATP angle: shilajit framed as ATP preservation + ETC enzyme protection under stress (mouse forced-swim model described). Stimulant vs metabolic: shilajit positioned as the opposite of “masking fatigue” (caffeine analogy). PQQ: framed as a catalytic redox molecule tied to mitochondrial biogenesis via PGC-1α / CREB signaling. Methylene blue: framed as a low-dose electron cycler that can bypass bottlenecks in the ETC, especially relevant to brain energy. Safety/precision: strong emphasis on dose hormesis + USP pharmaceutical grade only (avoid aquarium/industrial impurities). - Episode timeline 00:01:07–00:03:37 — Beyond Conference (Austin, May 27–29): booth location + product teases 00:03:56–00:05:58 — Speaking topics + Return to Nature (Franklin, June 11–12) + vibe contrast 00:06:13–00:06:51 — Tentative A4M (December) + lead-in to minerals line 00:06:51–00:07:59 — Minerals stack → pivot to BioShilajit announcement 00:07:59–00:10:23 — Why “binary medicine” fails fatigue/brain fog; “wrong level” diagnosis 00:10:24–00:12:34 — The “unlikely trio” frame: mountain resin + bacterial cofactor + blue dye 00:12:43–00:16:40 — Shilajit origin stories + sensory reality + what it is (paleo-humus) 00:20:14–00:22:17 — Molecular payload: fulvic/humic acids + trace minerals + safety/purity note 00:22:26–00:29:32 — Evidence + mechanisms: ATP/fatigue model + “not a stimulant” analogy 00:29:32–00:34:02 — Hormones + cognition: testosterone study overview + tau aggregation discussion 00:34:02–00:39:10 — Shilajit “matchmaker” model: fulvic delivery + DBP-style mitochondrial cleanup 00:39:10–00:48:53 — PQQ deep dive: discovery, “vitamin-like” role, redox cycling, biogenesis signaling 00:49:24–01:05:24 — Methylene blue: history → ETC bypass model → brain relevance → dose/sourcing warnings 01:05:24–01:12:25 — Closed-loop synergy: build engines (PQQ) + supply/protect (shilajit) + failsafe (MB) 01:12:25–01:15:48 — Launch details + discount code + deadline (through May 7) 01:15:54–01:18:41 — Product page “mini-library” + shoutout + closing - For the next week, save 20% on your order of BioShilajit!   And for the next week ONLY, you can combine this 20% discount with the Subscribe and Save 10% discount option* (choose on the product page when adding to cart).   This limited-time offer provides you with a 30% discount on BioShilajit and you will retain this exclusive discount of the lifetime of your subscription.   Discount code: BIOSHILAJIT20   Expires on 5/7, midnight PST   *must choose "Single" quantity option and then increase to desired amount   Shop BioShilajit! - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

In this Deep Dive, Dr. Mike Belkowski explores a fascinating question at the intersection of circadian biology and mitochondrial science: What if mitochondria do not merely respond to the body’s clock, but actively help keep it? Drawing from two reviews on mitochondrial chronobiology, the episode examines how mitochondrial fusion, fission, energy production, mitophagy, NAD metabolism, and oxidative stress follow rhythmic patterns throughout the day. It also breaks down the two-way conversation between the nuclear clock and the mitochondria, including how metabolic signals such as NAD, ATP, AMP, and acetyl-CoA can reshape clock-gene activity. The discussion moves even deeper into evidence that biological rhythms can persist without a nucleus, suggesting that mitochondria may retain elements of an ancient metabolic clock inherited from their bacterial ancestors. Ultimately, the episode reveals why light, food timing, exercise, sleep, and metabolism must remain synchronized to preserve mitochondrial efficiency, metabolic health, resilience, and longevity. (Educational content only, not medical advice.) - Articles Discussed in Episode: The Circadian nature of Mitochondrial Biology  Circadian coordination: understanding interplay between circadian clock and mitochondria  - Key Quotes From Dr. Mike: “What if mitochondria aren’t just responding to the circadian clock? What if they’re helping actually keep it?” “Your circadian clock isn’t simply measuring time. It’s also measuring energy.” “Our mitochondria aren’t just passive recipients of that information. They’re active participants in deciding what time it actually is.” “When the nucleus and mitochondria are in sync, energy production peaks exactly when you need it.” “The mitochondria beat more to a metabolic clock... Consistent eating patterns provide the metabolic cues necessary to keep mitochondrial activity on beat.” “Mitochondria are rhythmic shape-shifters... Failing to maintain this shape-shifting rhythm (i.e. fusion & fission) is a hallmark of cellular aging and metabolic decline.” - Key Points ⚡ Mitochondria are not simply ATP-producing organelles; they are signaling hubs, redox regulators, environmental sensors, and cellular decision-makers. ⚡ The relationship between the circadian clock and mitochondria is a two-way conversation rather than a one-directional command from the nucleus. ⚡ Clock genes influence mitochondrial biogenesis, mitophagy, fusion, fission, oxidative phosphorylation, NAD metabolism, and reactive oxygen species production. ⚡ Mitochondria communicate back to the nucleus through metabolites such as NAD, ATP, AMP, acetyl-CoA, and cellular redox status. ⚡ The circadian clock may be measuring both time and energy. ⚡ Mitochondrial fusion and fission follow rhythmic patterns that help cells adapt their physical structure to changing energy demands. ⚡ Fusion creates elongated mitochondrial networks optimized for efficient oxidative phosphorylation and energy production. ⚡ Fission separates mitochondrial networks into smaller units, supporting quality control and the removal of damaged components. ⚡ Loss of the normal fusion-fission rhythm is associated with cellular aging, oxidative stress, and metabolic decline. ⚡ SIRT1 acts as a metabolic sensor linking NAD availability to clock proteins such as PER2. ⚡ Biological rhythms can exist without nuclear DNA, as demonstrated by circadian peroxiredoxin oxidation in enucleated red blood cells. ⚡ Mitochondria also exhibit approximately 12-hour ultradian rhythms that appear to respond more strongly to metabolic and cellular stress cues than to light. ⚡ These independent rhythms support the theory that mitochondria retained ancient biological clocks from their bacterial ancestors. ⚡ Disrupting clock genes such as BMAL1, PER1, or PER2 physically damages mitochondrial structure and impairs cellular respiration. ⚡ Peripheral clocks in organs such as the liver, heart, and skeletal muscle respond strongly to feeding and fasting schedules. ⚡ Consistent meal timing can help synchronize mitochondrial enzyme activity, protein acetylation, NAD metabolism, and energy production. ⚡ Circadian disruption and mitochondrial dysfunction may reinforce one another, contributing to metabolic disease, neurodegeneration, accelerated aging, and reduced longevity. ⚡ Circadian health is influenced by more than light—it also depends on the timing of meals, exercise, sleep, temperature, and metabolic activity. - Episode timeline 00:00–00:25 — The Energy Code Deep Dives introduction 00:25–01:34 — Mitochondria as energy producers, signaling hubs, redox regulators, environmental sensors, and producers of ATP and EZ water 01:35–02:52 — The central question: Do mitochondria merely follow the circadian clock, or do they help keep it? 02:53–04:40 — Overview of mitochondrial rhythms, nuclear-mitochondrial communication, ancient biological clocks, and the two featured reviews 04:42–06:23 — Circadian disruption as a cellular power failure; the nucleus and mitochondria as a synchronized energy orchestra 06:24–07:30 — Takeaway 1: Mitochondria as rhythmic shape-shifters through fusion and fission 07:31–08:54 — Takeaway 2: Retrograde signaling and the two-way conversation between mitochondria and the nucleus 08:56–10:44 — Takeaway 3: Rhythms without a nucleus, red blood cells, 12-hour mitochondrial cycles, and the endosymbiotic theory 10:44–11:44 — Takeaway 4: The physical consequences of clock-gene disruption and mitochondrial structural damage 11:45–12:56 — Takeaway 5: Metabolism as a master synchronizer through feeding, fasting, SIRT3, NAMPT, and NAD biology 12:58–13:37 — Why the interaction between time and energy may be foundational to longevity 13:39–17:13 — Conclusions from the 2024 review: mitochondrial clocks, bacterial ancestry, disease, aging, and systemic circadian coordination 17:14–19:46 — Final analysis: mitochondrial timing appears especially responsive to metabolism and meal timing, not light alone 19:48–20:03 — Closing message and podcast outro - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

In this episode of The Energy Code, Dr. Mike Belkowski explores why circadian rhythm is not merely a sleep issue — it is a foundational regulator of metabolism, hormones, cardiovascular health, inflammation, cognition, mitochondrial function, and longevity. Drawing from five influential research papers, Dr. Mike explains how the eyes act as circadian sensors, why the timing, spectrum, and intensity of light all matter, and how modern life creates a damaging mismatch: too little bright, full-spectrum light during the day and too much blue-rich artificial light at night. He also breaks down why morning sunlight may be one of the most powerful free wellness interventions available — and why nighttime success begins shortly after waking. The episode concludes with practical strategies for designing a more circadian-friendly environment and introduces the BioLight Ember, a portable, rechargeable light with adjustable brightness and three evening-friendly modes: amber, red, and amber/red combined. The central message is simple: you cannot out-supplement or out-biohack a poor circadian rhythm, but you can begin correcting it by sending your biology the right light signals at the right time. (Educational content only, not medical advice.) - Articles Discussed in Episode: Effects of light on human circadian rhythms, sleep and mood Circadian Rhythm, Lifestyle and Health: A Narrative Review Systematic review of light exposure impact on human circadian rhythm Role of Circadian Health in Cardiometabolic Health and Disease Risk: A Scientific Statement From the American Heart Association The role of sunlight in sleep regulation: analysis of morning, evening and late exposure - Key Quotes From Dr. Mike: “You can’t out-supplement or out-biohack a poor circadian rhythm.” “The body doesn’t know what time it is. It only knows what signals it receives... Light is the strongest timing signal humans possess. Everything else is secondary.” “If there was one circadian intervention that consistently outperforms nearly every supplement, it’s morning sunlight.” “The goal isn’t to eliminate light altogether (at night). The goal is to become intentional about which light we’re exposing ourselves to and at what time.” “Health isn’t always about adding another piece of technology or nutraceutical. Sometimes it’s simply about changing the environment your biology evolved to expect.” - Key Points ⚡ Circadian rhythm is not simply about sleep; it influences metabolism, hormones, cardiovascular function, inflammation, cognition, mitochondrial health, and longevity. ⚡ Morning sunlight is one of the most powerful free habits for setting the body’s master clock and improving both daytime alertness and nighttime sleep. ⚡ The eyes contain specialized circadian sensors called intrinsically photosensitive retinal ganglion cells, or ipRGCs, that help determine whether the body interprets its environment as day or night. ⚡ The same light can produce opposite effects depending on when it is viewed. ⚡ Morning light advances the circadian clock, increases alertness, supports a healthy cortisol rise, and promotes earlier melatonin onset that evening. ⚡ Bright and blue-rich light at night delays the circadian clock, suppresses melatonin, increases alertness, and reduces sleep quality. ⚡ The body does not know what clock time it is — it responds to environmental signals, with light acting as the strongest timing cue. ⚡ Virtually every major organ and tissue contains its own molecular clock, including the liver, pancreas, gut, immune system, and mitochondria. ⚡ Shift work, late-night eating, artificial lighting, social jet lag, inconsistent schedules, and sleep deprivation all contribute to circadian mismatch. ⚡ Modern indoor lighting is often too dim during the day and too bright at night. ⚡ Typical indoor environments provide roughly 100–500 lux, while outdoor daylight can reach approximately 10,000–100,000 lux. ⚡ Circadian responses depend on both the brightness and color spectrum of light — not merely one or the other. ⚡ Blue-rich light disproportionately affects melanopsin signaling, cortisol, alertness, melatonin suppression, and circadian phase shifting. ⚡ Circadian disruption is linked with impaired insulin sensitivity, poor glucose control, cardiovascular dysfunction, inflammation, depression, cognitive decline, and increased disease risk. ⚡ Nighttime success begins in the morning: earlier outdoor sunlight exposure is associated with better circadian alignment, earlier melatonin onset, and improved sleep quality. ⚡ The goal is not to eliminate evening light entirely, but to become more intentional about its timing, intensity, and wavelength. ⚡ The BioLight Ember is portable and rechargeable, offers amber, red, and amber/red combination modes, and allows complete control over brightness. ⚡ The Ember is not a sedative or replacement for healthy sleep habits; it is designed to remove one major environmental source of circadian disruption. ⚡ Consistency, not perfection, is what ultimately moves the needle for circadian rhythm. - Episode timeline 00:00–00:25 — The Energy Code introduction 00:25–03:45 — Why circadian rhythm is foundational; morning sunlight, evening lighting, melatonin, and the importance of red light at night 03:46–05:14 — Introduction to five major circadian-health papers and the upcoming BioLight product announcement 05:15–09:55 — Paper 1: Light as a biological signal; ipRGCs, sleep, mood, hormones, alertness, and why timing changes the effect of light 09:57–10:25 — Morning sunlight and the evening environment as the two foundational circadian anchors 10:28–15:11 — Paper 2: Circadian rhythm as a whole-body health system; organ clocks, metabolic health, shift work, late eating, social jet lag, and artificial light 15:12–17:53 — Paper 3: Real-world artificial-light exposure; why indoor daytime lighting is biologically weak compared with outdoor sunlight 17:55–21:43 — Why nighttime lighting is often too bright; intensity versus spectrum and the foundation of modern circadian-lighting products 21:44–23:49 — Paper 4: The American Heart Association recognizes circadian disruption as a cardiometabolic risk factor 23:51–26:00 — Paper 5: Morning sunlight exposure, melatonin timing, sleep regulation, and why nighttime success begins in the morning 26:00–27:52 — The overarching lesson: modern health problems may partly reflect inaccurate environmental light signals 27:53–28:52 — Practical framing: modern life is not going away, so the goal is intentional light exposure rather than complete darkness 28:53–31:05 — Introduction to the BioLight Ember and why portability was central to its design 31:06–33:28 — Everyday use cases: reading, bathrooms, travel, hotel rooms, nightstands, and adjustable brightness 33:29–36:23 — The Ember’s three light settings: amber, red, and amber/red combination mode 36:24–39:10 — What the Ember is—and is not; reducing environmental stress rather than acting as a magic sleep device 39:11–42:31 — Practical circadian takeaways, Ember quantity options, potential sleep and HRV benefits, and why consistency matters 42:32–43:47 — Closing message: morning sunlight, evening-light hygiene, and mitochondrial medicine - Introducing Ember. Meet BioLight’s newest addition to your evening wellness routine. Ember is a rechargeable, portable circadian light designed to help create a healthier nighttime environment with three blue-free light modes: Amber, Red, and Amber + Red. With adjustable brightness and USB-C charging, it’s perfect for bedrooms, bathrooms, reading, travel, or anywhere harsh lighting gets in the way of your evening routine. Because better sleep doesn’t start when your head hits the pillow—it starts with the light you’re surrounded by. Check out Ember! - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

In this Deep Dive, Dr. Mike breaks down a randomized crossover trial comparing photobiomodulation, pneumatic compression boots, shockwave therapy, and passive rest in CrossFit athletes. The findings reveal a striking disconnect between feeling recovered and actually being physiologically recovered. Compression boots and shockwave therapy earned high satisfaction scores, but failed to outperform passive rest for muscle damage or power recovery. Photobiomodulation combined with a static magnetic field was the only intervention to preserve vertical-jump performance, reduce biochemical markers of muscle damage, and strengthen endogenous antioxidant defenses over the following 24 to 48 hours. The episode explores the study’s specific light protocol, the “invisible recovery window” immediately after intense exercise, and why mitochondrial and oxidative-stress recovery may matter more than how your legs feel in the moment. (Educational content only, not medical advice.) - Article Discussed in Episode: A randomised crossover trial comparing photobiomodulation therapy with other recovery strategies in CrossFit athletes - Key Quotes From Dr. Mike: “The most striking finding was the massive disconnect between an athlete’s subjective feelings and their objective physiology.” “Shock waves and compression boots might make post-WOD soreness more bearable, but they simply don’t help you regain peak power any faster.” “Photobiomodulation combined with a static magnetic field was the only intervention that significantly outperformed passive rest.” “To understand why photobiomodulation won, you have to look at the microscopic war zone inside your muscle cells... High-intensity CrossFit workouts trigger a massive spike in reactive oxygen species... Photobiomodulation acts as an internal antioxidant booster.” “Pneumatic boots are mostly for show... The boots provided no statistically significant benefit over passive recovery for muscle damage or power output.” “If you want to return to the barbell with maximum power, photobiomodulation is currently the only technology in this trial with scientific receipts to back it up.” - Key Points ⚡ The study compared photobiomodulation with a static magnetic field, pneumatic compression boots, shockwave therapy, and passive recovery in CrossFit athletes. ⚡ Compression boots and shockwave therapy received 83% satisfaction ratings, showing that athletes enjoyed the treatments. ⚡ Despite those high satisfaction scores, neither treatment significantly improved vertical-jump recovery or muscle-damage markers compared with passive rest. ⚡ The study highlights a major disconnect between subjective recovery and objective physiological recovery. ⚡ Photobiomodulation combined with a static magnetic field was the only intervention to significantly outperform passive recovery across functional and biochemical outcomes. ⚡ Athletes receiving PBM retained more vertical-jump power at the 24- and 48-hour marks. ⚡ PBM also reduced lactate dehydrogenase, a biomarker associated with muscle-cell membrane damage. ⚡ The study used a 32-minute protocol across eight treatment sites on each lower limb, targeting the quadriceps, hamstrings, and calves. ⚡ The device combined 905-nanometer super-pulsed lasers with 850-nanometer and 633-nanometer LEDs. ⚡ None of the recovery methods restored jump performance at the one-hour mark, including PBM. ⚡ PBM nevertheless increased antioxidant activity within 60 minutes, suggesting internal repair had begun before athletes felt or performed better. ⚡ PBM lowered markers of lipid and protein oxidation, including TBARS and carbonylated proteins. ⚡ It was also the only intervention to maintain or increase superoxide dismutase and catalase activity. ⚡ Compression boots may provide a strong sensory experience, but this trial did not show meaningful metabolic or performance recovery. ⚡ The central lesson: choose recovery tools based on how they affect performance 24 to 48 hours later—not merely how they feel immediately after training. - Episode timeline 00:00–01:49 — Introduction to the CrossFit recovery trial and the “science of the slay” 01:51–02:55 — Why a CrossFit WOD creates extreme mechanical, metabolic, and oxidative stress 02:57–04:30 — The satisfaction paradox: why compression boots and shockwave therapy feel effective without improving objective recovery 04:32–06:27 — PBM emerges as the leading intervention; improvements in jump performance and muscle-damage biomarkers 05:30–06:27 — The winning protocol: 32 minutes, eight sites per leg, and a combination of red/NIR LEDs and super-pulsed lasers 06:29–07:50 — The invisible recovery window: why no device restored performance one hour after the WOD 07:52–09:42 — The oxidative-stress battle: PBM’s effects on TBARS, carbonylated proteins, superoxide dismutase, and catalase 09:43–10:34 — Why pneumatic compression boots failed to outperform passive rest 10:35–11:24 — Feeling recovered versus being physiologically recovered 11:25–13:09 — The authors’ conclusion and the practical question every athlete should ask about recovery technology 13:11–13:27 — Closing message and podcast outro - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

In this Deep Dive, Dr. Mike Belkowski returns to the roots of The Energy Code by examining two newly published reviews on red light therapy. The first explores photobiomodulation for ocular aging and eye diseases, including age-related macular degeneration, dry eye, and childhood myopia. The second evaluates whether PBM can improve sleep quality by influencing brain metabolism, cerebral blood flow, neural networks, and melatonin-related pathways. Dr. Mike breaks down how light interacts with mitochondrial cytochrome c oxidase, improves electron flow and ATP production, and may restore bioenergetics in two of the body’s most energy-demanding tissues: the brain and retina. The episode also examines the LIGHTSITE clinical trials, repeated low-level red-light therapy for myopia, transcranial PBM for sleep, extra-pineal melatonin production, and why proper wavelength, irradiance, and dosage remain essential. The emerging message is that red light may be far more than a tool for skin, pain, and muscle recovery. It may represent an investigational strategy for restoring cellular energy in the tissues responsible for how clearly we see and how deeply we sleep. (Educational content only, not medical advice.) - Article Discussed in Episode: Near-Infrared and Red-Light Photobiomodulation for Ocular Aging and Diseases: A Narrative Review Photobiomodulation and sleep quality: systematic review and meta-analysis - Key Quotes From Dr. Mike: “Many of the conditions we associate with aging and declining function may ultimately be manifestations of an underlying energy problem.” “We are witnessing a bioenergetic tipping point where mitochondrial decay dictates the pace of systemic aging.” “The human eye is an ideal target for PBM due to its optical accessibility and the immense energy demands of the retina.” “Brief exposures to red light can slow the progression of myopia in children.” “PBM may help restore homeostatic sleep pressure — the biological need to sleep... Red and near-infrared wavelengths have the capability of improving our systemic melatonin production.” “The gastrointestinal tract is likely the largest source of melatonin in the body.” “If mitochondria contribute to melatonin production, all of a sudden full-body red light therapy becomes imperative for normalizing circadian rhythm.” - Key Points ⚡ Two new reviews examine photobiomodulation for ocular aging and disease and for sleep quality. ⚡ The brain and retina are among the body’s most energy-demanding tissues, making them especially vulnerable to mitochondrial decline. ⚡ Red and near-infrared light interact with cytochrome c oxidase, helping displace inhibitory nitric oxide, restore oxygen utilization, and increase ATP production. ⚡ PBM follows a Goldilocks dose response: too little may do nothing, while excessive light can become inhibitory or pro-oxidative. ⚡ The LIGHTSITE clinical trials reported modest but statistically significant visual-acuity gains of roughly four to five ETDRS letters in patients with dry age-related macular degeneration. ⚡ Ocular PBM may also reduce drusen burden and potentially slow geographic atrophy, although further clinical confirmation is needed. ⚡ Repeated low-level red-light therapy is being studied as a way to slow the abnormal eyeball elongation responsible for childhood myopia. ⚡ Ocular protocols differ by goal: age-related macular degeneration often uses multiple red, amber, and near-infrared wavelengths, while myopia protocols typically use red light alone. ⚡ Wavelength determines penetration depth; device strength primarily determines how quickly a therapeutic dose is delivered. ⚡ High-powered panels should not be used close to the eyes without carefully adjusting distance, exposure time, and irradiance. ⚡ Transcranial PBM may support sleep by influencing adenosine signaling, cerebral metabolism, astrocytes, and prefrontal and thalamocortical networks. ⚡ Current sleep findings are statistically promising, but may not yet represent clinically meaningful improvements. ⚡ Red and near-infrared light may also support sleep indirectly by improving mitochondrial function and extra-pineal melatonin synthesis. ⚡ Melatonin is produced throughout the body — including the retina, gastrointestinal tract, skin, immune cells, cardiovascular tissues, and mitochondria — not only in the pineal gland. ⚡ PBM should currently be viewed as a promising adjunctive and investigational tool, not a replacement for established medical care. - Episode timeline 00:00–03:17 — Return to the podcast’s red-light roots; introduction to two new reviews on sleep and ocular PBM 03:18–05:54 — Why the retina and brain are ideal — and very different — targets for red and near-infrared light 05:55–06:44 — Research context and Francisco Gonzalez-Lima’s involvement in both papers 06:45–08:48 — The invisible cellular engine: mitochondrial decline, aging, and PBM as a nonthermal bioenergetic intervention 08:49–10:24 — The mitochondrial master switch: cytochrome c oxidase, nitric oxide displacement, oxygen utilization, ATP, and the biphasic dose response 10:25–13:28 — Saving sight: the LIGHTSITE clinical program, ETDRS letter gains, drusen reduction, and dry macular degeneration 13:29–16:25 — The myopia paradox: how low-level red light may slow abnormal eye elongation in children 16:27–17:56 — Comparing ocular protocols: multi-wavelength PBM for macular degeneration versus red-only treatment for myopia 17:58–21:20 — Practical eye-treatment considerations: irradiance, distance, exposure time, low-powered devices, and screen-light balancing 21:21–22:46 — The prefrontal “off switch”: transcranial PBM, adenosine signaling, brain-network efficiency, and sleep quality 22:47–23:21 — Research limitations: statistical significance versus clinically meaningful improvement 23:22–26:49 — Extra-pineal melatonin: the retina, gut, skin, immune cells, reproductive tissues, and mitochondria 26:50–27:38 — How consistent PBM, sunlight, evening darkness, and circadian lighting may work together to support sleep 27:40–29:35 — Final synthesis: PBM as an investigational adjunct, future applications in spaceflight, and illuminated healthcare - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

In Part 3 of his presentation at Dave Asprey's BEYOND Biohacking conference in May, Dr. Mike completes this three-part series by moving fully into the practical applications of mitochondrial optimization. After recapping the six pillars of mitochondrial function — energy production, mitogenesis, mitophagy, dynamics, ROS protection, and light — this episode breaks down the major tools, compounds, and lifestyle strategies that can help support each pillar. Dr. Mike covers urolithin A and B, shilajit, mitochondrial peptides, nano gold, taurine, molecular hydrogen, deuterium depletion, hyperbaric oxygen therapy, circadian light, indoor lighting, and grounding. The episode then brings everything together into a practical “Energy Code Blueprint,” outlining a daily and weekly framework for the true mitochondriac: sunlight, grounding, mitohormesis, red light therapy, methylene blue, selective antioxidants, mitochondrial peptides, and foundational compounds that support cellular energy, resilience, and longevity. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: “Urolithin A is simply one of the most effective, efficient, efficacious ways to activate the mitophagy switch.” “SS-31 arguably is the top peptide I would recommend for overall mitochondrial function.” “MOTS-c… is essentially exercise in a molecule... Humanin… is known as a cognitive or neuroprotector in terms of a peptide... SHLP-2… is the cellular survival signal peptide... (SS-31, MOTS-c, Humanin & SHLP-2) are the peptides I would look at from a mitochondriac perspective.” “Nano gold itself doesn’t create energy; it multiplies & amplifies the light that does.” “Molecular hydrogen penetrates every cellular compartment, including the mitochondria.” “Deuterium depletion is one of the most powerful overlooked levers to upgrade mitochondrial function.” “Morning sun is a must.” - Key Points ⚡ This episode completes the three-part breakdown of The Energy Code Blueprint: Longevity Starts in the Mitochondria. ⚡ Part 3 focuses on the practical applications: what people can actually do to support the six pillars of mitochondrial function. ⚡ Urolithin A is framed as one of the most effective ways to activate mitophagy, helping clear damaged mitochondria and restore mitochondrial quality control. ⚡ Urolithin B is positioned as an anabolic mitokine that may support muscle retention, protein synthesis, joint health, and metabolic resilience. ⚡ Shilajit is described as a foundational mitochondrial compound because of its fulvic acid, trace minerals, CoQ10 support, and ability to improve ATP and EZ water production. ⚡ The four core mitochondrial peptides highlighted are SS-31, MOTS-c, SHLP-2, and Humanin, with honorable mentions for Epitalon, GHK-Cu, and Pinealon. ⚡ Nano gold is presented as a light-amplifying mitochondrial tool that may enhance the effects of red and near-infrared light via surface plasmon resonance. ⚡ Taurine is described as a mitochondrial game changer due to its effects on oxidative stress, ETC efficiency, mitophagy, inflammation, brain health, heart health, and calcium regulation. ⚡ Molecular hydrogen is framed as a selective antioxidant that neutralizes the most harmful radicals while preserving beneficial redox signaling. ⚡ Deuterium depletion is explained as an overlooked lever for improving ATP synthase efficiency, electron flow, mitochondrial respiration, and cellular energy. ⚡ Hyperbaric oxygen therapy is discussed as a mitochondrial oxygenation strategy that may improve ATP production, mitogenesis, cellular repair, and the nitric oxide “golden ratio.” ⚡ Circadian light hygiene—morning sun, evening darkness, amber/red lighting, and blue-light blocking—is positioned as a foundational mitochondrial signal. ⚡ Grounding is described as a free electron-transfer strategy that supports redox potential, inflammation control, blood flow, sleep, and mitochondrial function. ⚡ The final Energy Code Blueprint begins with the free foundations: sunlight, circadian rhythm, grounding, and mitohormesis. ⚡ The “multiplier effect” is the main theme: when foundational signals align, every other mitochondrial tool works better. - Episode timeline 0:00–2:10 — Part 3 intro and recap of Parts 1–2: bioenergetics, six pillars, and earlier applications 2:11–9:03 — Urolithin A: mitophagy activation, mitochondrial quality control, muscle performance, and long-term cellular renewal 9:04–13:51 — Urolithin B: anabolic signaling, muscle retention, joint protection, osteoarthritis support, inflammation, and metabolic flexibility 13:52–18:18 — Shilajit: fulvic acid, trace minerals, CoQ10 recycling, ATP/EZ water production, brain support, and mineral replenishment 18:21–27:43 — Mitochondrial peptides: SS-31, MOTS-c, SHLP-2, Humanin, plus Epitalon, GHK-Cu, and Pinealon as honorable mentions 27:43–32:52 — Nano gold: light amplification, surface plasmon resonance, red/NIR synergy, and mitochondrial activation 32:54–38:06 — Taurine: antioxidant defense, ETC support, mitophagy, inflammation control, neurotransmitters, metabolic health, and synergy with methylene blue 38:09–42:16 — Molecular hydrogen: selective antioxidant activity, delivery methods, systemic vs gut benefits, and daily use potential 42:16–49:37 — Deuterium depletion: hydrogen vs deuterium, ATP synthase function, light water, mitochondrial efficiency, and anti-aging implications 49:37–54:07 — Hyperbaric oxygen therapy: oxygen delivery, mitochondrial energy production, wound healing, immune support, and the nitric oxide “golden ratio” 54:08–56:52 — Circadian light and indoor lighting: morning sun, evening darkness, blue light, amber/red bulbs, and sleep signaling 56:54–59:47 — Grounding/earthing: electron transfer, redox potential, inflammation, blood viscosity, melatonin, cortisol rhythm, and wound healing 59:48–1:00:13 — Recap of all mitochondrial applications covered across the series 1:00:14–1:03:40 — The Energy Code Blueprint: foundations, multiplier effect, and matching applications to the six pillars 1:03:42–1:07:31 — Daily checklist example: morning sunlight/grounding, urolithins, shilajit, blue spirulina, methylene blue, red light, SS-31, PQQ, C60, hydrogen, and lighting upgrades 1:07:33–1:08:54 — Hard reboot strategy for beginners and closing message: “The mitochondrial revolution is not the future, it’s now.” - Introducing BioLight Labs! For years, BioLight has been dedicated to advancing mitochondrial wellness through education, red and near-infrared light therapy, methylene blue, and targeted nutritional solutions.   Our initial offerings will focus on some of the most promising peptides in the fields of healthy aging, cellular resilience, recovery, and mitochondrial function, with many more innovative compounds and educational resources to come.   BioLight Labs was created to serve researchers, practitioners, and health enthusiasts seeking the next frontier of bioenergetic optimization.   The future of wellness is bioenergetic. The future is BioLight Labs.   Explore BioLight Labs → - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

In this peptide-focused Deep Dive, Dr. Mike explores Humanin, one of the most fascinating and underappreciated mitochondrial-derived peptides in the longevity space. First discovered in 2001 while researchers were searching for molecules that could protect neurons from Alzheimer’s-related toxicity, Humanin appears to act as one of the body’s natural cellular survival signals — helping cells withstand oxidative stress, inflammation, mitochondrial damage, metabolic dysfunction, and age-related decline. This episode breaks down a 2023 systematic review from Biology titled “Humanin and Its Pathophysiological Roles in Aging”, covering Humanin’s unusual mitochondrial origin, its role in neuroprotection, mitohormesis, chaperone-mediated autophagy, metabolic health, cardiovascular function, inflammation, and lifespan research. Dr. Mike also explains why Humanin may deserve a place alongside SS-31 and MOTS-c as one of the top mitochondrial peptides for anyone interested in mitochondrial wellness, resilience, and longevity. (Educational content only, not medical advice.) - Article Discussed in Episode: Humanin and Its Pathophysiological Roles in Aging: A Systematic Review - Key Quotes From Dr. Mike: “Humanin was originally isolated from surviving neurons in the brains of patients with Alzheimer’s disease" "It was named 'Humanin' to reflect its potential role in preserving human health and survival."  “Humanin appears to function as one of the body’s natural cellular survival signals... acting as a molecular shield and mitokine." “Humanin restores the communication link that tells the cleanup crew exactly where the toxic debris is hiding.” “By addressing the mitochondrial origin of this inflammation — the leaky battery problem — Humanin hits multiple diseases simultaneously.” "These are the top three peptides if you’re a mitochondriac: SS-31, MOTS-c, and now you can see why the third is Humanin.” - Key Points ⚡ Humanin is a small mitochondrial-derived peptide first discovered in 2001 during research into Alzheimer’s disease-related neuronal protection. ⚡ It was originally isolated from surviving neurons in the brains of Alzheimer’s patients, which helped shape its identity as a cellular survival peptide. ⚡ Humanin is encoded within the mitochondrial genome, specifically inside the 16S ribosomal RNA gene, giving mitochondria their own “voice” beyond ATP production. ⚡ It exists in two forms: a 21-amino-acid version when translated in mitochondria and a 24-amino-acid version when translated in the cytoplasm. ⚡ Humanin is highly conserved across species, suggesting it may play a fundamental role in multicellular survival and stress resistance. ⚡ It may protect against Alzheimer’s-related toxicity by interfering with amyloid beta toxicity and blocking pro-apoptotic pathways like Bax activation. ⚡ Humanin functions as a mitokine, released during periods of mitochondrial stress to coordinate resilience across cells and tissues. ⚡ Humanin levels generally decline with age, although some very old individuals may show compensatory spikes as a last-ditch mitohormetic stress response. ⚡ It supports chaperone-mediated autophagy, helping the cell’s “precision cleanup crew” remove damaged or oxidized proteins. ⚡ Humanin has broad systemic effects, including potential benefits for brain health, cardiovascular aging, insulin sensitivity, visceral fat, lean mass, inflammation, stem cell survival, and reproductive health. ⚡ Animal models suggest even modest increases in circulating Humanin may provide protection against toxic insults and inflammatory markers. ⚡ A synthetic analog called HNG / Humanin S14G may be up to 1,000 times more potent than naturally occurring Humanin in certain models. ⚡ Dr. Mike frames Humanin as the third part of a mitochondrial peptide “big three” alongside SS-31 and MOTS-c. - Episode timeline 0:00–0:40 — Introduction to Humanin as another mitochondrial-derived peptide; article title and source 0:40–1:47 — Historical overview: Humanin discovery in 2001, Alzheimer’s research, and the birth of mitochondrial-derived peptide science 1:47–3:23 — Humanin’s potential benefits: mitochondrial function, oxidative stress protection, metabolism, brain health, inflammation, stem cells, fertility, and cellular resilience 3:23–4:52 — Big-picture framing: Humanin as a cellular survival signal and ancient mitochondrial communication molecule 4:52–6:55 — Section 1: Humanin as an ancient signal from the mitochondrial genome; 16S rRNA origin, two peptide lengths, evolutionary conservation 6:55–8:04 — Section 2: Alzheimer’s origin story; Humanin as a neuroprotective molecule that interferes with amyloid beta and apoptotic pathways 8:04–9:15 — Section 3: Mitohormesis; Humanin as a stress-responsive mitokine and possible last-ditch survival signal in advanced age 9:15–10:35 — Section 4: Chaperone-mediated autophagy; Humanin as the “supervisor” of cellular cleanup and damaged protein removal 10:35–12:00 — Section 5: Pleiotropic effects beyond the brain: heart, diabetes, metabolism, inflammation, inflammaging 12:00–13:32 — Section 6: Lifespan and health span research; 16% circulating Humanin increase, C. elegans lifespan, FOXO/IGF-1 pathway, and HNG analog 13:32–14:32 — Review conclusion: aging as a breakdown in ancient mitochondrial signaling rather than inevitable wear and tear 14:32–16:26 — Dr. Mike’s viewpoint: Humanin as underappreciated, part of the top three mitochondrial peptides with SS-31 and MOTS-c - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

In this episode of The Energy Code, Dr. Mike Belkowski breaks down BPC-157, one of the most popular and debated peptides in the wellness, recovery, and biohacking worlds. He covers its origins as a synthetic fragment of a protective compound found in gastric juice, its potential roles in tendon, ligament, muscle, gut, nerve, and tissue repair, and the major caveat around angiogenesis. The episode then unpacks a recent Pharmaceutics review highlighting the central paradox of BPC-157: decades of compelling animal data and powerful anecdotal reports, but still a major lack of rigorous human clinical evidence, standardized formulations, and long-term safety data. Ultimately, BPC-157 is framed as a high-potential, low-certainty peptide — promising enough to deserve serious attention, but not yet proven enough to justify blind faith. (Educational content only, not medical advice.) - Article Discussed in Episode: BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers - Key Quotes From Dr. Mike: “BPC-157 has been investigated primarily through studies looking at gastrointestinal protection, tissue repair, and healing mechanisms.” “BPC-157’s gastric stability does not equal oral bioavailability… “The claim that oral BPC-157 reaches systemic circulation is an unverified hypothesis, not a clinical fact.” “It enters the blood, triggers a response, and is cleared by the kidneys almost instantly. Yet its healing effects can persist for days or weeks.” “There are over 544 peer-reviewed studies, mostly in rodents… In terms of total human efficacy subjects, there’s fewer than 30 people documented in all history.” “For now, BPC-157 remains the ultimate biological paradox: a compound that can seemingly heal anything in the lab, but officially nothing in the clinic.” - Key Points ⚡ BPC-157 stands for Body Protecting Compound 157 and is derived from a protective protein found in human gastric juice. ⚡ It has been studied mostly in animal models for tissue repair, tendon healing, ligament recovery, muscle injury, gut protection, angiogenesis, nerve support, inflammation modulation, and oxidative stress reduction. ⚡ Despite its popularity, BPC-157 has almost no robust human clinical data. ⚡ A recent Pharmaceutics review describes BPC-157 as an investigational peptide with major formulation, pharmacokinetic, regulatory, and translational barriers. ⚡ BPC-157 is unusually stable in acidic stomach-like environments, but gastric stability does not prove oral bioavailability. ⚡ Its systemic half-life appears to be under 30 minutes, yet animal studies suggest effects may last days or weeks, creating a major pharmacokinetic/pharmacodynamic mystery. ⚡ The review suggests BPC-157 may act as a transcriptional primer, briefly triggering gene and growth-factor cascades that continue after the peptide is cleared. ⚡ The evidence base is heavily skewed toward preclinical animal studies, with very limited human data. ⚡ Much of the BPC-157 literature comes from one research group at the University of Zagreb, creating a need for independent replication. ⚡ BPC-157’s native stability may make it difficult to patent, reducing pharmaceutical incentive to fund large clinical trials. ⚡ Current gray-market products are research chemicals, not FDA-approved pharmaceutical-grade human therapeutics. ⚡ Potential risks include inconsistent dosing, lack of GMP oversight, lack of long-term safety data, and theoretical concern around angiogenesis in the setting of hidden malignancy. ⚡ Dr. Mike’s view: BPC-157 has earned scientific curiosity, but not scientific certainty. - Episode timeline 0:00 – Introduction to BPC-157 Dr. Mike introduces BPC-157 as one of the most popular peptides outside the GLP-1 category and explains that BPC stands for Body Protecting Compound 157.   0:49 – The Review Being Covered The episode centers on a recent Pharmaceutics review titled BPC 157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers.   1:20 – Brief History of BPC-157 BPC-157 is described as a synthetic peptide derived from a protective protein naturally found in human gastric juice, with research beginning in the 1990s.   2:05 – Anecdotal Use and Recovery Claims Dr. Mike discusses how BPC-157 is often used anecdotally for soft-tissue injuries, chronic pain, muscle strains, tendons, ligaments, cartilage, and athletic recovery.   2:45 – Potential Benefits The episode outlines possible benefits including tendon repair, ligament recovery, muscle healing, wound healing, gut protection, joint support, angiogenesis, inflammation reduction, oxidative stress modulation, nerve regeneration, and overuse injury recovery.   3:36 – Angiogenesis Caveat Dr. Mike notes that while blood vessel formation can support healing, it may theoretically be problematic in the presence of active or hidden cancer.   4:11 – The Phantom Peptide BPC-157 is framed as a paradox: one of the most popular experimental peptides with decades of animal data but almost no validated human evidence.   5:42 – The Gastric Survivor The review highlights BPC-157’s unusual stability in acidic gastric environments, while emphasizing that stomach stability does not equal proven oral absorption.   7:25 – The 30-Minute Phantom Dr. Mike explains the pharmacokinetic/pharmacodynamic disconnect: BPC-157 appears to clear rapidly, yet may trigger longer-lasting biological effects.   8:49 – The 554-to-1 Evidence Gap The episode breaks down the huge imbalance between preclinical studies and human clinical data, including fewer than 30 documented human efficacy subjects.   9:35 – The Zagreb Paradox Much of the BPC-157 literature comes from a single research group at the University of Zagreb, creating a major need for independent replication.   10:15 – Armor Made of Proline BPC-157’s structural durability is explained through its proline-rich sequence, which may help protect it from enzymatic breakdown.   10:47 – Why Big Pharma May Not Be Interested Because BPC-157 is natively stable and difficult to patent as a new chemical entity, there may be limited financial incentive for large pharmaceutical trials.   11:48 – Regulatory Limbo The episode discusses gray-market availability, lack of pharmaceutical-grade versions, research-chemical status, and possible FDA scrutiny.   13:23 – What BPC-157 Needs Next Dr. Mike explains the need for validated LC-MS/MS methods, ICH Q1A stress testing, and independent replication of the Zagreb data.   15:18 – Dr. Mike’s Viewpoint BPC-157 is described as neither miracle nor fraud, but a promising yet uncertain compound that deserves open-minded skepticism.   16:55 – Scientific Curiosity vs. Scientific Certainty The episode closes by emphasizing that BPC-157 has compelling preclinical evidence and strong anecdotal support, but still lacks definitive human evidence. - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

In Part 2 of Dr. Mike's podcast special of his presentation from Dave Asprey's BEYOND Biohacking Conference, we finish all six pillars of mitochondrial wellness — from mitophagy (quality control) & mitochondrial dynamics (fusion/fission balance) to ROS intelligence (selective antioxidant strategy) & light (red/NIR as the master signal). Then we move from theory to action: the episode begins the “applications” section with a practical, research-backed toolkit — red light therapy, methylene blue, blue spirulina, & Carbon 60 — including how they work, how they stack, & why the right strategy is less about “more antioxidants” & more about restoring electron flow, managing oxidative stress, & building cellular resilience. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: “If mitophagy is not working properly, then those damaged mitochondria are allowed to linger and be pro-inflammatory and be pro-oxidative stress.” “Specifically, red and near-infrared are the spectra that excites the mitochondria and the cytochrome c oxidase. No other wavelengths accomplish this.” “Simply by exposing your body… to red and near-infrared light (whether sun or red light therapy devices)… this is likely the most powerful way to remedy mitochondrial dysfunction.” “Methylene blue is one of the only ways I know of that’s able to actually restore energy in mitochondria with broken electron transport chains.” “We have an amazing natural alternative to methylene blue… and that is blue spirulina, which has phycocyanins that absorbs red light to protect neurons and strengthen our mitochondrial performance.” “Carbon 60 is essentially a free radical sponge… it’s only gonna remove the excess ‘bad’ free radicals and allow the good signaling molecules to stay.” - Key Points ⚡️ Mitophagy = mitochondrial quality control: PINK1 “inspects,” Parkin “tags,” autophagosomes “remove.” When it fails, damaged mitochondria linger & inflammation/oxidative stress snowball. ⚡️ Dysfunctional mitochondria can self-propagate, accelerating decline unless quality control is restored. ⚡️ Mitochondrial dynamics (fusion/fission) is a Goldilocks game: Too much fission → fragmentation & energy collapse Too much fusion → damage spreading through hyperfusion ⚡️ ROS aren’t “all bad”: low-level ROS are essential signals; the goal is selective antioxidant defense, not blanket quenching. ⚡️ Light is a mitochondrial master regulator: red/NIR stimulate cytochrome c oxidase, dissociate nitric oxide, allow oxygen back in → better ATP + EZ water. ⚡️ Red light therapy is wavelength-driven, not “power-driven”: red = skin; NIR = deeper tissues; power mainly affects time-to-dose. ⚡️ Methylene blue = electron chaperone: bypasses ETC bottlenecks (esp. complex I/III) by shuttling electrons toward complex IV; synergizes with red light. ⚡️ Blue spirulina (phycocyanin) = natural photodynamic partner: less potent than MB but strong synergy with red light; quality matters (E10→E40). ⚡️ Carbon 60 = selective free radical sponge: mops up “excess” ROS while preserving beneficial signaling; quality control is crucial. - Episode timeline 0:00–2:00 — Why this “Part 2” exists (no event time limit) + recap: bioenergetics + pillars 1–2 from Part 1 2:00–8:30 — Pillar 3: Mitophagy (PINK1/Parkin, why failure drives disease, self-propagation, urolithin A mention) 8:30–12:45 — Pillar 4: Mitochondrial dynamics (fusion vs fission, benefits, dangers of imbalance) 12:45–16:30 — Pillar 5: ROS protection (signal vs damage, selective antioxidants, why “antioxidant overload” backfires) 16:30–25:00 — Pillar 6: Light (cytochrome c oxidase, NO vs oxygen competition, why red/NIR are special, darkness as a mitophagy signal) 25:00–33:00 — Applications begin: Red light therapy (wavelength vs penetration, power vs efficiency, dosing logic, third-party testing) 33:00–41:45 — Methylene blue (electron chaperone + regenerative redox cycling + brain affinity + SSRI nuance + photodynamic synergy) 41:45–46:45 — Blue spirulina (phycocyanin, how to use, why E40 matters, timing before light) 46:45–54:45 — ESS60 / Carbon 60 (selective ROS sponge, quality warnings, classic longevity study discussion, why it completes the “triad”) 54:45–end — Why this becomes a 3-parter + what’s coming next (remaining applications + “Energy Code Blueprint” day/week examples) - Introducing BioLight Labs! For years, BioLight has been dedicated to advancing mitochondrial wellness through education, red and near-infrared light therapy, methylene blue, and targeted nutritional solutions.   Our initial offerings will focus on some of the most promising peptides in the fields of healthy aging, cellular resilience, recovery, and mitochondrial function, with many more innovative compounds and educational resources to come.   BioLight Labs was created to serve researchers, practitioners, and health enthusiasts seeking the next frontier of bioenergetic optimization.   The future of wellness is bioenergetic. The future is BioLight Labs.   Explore BioLight Labs → - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

In this peptide-focused Deep Dive, Dr. Mike moves from SS-31 to MOTS-c — one of the most popular mitochondrial-derived peptides for metabolic resilience and mitochondrial wellness. You’ll get a fast, practical primer (what it is + key benefits), then a walkthrough of a review titled “MOTS-c Functionality Prevents Metabolic Disorders,” explaining how MOTS-c acts as a mitochondrial “telegram” to your DNA via retrograde signaling. The episode breaks down MOTS-c’s “exercise mimetic” mechanisms (AMPK activation via AICAR), its reported effects across metabolism, muscle, bone, immune aging, and senescence clearance, and finishes with an actionable playbook for supporting endogenous MOTS-c through mitohormetic lifestyle inputs — and a thoughtful strategy for stacking MOTS-c with SS-31. (Educational content only, not medical advice.) - Article Discussed in Episode: MOTS-c Functionally Prevents Metabolic Disorders - Key Quotes From Dr. Mike: “MOTS-c… helps regulate cellular energy production, metabolic flexibility, and stress adaptation.” “MOTS-c functionally prevents metabolic disorders.” “When the cells are under metabolic stress, MOTS-c… can be rapidly transferred from mitochondria to the nucleus and regulates nuclear gene expression.” “Because MOTS-c is easily destroyed by digestive enzymes, oral delivery remains a significant challenge…” “Some researchers view MOTS-c as a mitochondrial distress signal… mitochondria release more MOTS-c when challenged, not when everything is perfectly comfortable.” “If you want the best of both worlds (for mitochondrial optimization)... stack SS-31 and MOTS-c together.” - Key Points SS-31 and MOTS-c are framed as the “top two” mitochondrial peptides (SS-31 = not mitochondrially-derived but highly mito-targeted; MOTS-c = mito-derived). MOTS-c is positioned as a mitochondrial optimization + metabolic flexibility peptide and an “exercise mimetic.” Core benefits highlighted: energy production, glucose utilization/insulin sensitivity, body composition, endurance/recovery, stress adaptation, longevity support. Big concept: mitochondria aren’t passive; they signal back to the nucleus. MOTS-c can translocate to the nucleus under metabolic stress and regulate gene expression. Mechanism highlighted: MOTS-c disrupts folate–methionine cycle → increases AICAR → activates AMPK → boosts fatty acid oxidation + insulin sensitivity. Review claims include: prevention of diet-induced obesity; possible cardiac protection against remodeling (NRG1–ERBB4 pathway mentioned). Longevity genetics angle: a mitochondrial polymorphism (noted as prevalent in Japanese population) may alter MOTS-c structure and associate with exceptional lifespan. Frailty/bone/muscle: MOTS-c described as inhibiting FOXO1 (muscle wasting signals), supporting myotube formation (STAT3), and reducing osteoclast differentiation (anti-osteoporosis). “Endogenous edge”: as a bioidentical peptide, MOTS-c is framed as potentially less immunogenic than some drugs, but oral delivery is a challenge due to peptide fragility. Practical close: best endogenous stimuli are mitochondrial challenges—exercise, fasting, heat/cold, hypoxia—plus circadian alignment and mitochondrial support nutrients. - Episode timeline 0:00–1:55 — Transition from SS-31 to MOTS-c; why MOTS-c is a “top two” peptide; new format: quick primer before the paper 1:55–4:33 — MOTS-c snapshot: what it is + core benefits list (metabolism, insulin sensitivity, fat loss, endurance, longevity) 4:33–7:57 — Review intro: mitochondria as control centers; retrograde signaling; MOTS-c as a mitochondrial messenger to DNA 7:57–10:44 — “Exercise mimetic” mechanism: folate–methionine cycle → AICAR → AMPK; obesity/metabolic protection examples 10:44–12:05 — Longevity genetics: MOTS-c polymorphism + “nature vs nurture” discussion 12:05–13:52 — Frailty defense: muscle (FOXO1/STAT3), bone (osteoclast suppression; OPG/RANKL mention) 13:52–15:46 — Endogenous/bioidentical angle; immune aging + senescent cell clearance; oral delivery limitations 15:46–19:31 — How to boost endogenous MOTS-c: exercise intensity, fasted training nuance, AMPK activators, TRE/IF/CR 19:31–24:25 — Cold/heat/circadian alignment + mitochondrial support stack (taurine, urolithin A, CoQ10, PQQ, etc.) 24:25–26:10 — “Distress signal” nuance: mitochondria release more MOTS-c when challenged 26:10–29:41 — Practical stacking: SS-31 first (engine repair) → add MOTS-c; daily timing suggestions; closing message - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

This is the first dedicated peptide deep dive of The Energy Code — and it starts with arguably the most mitochondrial-centric peptide on the board: SS-31 (Elamipretide). Dr. Mike breaks down a new paper showing how SS-31 may protect neurons in Parkinson’s disease by competing with alpha-synuclein at lipid membranes, slowing toxic aggregation, restoring mitochondrial respiration, and even reducing alpha-synuclein cellular entry. You’ll also hear a key caution: SS-31 appears highly protective at moderate doses, but too much may flip the benefit into harm, reinforcing the “dose makes the medicine” rule in mitochondrial pharmacology. (Educational content only, not medical advice.) - Article Discussed in Episode: Therapeutic Peptide SS-31 Modulates Membrane Binding and Aggregation of α-Synuclein and Restores Impaired Mitochondrial Function - Key Quotes From Dr. Mike: “The future of Parkinson’s therapy may not lie in cleaning up the mess, but rather in providing our neurons with a permanent molecular shield…” “SS-31 acts as a molecular shield protecting the brain’s energy supply…” “SS-31 acts as a molecular bouncer, physically evicting alpha-synuclein from lipid membranes…” “SS-31 substantially prolonged the lag phase of aggregation, essentially stalling the clock on protein buildup.” “These findings underscore the multifaceted protective role of SS-31 against mitochondrial dysfunction caused by alpha synuclein aggregation... SS-31 reversed this decline with a 10 micromolar dose…” - Key Points SS-31 is framed as a mitochondria-first peptide: “restore impaired mitochondrial function” is the headline. Parkinson’s pathology is presented as a cellular power failure inside dopaminergic neurons driven by alpha-synuclein toxicity. SS-31 may act like a “molecular bouncer” — outcompeting alpha-synuclein for anionic lipid membranes and preventing harmful binding/folding. The episode highlights the real-world complication: N-terminal acetylated alpha-synuclein (common in humans) embeds deeper and is harder to displace. SS-31 appears to delay aggregation kinetics (longer “lag phase”) and shift aggregate morphology toward potentially less toxic off-pathway forms. Mitochondrial function was assessed with a Seahorse mito stress test; SS-31 is described as restoring basal/max respiration (at a cited 10 μM dose). Mechanistically, SS-31 is explained as: Cardiolipin binding → supports OXPHOS efficiency/ATP output ROS scavenging (tyrosine residue) → reduces oxidative damage SS-31 may also reduce alpha-synuclein oligomer uptake by altering membrane electrostatics (less negative surface charge). A major warning: very high concentrations (described as >100 μM) may trigger apoptosis / reduce viability. Big-picture: SS-31 supports a “prevention-first” strategy — block the lipid–protein interaction upstream, rather than “cleaning up the mess” later. - Episode timeline 0:00–0:40 — Why peptides are the next major content focus; why SS-31 is the first peptide deep dive 0:40–3:55 — Paper intro + “SS-31 restores impaired mitochondrial function” framing; what the show will cover and why it matters 3:55–5:44 — Parkinson’s as mitochondrial “power failure”; alpha-synuclein as the driver; SS-31 as a BBB-permeable candidate 5:44–6:58 — Takeaway #1: SS-31 as a “molecular bouncer” displacing alpha-synuclein from membranes (dose-dependent) 6:58–8:16 — Takeaway #2: N-terminal acetylation makes alpha-synuclein “stickier” and harder to displace (real-human relevance) 8:16–9:40 — Takeaway #3: Aggregation kinetics + morphology shifts (stalling the “snowball”) 9:40–11:40 — Takeaway #4–#5: Respiration rescue + membrane/cell-entry effects; the dual mechanism (cardiolipin + ROS) 11:40–13:20 — Dose caution, wrap-up, and the “designer peptides” future-forward conclusion - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

In this special edition of The Energy Code, Dr. Mike shares a more in-depth discussion on his presentation from Dave Asprey’s BEYOND Biohacking event in Austin: The Energy Code Blueprint: Longevity Starts in the Mitochondria. He introduces BioLight Labs’ initial focus on mitochondrial and longevity peptides, then delivers a thorough foundation on bioenergetics — why “more energy per cell” translates to more vitality, how redox/voltage and electrons relate to inflammation, and why mitochondria act as environmental sensors that drive epigenetics. From there, the episode begins the 6 Pillars of Mitochondrial Wellness, covering Pillar 1 (Energy Production ) —including electron transport chain efficiency and EZ water — and Pillar 2 (Mitogenesis) —with key activators like exercise, fasting, cold exposure, PQQ, urolithin A, and red/near-infrared light. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: “The more energy you produce per cell, the more vitality you will have... The less energy you produce per cell, the closer to a state of disease you will be.”“Around 80% of modern diseases are directly tied to mitochondrial dysfunction.”“Any wellness strategy that involves harnessing electrons is inherently anti-aging.”“Epigenetics is rooted in the mitochondria. They sense your environment and then send signals to the cell nucelus, which then turns genes on/off based on those mitochondrial signals."“Cardiolipin… is like the bedrock of mitochondrial function... Many researchers now believe cardiolipin deterioration is one of the central hallmarks of mitochondrial aging.”“SS-31’s mission is to fix and repair and prevent damage to cardiolipin. This makes SS-31 the MOST IMPORTANT peptide for mitochondrial function and anti-aging, from the bioenergetic perspective."“After the age of 30, we typically lose about 1% of energy production annually.”“Mitochondrial decline drives the hallmarks of aging... The future is clearly bioenergetic.” - Key Points ⚡️ Longevity is downstream of bioenergetics: more energy produced per cell → more vitality; less energy → disease trajectory. ⚡️ Mitochondria are upstream of symptoms: dysfunction can precede diagnosis by years/decades. ⚡️  “Healing is Voltage”: redox potential, electron availability, pH, and inflammation are tightly linked. ⚡️ Mitochondria are not just power plants — they are environmental sensors (MIPS) driving epigenetic gene expression via retrograde signaling. ⚡️ Mitohormesis reframes “stress” as a dose-dependent upgrade signal for mitochondria (exercise, fasting, cold/heat, light, key compounds). ⚡️ Cardiolipin is presented as “the mitochondria of the mitochondria,” central to cristae structure, ETC organization, and mitochondrial aging. ⚡️ SS-31 is framed as a top-tier cardiolipin-targeting peptide; MOTS-c, Humanin, SHLP-2 as key mitochondrial-derived peptides. ⚡️ Energy production includes ATP + EZ water: ATP as immediate currency; EZ water as mitochondrial “battery pack” and hydration reserve. ⚡️ Red and near-infrared light are positioned as major tools to expand EZ water and support mitochondria across multiple pillars. ⚡️ The presentation tees up a “6 pillars” framework and promises a next episode continuation (pillars 3–6 + applications). - Episode timeline 00:00–01:55 — Special edition + Beyond Biohacking context; BioLite Labs intro (peptides focus)   01:55–04:52 — Talk format notes + offer to email slides as a resource   04:52–08:54 — Overview: bioenergetics → 6 pillars → optimization strategies → “day in the life” blueprint   08:55–11:02 — Bioenergetics foundation: “more energy per cell = more vitality” (Doug Wallace framing)   11:03–13:50 — Mitochondria as root cause: cells → tissues → organs → systems; symptoms appear late   13:51–17:32 — Voltage/redox: electrons, pH, inflammation; examples (sunlight, grounding, electron-rich strategies)   17:33–19:04 — “Anti-aging via electrons”: shared thread across many wellness strategies   19:07–21:21 — Mitochondria as environmental sensors (MIPS) + retrograde signaling → epigenetics   21:23–24:42 — Mitohormesis: what doesn’t kill mitochondria makes them stronger; key stressors/benefits   24:45–31:56 — Cardiolipin deep dive: cristae structure, fragility to oxidative stress, downstream consequences; SS-31 spotlight   31:57–35:55 — Mitochondrial lens of aging: “energy cliff” concept; mitochondrial decline drives aging hallmarks   36:39–38:00 — “Future is bioenergetic”: move from managing decline to engineering resilience   38:01–40:10 — Six pillars introduced: energy, biogenesis, mitophagy, dynamics, ROS protection, light   40:11–46:22 — Pillar 1 (part 1): ETC mechanics; complex I/III issues; methylene blue + taurine note   46:23–51:25 — Pillar 1 (part 2): EZ water as battery/hydration; expanding EZ with red/NIR and sauna   52:00–58:17 — Pillar 2: Mitogenesis/PGC-1α activation (exercise, fasting, cold, PQQ, urolithin A, red light)   58:19–01:00:43 — Wrap: “halfway through” + next episode teaser (pillars 3–6 + 15 applications) - Introducing BioLight Labs! For years, BioLight has been dedicated to advancing mitochondrial wellness through education, red and near-infrared light therapy, methylene blue, and targeted nutritional solutions.   Today, we’re excited to introduce BioLight Labs — our new research-focused division dedicated to cutting-edge peptides, bioenergetics, longevity, and advanced mitochondrial science.   Our initial offerings will focus on some of the most promising peptides in the fields of healthy aging, cellular resilience, recovery, and mitochondrial function, with many more innovative compounds and educational resources to come.   BioLight Labs was created to serve researchers, practitioners, and health enthusiasts seeking the next frontier of bioenergetic optimization.   The future of wellness is bioenergetic. The future is BioLight Labs.   Explore BioLight Labs → - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

This Deep Dive breaks down a preprint review from Free Radical Biology & Medicine titled “Mitoredox Shifts in Mitochondrial Dysfunction.” Dr. Mike opens with a TL;DR and then goes deeper into the core idea: a “mitoredox shift” (a disruption in mitochondrial redox balance) may be the unifying axis linking oxidative stress to mitochondrial quality-control failure, genome instability, heteroplasmy drift, and regulated cell death. The episode draws a clean line between primary genetic mitochondrial syndromes and far more common secondary mitochondrial dysfunction driven by environmental/metabolic stressors, then explores five big concepts: why redox imbalance collapses mitophagy and mtDNA stability, how “healthy” mitochondria can become hyperactive and accelerate disease, the 60–80% heteroplasmy tipping point, the reperfusion paradox, and emerging frontiers like mitochondrial transplantation, AI-driven oculomics, and new redox-modulating drugs — plus Dr. Mike’s “mitochondrial triad” lens (red light, methylene blue, C60). (Educational content only, not medical advice.) - Article Discussed in Episode: Mitoredox shifts in mitochondrial dysfunction - Key Quotes From Dr. Mike: “Mito-redox shifts… serve as a central link between oxidative stress and various diseases.” “These shifts destabilize essential cellular processes such as mitophagy and mitochondrial DNA stability…” “We are entering an era of mito redox medicine where we manage the electron flow of life itself.” “The retina is the only part of the central nervous system that can be imaged non-invasively… Whereby fluorescence imaging can detect metabolic failures years before physical symptoms appear… that is game changing.” “Life is defined by the steady controlled flow of electrons… when that flow is disrupted… our mitoredox shifts towards mitochondrial dysfunction and, ultimately, disease." - Key Points The review frames mitoredox shifts as a central link between oxidative stress and diverse diseases. Distinguishes primary mitochondrial syndromes (genetic) vs secondary disorders (environmental/metabolic)—with secondary being far more common. Mitoredox shifts destabilize mitophagy + mtDNA stability, leading to dysfunctional organelle buildup and cell death. The shift acts like an upstream master switch, biasing cells toward regulated death programs (e.g., ferroptosis, cuproptosis). “Healthy mitochondria can be hyperactive”: compensatory overwork can spike ROS and accelerate heteroplasmic drift. Heteroplasmy threshold: symptoms often emerge when mutated mtDNA crosses ~60–80%. Proposed takeover mechanisms: faster replication of truncated genomes, mitophagy decline, “survival of the sickest” evasion, random drift. Reperfusion paradox: restoring oxygen after ischemia can trigger a ROS surge that worsens injury and inflammation. Diagnostics: biomarkers + retinal imaging/oculomics, with AI methods potentially detecting dysfunction yearsearly. Therapeutics: mitochondrial transplantation, novel redox modulators (e.g., PMX 500FI), and “electron-flow stabilization” strategies. - Episode timeline 0:00–0:20 — Intro + review title + journal + preprint context (publishing Sept 2026) 0:20–1:22 — New format: TL;DR first, then deeper dive 1:22–2:56 — TL;DR: mitoredox shifts as the bridge between oxidative stress and disease; primary vs secondary; diagnostics + therapies; goal = restore homeostasis 3:00–5:01 — Mythology + endosymbiosis framing: “bioenergetic fire,” mitochondria as life/death controllers 5:01–6:58 — Concept 1: Mitoredox shift as the “unified field theory” linking ROS/antioxidants, QC failure, genome instability, regulated cell death 7:03–9:05 — Concept 2: “Healthy mitochondria” hyperactivity + metabolic asymmetry + heteroplasmic drift 9:05–11:59 — Concept 3: 60–80% tipping point; takeover mechanisms; aerobic glycolysis as a “stealth” adaptation 11:59–13:38 — Concept 4: reperfusion paradox; ROS overload → vascular destabilization + inflammation; eye/oculomics relevance 13:41–18:26 — Concept 5: future interventions—mito transplantation, AI oculomics, redox drugs (PMX 500FI) + Mike’s redox “triad” (RLT/MB/C60) 18:26–19:25 — Closing: mitochondria as redox arbiters; “electron flow of life” question + final thought - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

Atrial fibrillation is typically treated like an electrical glitch — rate control, rhythm control, anticoagulation. But this Deep Dive explores a newer frame: AFib may be driven by metabolic collapse and fibrotic remodeling rooted in mitochondrial dysfunction. Dr. Mike breaks down a May 5 Biomedicines paper titled “Humanin and MOTS-c attenuate atrial fibrillation by suppressing fibrosis and mitochondrial dysfunction,” highlighting why mitochondrial-derived peptides (MDPs) — Humanin and MOTS-c — may function as stress-responsive guardians that help preserve mitochondrial integrity, reduce oxidative stress, and blunt fibrosis. You’ll hear the key human tissue findings (both peptides downregulated in AFib atrial appendages), the biomarker signal (plasma MOTS-c inversely tracking NT-proBNP), the “Humanin paradox” (plasma up while atrial tissue down), and the mouse data showing peptide treatment reduced AFib inducibility and structural remodeling. The episode closes with a big question: if heart health is about fueling cellular engines, not just fixing wiring, how does that reshape aging medicine? (Educational content only, not medical advice.) - Article Discussed in Episode: Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction - Key Quotes From Dr. Mike: “For decades, the medical establishment has approached AFib as an electrical failure…The true culprit may not be the wiring, but rather the power plants.” “In patients with atrial fibrillation, these protective peptides essentially vanish... The more severe the peptide depletion, the more advanced the structural damage appeared to be.” “Our study identifies down regulation of Humanin and MOTS-c as a novel feature of human afib that correlates with fibrosis... As Humanin and MOTS-c levels drop, collagen deposition and atrial fibrosis increase.” “Humanin predominantly influences cell adhesion and immune response pathways, while mots C targets metabolic processes... They effectively attenuated structural remodeling and significantly reduced afib inducibility…” “These micropeptides are born directly within the mitochondrial DNA... They are exercise sensitive myokines, meaning physical activity naturally stimulates their production.” - Key Points The featured paper (May 5, Biomedicines): Humanin + MOTS-c attenuate AFib by suppressing fibrosis and mitochondrial dysfunction. AFib is framed as a growing societal burden and a driver of stroke/heart failure; current therapies mainly manage the “wiring.” Humanin + MOTS-c are mitochondrial-derived peptides encoded in mtDNA, acting as cytoprotective stress messengers. AFib atrial tissue shows significant downregulation of both peptides (spatial transcriptomics + histology). Severity link: more depletion → more structural damage/fibrosis. Biomarker link: plasma MOTS-c is decreased and inversely correlates with NT-proBNP. The “Humanin paradox”: Humanin depleted in atrial tissue but slightly elevated in plasma — blood levels can mislead. In a mouse model, HNG (Humanin analog) + MOTS-c reduced AFib inducibility and structural remodeling. Mechanistic themes: preserved mitochondrial ultrastructure, normalized fission dynamics, reduced hypertrophy, lowered IL-1β and IL-6. Dual-pronged fibroblast control: Humanin influences adhesion/immune pathways, MOTS-c targets metabolic pathways. - Episode timeline 0:00–0:57 — Intro: peptide-focused season; “future of mitochondrial medicine” 0:57–2:32 — Paper setup + personal relevance; why AFib is a mitochondria-dense tissue problem 2:32–3:50 — Reframing AFib: from electrical “wiring” to mitochondrial “power plants” + micropharmacology 3:50–4:56 — Humanin + MOTS-c basics: mtDNA-encoded “guardians,” exercise-sensitive signaling 4:56–6:51 — Human atrial tissue findings: downregulation, severity correlation, MOTS-c vs NT-proBNP 6:51–7:56 — Fibrosis link + RAAS context; peptides as complementary anti-scarring pathway 7:56–9:47 — Mouse model: HNG + MOTS-c outcomes (ultrastructure, fission, hypertrophy, cytokines) 9:47–11:15 — The Humanin paradox: plasma vs tissue concentration; biomarker caution 11:15–12:20 — Fibroblast behavior + RNA-seq: Humanin vs MOTS-c “two angles” 12:20–13:26 — Synthesis + limitations + closing question (“fueling the cell” paradigm) - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

Spinal cord injury is usually framed as a permanent structural problem — axons torn, connections lost, paralysis inevitable. This Deep Dive flips that assumption: the real long-term roadblock may be a secondary mitochondrial energy crisis that turns a helpful early scar into a toxic, permanent barrier. Using a 2026 Frontiers in Neurology review, Dr. Mike and Don unpack how ATP collapse, ROS signaling, failed mitophagy, and mtDNA “false infection” alarmsdrive chronic sterile inflammation, fibrotic hardening, and growth cone collapse. Then they explore the new therapeutic frontier: mitochondria-targeted antioxidants (MitoQ), membrane stabilizers (SS-31), NAD+/AMPK reprogramming, fission/fusion tuning (DRP1/MFN2), mitophagy restoration (PINK1/Parkin, BNIP3/NIX), and even mitochondrial delivery + mtDNA base editing — with the critical caveat: timing matters, because the early scar is initially protective. (Educational content only, not medical advice.) - Article Discussed in Episode: Effect of mitochondrial dysfunction on scar formation after spinal cord injury - Key Quotes From Dr. Mike: “What if the real reason the nerves can’t heal is actually a microscopic energy crisis?” “This entire battle is governed by the powerhouses of our cells, the mitochondria.” “In a severe spinal cord injury, that recycling process… mitophagy… completely fails.” “SS-31… physically binds and stabilizes the cardiolipin… preventing cytochrome C release... It acts like an emergency fuel drop.” “The answer lies in sustained mitochondrial failure.” - Key Points SCI disability isn’t only the “cut” — it’s the secondary metabolic battle that follows. Early glial scar formation is protective: it walls off necrotic tissue and contains inflammation. Acute mitochondrial rupture causes ATP drop + moderate ROS burst that acts as an alarm: ROS → STAT3 activation in astrocytes (glial boundary) ROS → TGF-β1 activation in fibroblasts (ECM deposition) Chronic problem: mitophagy failure leaves fragmented mitochondria leaking mtDNA + excess ROS. Leaked mtDNA looks “bacterial,” driving sterile inflammation via NLRP3 and sustained microglial activation. Chronic inflammatory signaling stabilizes HIF-1α → fibrosis hardens; astrocytes secrete CSPGs that repel axon regrowth. Regenerating axons fail via growth cone collapse from local ATP scarcity + toxic environment. Interventions target the power grid, not just the scar: MitoQ (TPP “VIP pass” into mitochondria) scavenges ROS at the source. SS-31 stabilizes cardiolipin → prevents cytochrome-c leak/apoptosis. AMPK agonists + NAD+ precursors (NMN/NR) boost energy + suppress NF-κB inflammation. DRP1 inhibitors / MFN2 agonists restore fission–fusion balance. PINK1/Parkin + BNIP3/NIX reboot mitophagy and clear damaged mitochondria. “Sci-fi tier”: mitochondrial delivery (nanocarriers, MSC exosomes, iPSCs) + mtDNA base editing (DDCBE via AAV). Translational bottleneck: spatiotemporal timing — block scarring too early and you remove the protective “sandbag wall.” - Episode timeline 0:19–1:30 — Premise: paralysis as a secondary energy crisis; 2026 Frontiers in Neurology review introduced 1:30–2:31 — Shift from structural damage to metabolic pathology 2:31–5:20 — Acute phase: mitochondrial rupture → ATP drop + ROS alarm → STAT3 astrocytes + TGF-β1 fibroblasts → protective boundary 5:20–6:49 — Why the protective wall becomes a permanent roadblock: sustained mitochondrial failure 6:49–9:47 — Mitophagy failure → mtDNA/ROS leak → “false infection” → NLRP3, HIF-1α fibrosis, CSPGs, growth cone collapse (ATP starvation) 9:47–12:54 — Targeted mitochondrial pharmacology: MitoQ delivery logic; SS-31 cardiolipin stabilization 12:54–13:55 — Metabolic reprogramming: AMPK agonists + NAD+ precursors → energy support + NF-κB suppression 13:55–16:45 — Dynamics + cleanup: DRP1/MFN2 tuning; PINK1/Parkin, BNIP3/NIX mitophagy + ubiquitin “barcode” clearance 16:45–19:55 — “New hardware” strategies: mito-nanocarriers, MSC exosomes, iPSCs; mtDNA editing (DDCBE/AAV), HDAC inhibitors, ncRNAs 19:55–20:53 — The timing problem: preserve early protective scar, prevent later inhibitory scar 20:53–22:23 — Final synthesis + fibrosis crossover question; close - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

What if the next leap in cancer therapy doesn’t come from a billion-dollar lab — but from sea sponges, brown seaweed, fungi, and everyday plants? In this Deep Dive, Dr. Mike and Don unpack a 2025 review on natural compounds that target cancer by attacking mitochondrial metabolism — the tumor’s true center of gravity. You’ll learn how cancer “hotwires” its mitochondria for growth, blocks apoptosis with BCL-2 “bouncers,” and even hijacks mitophagy to survive starvation. Then we break down how compounds like CBD, curcumin, resveratrol, EGCG, fucoidan, and marine/fungal molecules can drain mitochondrial voltage, overload oxidative stress, trigger lethal mitophagy, or cut glutamine supply lines. Finally, we tackle the real bottleneck — delivery — and why conjugates, gold nanoparticles, nanoencapsulation, and synthetic biology may be the bridge from petri-dish magic to real-world oncology. (Educational content only, not medical advice.) - Article Discussed in Episode: Natural compounds targeting mitochondrial metabolism in cancer therapy: a literature review - Key Quotes From Dr. Mike: “Natural compounds… can actually be weaponized against the very unique way a cancer cell feeds itself.” “The tumor massively overproduces those BCL2 bouncers... CBD aggressively drains that battery… the BCL2 bouncers literally lose their grip.” “Curcumin… clogs the exhaust pipes until the factory suffocates on its own fumes.” “Resveratrol… triggers what we call lethal mitophagy.” “EGCG doesn’t just attack the power plant, it cuts off the supply lines entirely.” “Gold nanoparticles are… microscopic armored vehicles... It’s basically a Trojan horse made of gold.” - Key Points Cancer mitochondria aren’t “broken” (Warburg was incomplete) — tumors reprogram mitochondria into biosynthetic superfactories. Tumors rely on fatty acid oxidation and often become glutamine-addicted to feed the TCA “manufacturing hub.” Mitochondria also control apoptosis; cancer survives by overexpressing BCL-2 to block BAX/BAK pore formation and cytochrome c release. Mitophagy is a paradox: early tumor suppression vs. later survival cannibalism under hypoxia/starvation. Natural compounds target key failure points: CBD: drops mitochondrial membrane potential → releases apoptotic blockade. Curcumin: amplifies ROS + mtDNA damage → mitochondrial rupture/apoptosis. Resveratrol: pushes mitophagy into lethal overdrive. EGCG: blocks glutamine utilization (cuts supply lines). Fucoidan: reduces anti-apoptotic defenses across multiple proteins. Marine/fungal agents: uncoupling, ETC complex blockade, ER stress cascades. Biggest barrier: bioavailability + rapid metabolism (“forgot the zip code”). Solutions: drug hybrids/conjugates, gold nanoparticles, nanocarriers, and synthetic biology fermentation for scalable supply. Final provocative arc: if we can deliver payloads to kill tumor mitochondria, can we use the same delivery logic to repair mitochondria in aging? - Episode timeline 0:19–1:18 — Hook + episode premise: nature as an anti-cancer weapons lab; source paper introduced 1:18–2:25 — Why this matters: cancer scale + limits of “blunt instrument” therapies 2:25–4:24 — Warburg effect explained (glycolysis “backup generators”) and why the old assumption misled the field 4:24–6:31 — Metabolic reprogramming: mitochondria as tumor superfactories; fatty acid oxidation + glutamine dependence 6:31–9:15 — Apoptosis control: BCL-2 “bouncers,” BAX/BAK “cops,” cytochrome c “fire alarm” 9:15–10:59 — Mitophagy paradox: tumor suppression → survival cannibalism in hypoxic/starved tumor cores 10:59–15:18 — Plant compounds mechanics: CBD (voltage), curcumin (ROS), resveratrol (lethal mitophagy), EGCG (glutamine blockade) 15:18–19:07 — Marine + fungal compounds: fucoidan; sponge uncouplers; ER-stress triggers; ETC complex blockers 19:07–20:48 — The “zip code” problem: bioavailability, metabolism, delivery failure in humans 20:48–23:19 — Delivery solutions: conjugates/hybrids, gold nanoparticles, nanoencapsulation 23:19–24:30 — Scaling without ecosystem damage: synthetic biology “brew the medicine” 24:30–26:21 — Final synthesis + aging crossover question (deliver killers vs. deliver repair) - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

Mitophagy sounds technical — until you realize it may be one of the most important biological processes behind aging, cardiovascular disease, eye degeneration, inflammation, and cellular energy. In this episode, Dr. Mike and Don break down three recent scientific reviews that converge on one central message: when mitochondrial cleanup fails, tissues don’t just lose ATP — they become inflamed, oxidatively stressed, and vulnerable to disease. You’ll learn the difference between autophagy and mitophagy, why damaged mitochondria act like inflammatory “danger beacons,” what this looks like in Fabry disease cardiomyopathy, inflammatory cardiovascular disease, and ophthalmic diseases like glaucoma/AMD/diabetic retinopathy — and why the future of mitochondrial medicine is about restoring the rhythm of removal + renewal. (Educational content only, not medical advice.) - Articles Referenced in Episode:   Mitophagy in ophthalmic pathologies: Molecular mechanisms and therapeutic implications   Understanding Dysfunctional Autophagy and Mitophagy in Inflammatory Cardiovascular Disease   Early mitophagy defects and impaired mitochondrial energy metabolism drive target organ damage progression: lessons from the Fabry heart - Key Quotes From Episode: “Mitophagy… means the body’s process for identifying damaged mitochondria, removing them, and making room for healthier mitochondria to take their place.” “When mitochondrial cleanup fails, the cell doesn’t just lose energy — it becomes inflamed, stressed, and vulnerable to disease.” "Mitochondrial quality control is not a side issue. It may be one of the central mechanisms that determines whether high-demand tissues stay resilient or begin to fail.” “A healthy cell is always asking: which mitochondria are still efficient, and which ones are leaking too much oxidative stress?” “Mitophagy is the process that removes the liabilities.” “Damaged mitochondria are not just weak energy producers. They can actually become inflammatory.” - Key Points Autophagy = general cellular recycling; mitophagy = targeted recycling of damaged mitochondria. Mitochondria are dynamic networks, not static “batteries” — they’re constantly tested, repaired, fused/fissioned, and removed. Damaged mitochondria don’t just make less ATP—they can trigger sterile inflammation by leaking ROS, mtDNA, cardiolipin, etc. Fabry disease heart model: lysosomal dysfunction → impaired mitophagy → damaged mitochondria → less ATP + more ROS → worse lysosome function (a mito–lysosomal vicious cycle). Inflammatory cardiovascular disease: damaged mitochondria activate inflammatory pathways (e.g., NLRP3) and worsen vascular/heart pathology. Ophthalmology: retina is extremely energy-hungry; mitophagy failure contributes to glaucoma/AMD/diabetic retinopathy vulnerability. Shared “cast” across tissues: PINK1/Parkin, BNIP3/NIX/FUNDC1, AMPK–mTOR, sirtuins, FOXO3, PGC-1α(cleanup + rebuilding). The winning strategy isn’t “maximize mitophagy” — it’s balanced flux: remove damaged mitochondria and replace them via biogenesis. - Episode timeline 00:00–03:30 — Cold open: why mitophagy changes how you think about aging, heart health, eye health, inflammation, energy 03:30–09:00 — Definitions: autophagy vs mitophagy + “city waste management” analogy 09:00–14:30 — Core principle: damaged mitochondria as inflammatory triggers (sterile inflammation) 14:30–27:30 — Paper 1 (Fabry + heart): lysosome impairment → impaired mitophagy → early mitochondrial dysfunction → vicious cycle; early-before-symptoms concept 27:30–39:30 — Paper 2 (inflammatory cardiovascular disease): mtDNA/ROS danger signals → NLRP3 + immune activation; mitophagy as anti-inflammatory defense 39:30–49:00 — Paper 3 (eye disease): retina energy demand; mitophagy failure in glaucoma/AMD/diabetic retinopathy; why visual tissues are vulnerable 49:00–54:30 — Unified model: “high-demand tissues + failed cleanup = energy loss + chronic inflammation + degeneration” 54:30–56:12 — Final synthesis: mitophagy = energy defense + immune regulation; “removal + renewal” rhythm - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram Facebook

What if a fractured wrist didn’t automatically mean weeks of brutal pain — and a medicine cabinet full of NSAIDs or opioids? In this Deep Dive, Dr. Mike and Don break down a 2026 systematic review and meta-analysis (12 randomized controlled trials across 5 countries, ~500 patients) showing that photobiomodulation (red/near-infrared light) can significantly reduce acute fracture pain, improve early upper-limb grip strength, and dramatically reduce sleep-wrecking nocturnal pain — all without reported side effects. You’ll learn why this isn’t “heat therapy,” how mitochondria and cytochrome c oxidase translate photons into biochemical calm, why results are strongest early (and fade later), and what the evidence does not yet prove about speeding true bone knitting on X-ray. (Educational content only, not medical advice.) - Article Discussed in Episode: Effect of photobiomodulation on pain relief and functional improvement in fractures: a systematic review and meta-analysis - Key Quotes From Dr. Mike: “At the 1-week mark… pain scores were significantly lower in the group receiving photobiomodulation.” “At 4 weeks out… grip strength was significantly greater in the light therapy group.” “The risk of experiencing severe sleep-disrupting nocturnal pain was cut exactly in half.” “Photobiomodulation primarily targets the acute inflammatory phase.” “When you irradiate the fracture site directly… you’re acting locally… But laser acupuncture acts systemically.” - Key Points PBM is photochemical, not photothermal — it’s not a heating pad. Mechanism centers on cytochrome c oxidase (mitochondria) → ↑ATP + signaling (NO, Ca²⁺, low “healthy” ROS). Acute pain reduction is strongest at ~1 week vs. sham treatment (VAS/NRS). Nocturnal pain risk cut ~in half (reported risk ratio ~0.49) → major quality-of-life and recovery leverage. Upper-limb fractures: ~+5 kg grip strength improvement around week 4 vs placebo. PBM can work locally (fracture site) and systemically (laser acupuncture points) via neurochemical pain pathways (endorphins, serotonin/norepinephrine, spinal gating/DNIC). Long-term (4–26 weeks): differences in pain/function often wash out as recovery enters remodeling phase. Evidence for faster radiographic bone healing is inconsistent across trials. Energy density window for analgesia looks broad; wavelength matters more (NIR penetrates deeper than red). Big gap: trials largely didn’t measure angiogenesis endpoints, which may matter for longer-term remodeling. - Episode timeline 0:19–1:26 — Fracture scenario + why alternatives to NSAIDs/opioids matter 1:26–2:51 — Source setup: 2026 systematic review/meta-analysis (12 RCTs; 5 countries; ~500 patients) 2:51–4:16 — “Not a heating pad”: photochemical vs photothermal PBM 4:16–6:12 — Mechanism: mitochondria → cytochrome c oxidase → ATP + NO/Ca²⁺/low ROS signaling 6:12–7:55 — Why fractures hurt: periosteum + inflammation + swelling + spasm; NO → microcirculation + waste clearance 8:19–9:18 — Main early outcome: lower pain at 1 week (VAS/NRS; sham-controlled) 9:21–10:30 — Function: grip strength improved at 4 weeks (+5 kg) in upper-limb fractures 10:41–13:56 — Local PBM vs laser acupuncture: endorphins + neurotransmitters + spinal “circuit breaker” (DNIC) 14:20–16:23 — Why effects fade later: PBM targets acute inflammatory phase more than long remodeling 16:53–17:38 — Radiographic healing: inconsistent evidence for faster cortical bridging/BMD 18:43–21:05 — Parameters: broad effective energy-density range for analgesia; NIR penetrates deeper than red 21:12–22:24 — Missing metrics: angiogenesis not evaluated in included trials 22:36–23:09 — Long-term tracking tools (e.g., PRWE) vs simple pain scales 23:14–24:18 — Nocturnal pain finding: risk ratio ~0.49 (sleep-disrupting pain roughly halved) 24:41–26:15 — Synthesis: best-supported benefits + what PBM isn’t (not proven to speed full bone knitting) 26:33–27:36 — Closing question: why isn’t this standard in trauma care yet? - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

Most people think “metabolic treatment” means fewer cravings and a changing number on the scale. This Deep Dive goes microscopic — into the ER–mitochondria contact sites (mito-ERCS) where metabolic dysfunction may begin as a structural failure, not just a hormone problem. Using the paper “GLP-1 receptor and mitochondria contact sites: an emerging mechanism of metabolic regulation,” Dr. Mike and Don explain how chronic metabolic stress can sever a ~20-nanometer communication bridge between the endoplasmic reticulum (cellular “factory”) and mitochondria (cellular “power plant”). Then they explore a provocative idea: GLP-1 receptor agonists may work partly by forming localized “signalosome” hubs at these contact sites — boosting cAMP right where it’s needed — to upregulate MFN2, a tethering “winch” that helps pull fragmented mitochondria back into proper contact and restore calcium/lipid exchange and metabolic flexibility. (Educational content only, not medical advice.) - Article Discussed in Episode: GLP-1 receptor and Mitochondria-ER Contact Sites: an emerging mechanism of metabolic regulation - Key Quotes From Dr. Mike: “The paper introduces a breakthrough concept here called signalosomes.” “GLP-1 receptors physically organize into specialized, highly concentrated hubs… directly at the site of the severed connection.” “Could targeting these microscopic contact sites hold the key to reversing the cellular decay of aging itself?” “When your body enters a state of chronic metabolic dysfunction, the stress acts like a biochemical wrecking ball inside that factory.” “These GLP-1 therapies are far more than just systemic appetite suppressants… They are literal microscopic architects.” - Key Points Metabolic disease may involve physical disruption of ER–mitochondria contact sites (mito-ERCS), not only “slow metabolism” in a vague sense. The paper frames mito-ERCS as a ~20 nm bridge enabling critical ER↔mitochondria communication. Chronic stress is described as triggering an ATF4 → PDE4D → cAMP degradation cascade, contributing to bridge failure. When contact sites fail, mitochondria can fragment, contributing to an “energy crash” phenotype. GLP-1 receptors may assemble into localized signalosomes at mito-ERCS — targeting repair rather than broadcasting diffuse signaling. Local cAMP signaling can promote MFN2 upregulation, helping re-tether mitochondria back to ER at the correct distance. Restored contact sites may normalize calcium and lipid transfer, supporting metabolic flexibility. Big takeaway: GLP-1s may be cellular architects, not just appetite suppressants — raising the question of whether “contactomics” could extend into aging biology. - Episode timeline 0:19–0:41 — Intro: metabolic treatment isn’t just “scale changes”; we’re going microscopic 1:00–1:18 — Grounding paper: GLP-1 receptor + mitochondria contact sites as metabolic regulation 1:34–2:11 — Core architecture: ER as “factory,” mitochondria as “power plant,” bridged by ~20 nm contact sites 2:11–3:18 — Metabolic collapse model: chronic stress → ATF4 → PDE4D → cAMP loss → contact sites sever + mitochondrial fragmentation 3:27–4:20 — Main question: how do GLP-1 therapies fix a precise structural failure without chaotic signaling? 4:09–4:56 — “Signalosomes”: GLP-1 receptors form concentrated hubs at mito-ERCS (targeted repair zone) 4:56–5:36 — Local cAMP boost → MFN2 upregulation: the “winch” that re-tethers and rebuilds the bridge 5:36–6:25 — Function restored: calcium/lipid exchange resumes; factory + power plant back online 6:25–7:13 — Bigger implication: GLP-1s as “microscopic architects”; does contactomics extend to aging? - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

This episode of The Energy Code reframes mitochondria from “powerhouses” into master environmental sensors — and explains why mild cellular stress can be the very signal that upgrades your biology. Dr. Mike and Don unpack mitohormesis: the bell-curve logic where too much stress destroys cells, too little causes stagnation, and the “just right” dose triggers repair, resilience, and longer healthspan. You’ll learn how mitochondria “shout” to the nucleus through stress pathways like UPRmt and the Integrated Stress Response (ISR) — including an elegant “fire alarm” cascade (OMA1 → DLE1 cleavage → HRI → eIF2α → ATF4). Then the lens widens from single-cell survival to whole-body adaptation via mitokines like FGF21 and GDF15 (appetite suppression, energy expenditure), plus mitochondrial peptides like MOTS-c. The episode connects this to exercise, fat “browning,” stem-cell hypoxic “seed vaults,” and the darker edge: how cancer hijacks the same survival program to create therapeutic resistance. Finally, it hits the headline takeaway: the future isn’t “eliminate all stress with antioxidants” — it’s precision control of the Goldilocks zone. (Educational content only, not medical advice.) - Articles Referenced in Episode: Mitohormesis Mammalian mitohormesis: from mitochondrial stressors to organismal benefits Mitohormesis; Potential implications in neurodegenerative diseases Mitohormesis and mitochondrial dynamics in the regulation of stem cell fate MITOHORMESIS: THE CORNERSTONE OF THERAPEUTIC RESISTANCE IN CANCER CELLS - Key Quotes From Episode: “Mitohormesis is essentially weightlifting for your cellular engines.” “The very thing causing the damage… is the required key to turn on the system that builds the fire extinguishers.” “Regular physical exercise is, at its core, a mitohormetic stressor.” “If you hit an optimal threshold of mild to moderate mitochondrial stress… it triggers a beneficial, highly active adaptive response.” “We need to start looking at [mitochondria] as the master environmental sensors of the entire human body.” - Key Points Mitohormesis = a nonlinear (bell-curve) response: too much stress → mitochondrial rupture → inflammation → apoptosis too little stress → no upgrades (stagnation) “just right” stress → adaptive reprogramming → resilience + longevity Mitochondria are framed as environmental sensors, not just ATP factories. Key triggers: ROS, misfolded proteins, hypoxia, fasting/substrate deficiency, mtDNA mutations. Core “fire alarm” signaling described: OMA1 cleaves DLE1 → DLE1S activates HRI → eIF2α → ATF4 → DNA-level survival reprogramming. ATF4 shifts metabolism, boosts amino acid import, supports DNA repair via one-carbon metabolism, restores redox balance via endogenous antioxidants (e.g., glutathione). Built-in redundancy: “import arrest” still triggers ISR when DLE1 accumulates outside the mitochondria. Systemic mitohormesis: stressed tissues secrete mitokines that upgrade distant organs. Examples: FGF21 → higher energy expenditure + fat metabolism signaling GDF15 crosses BBB → appetite/taste aversion (energy conservation + toxin avoidance) MOTS-c → improves metabolic homeostasis + exercise capacity NAT (N-acetyl-L-tyrosine) → induces tiny ROS burst → activates FOXO/KEAP1/Nrf2 defense axis Exercise is framed as the most reliable, natural Goldilocks stressor: ROS + low ATP + hypoxia → ISR/mitokines → whole-body resilience. Stem cells live in hypoxic “seed vault” niches to preserve stemness and avoid ROS damage; differentiation requires fusion → OXPHOS surge → ROS signal. Dark side: cancer can hijack mitohormesis → therapeutic resistance; precision medicine must both trigger and block these pathways contextually. - Episode timeline 00:00:37–00:02:25 — The paradox: stress/toxins/starvation can upgrade cells → mitohormesis defined 00:02:25–00:04:34 — Research stack overview (Gunawan 2025; Barzegari 2022; Cheng/Liu/Finkel 2024; Gohil/Singh 2021; Boet 2024) + thesis: mitochondria as sensors 00:04:46–00:06:40 — Hormesis history + “dose makes the poison” → bell curve explained 00:06:40–00:10:23 — Three zones: catastrophic failure vs stagnation vs Goldilocks adaptation; strength-training analogy 00:10:23–00:13:32 — “Cellular dumbbells”: ROS, misfolded proteins, hypoxia, fasting, mtDNA mutations 00:13:32–00:24:28 — How mitochondria signal the nucleus: UPRmt + ISR; deep dive into OMA1 → DLE1 → HRI → eIF2α → ATF4 + redundancy via import arrest 00:24:28–00:29:31 — From one cell to the whole organism: systemic mitohormesis + mitokines 00:29:31–00:33:10 — NAT discovery (army worm → humans): controlled ROS “match” → KEAP1/Nrf2 defense amplification 00:33:10–00:37:28 — Exercise redefined: mitohormetic stressor → mitokines → whole-body upgrades + white fat browning 00:37:28–00:47:44 — Stem cell fate (Barzegari 2022): hypoxic niches, HIF1α, glycolysis, “seed vault” model; fusion/fission dictates stemness vs differentiation 00:47:44–00:49:55 — Dark pivot: cancer hijacks mitohormesis → therapeutic resistance; Warburg framing introduced 00:49:56–00:58:34 — Aging/Alzheimer’s + interventions: “ring the alarm”; urolithin A (postbiotic → mitophagy); antioxidant paradox setup + Ristow 2009 (C+E blunting exercise adaptation) 00:58:34–01:02:17 — Synthesis: mitochondria as sentries; precision medicine = manage Goldilocks zone; modern comfort “signal deprivation” question - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram Facebook

Sepsis is deadly on its own — but in diabetes, the baseline oxidative stress turns it into a full-blown organ-killing fire. In this Deep Dive, Dr. Mike and Don unpack a new study where water-soluble, hydroxylated fullerene C60 acts like a nanoscale “electron sink,” neutralizing free radicals the way depleted antioxidant enzymes can’t. In a diabetic sepsis model (CLP), C60 sharply reduced lipid peroxidation and protected multiple organ systems — liver, heart, and brain — while also boosting native antioxidant capacity (catalase). The big question: is this just an acute rescue tool… or a future prophylactic “organ armor” strategy? (Educational content only, not medical advice.) - Article Discussed in Episode: Effects of fullerenol C60 on the liver, heart and brain tissues of streptozotocin‑induced diabetic rats with sepsis - Key Quotes From Dr. Mike: "Think of sepsis as a massive fire breaking out in a house… and diabetes like having gasoline already spilled all over the floor." Regarding C60: “It has this amazing capacity to attract and neutralize rogue, unbalanced electrons from free radicals.” “In the liver, there was vastly reduced hepatocyte necrosis.” “In the heart, they saw reduced interstitial fibrosis and way less myocardial disorganization.” “They noted a major decrease in inflammatory cellularity in the brain.” “It’s (C60) not just blocking the fire—it’s like upgrading the body’s sprinkler system.” - Key Points Diabetes pre-loads the system with oxidative stress, making sepsis dramatically more damaging. The model: polymicrobial sepsis via CLP in diabetic rats. “Regular” C60 is insoluble/toxic in biology, but hydroxylated C60 becomes water-soluble and biologically usable. Mechanism frame: C60 as an “aggressive electron sink” that neutralizes free radicals and mimics SOD-like activity. Marker shift: TBARS ↓ (less lipid peroxidation / less membrane damage). Organ protection signals: Liver: necrosis ↓; AST/ALT/GGT/bilirubin ↓ Heart: fibrosis ↓; myocardial disorganization ↓ Brain: inflammatory cellularity ↓ (macrophages, astrocytes) Not just a shield: catalase activity ↑, suggesting support of native defenses. Closing provocation: could daily use in vulnerable populations precondition organs against oxidative storms? - Episode timeline 00:00:19–00:00:52 — Show intro + mission: C60 study + sepsis organ failure in diabetics 00:00:52–00:01:42 — Model setup: diabetic rats + polymicrobial sepsis via CLP 00:01:42–00:02:26 — Why diabetes worsens sepsis: chronic hyperglycemia → higher ROS baseline (“gasoline on the floor”) 00:02:26–00:03:28 — Key chemistry: insoluble/toxic C60 vs hydroxylated, water-soluble C60 00:03:28–00:04:28 — Mechanism: nanoscale “soccer ball” + alternating bonds → electron sink / SOD-mimic framing 00:04:28–00:04:59 — Oxidative damage readout: TBARS ↓ → lipid peroxidation reduced 00:04:59–00:05:37 — Liver protection: necrosis ↓; enzymes (AST/ALT/GGT/bilirubin) ↓ 00:05:37–00:05:58 — Heart protection: fibrosis ↓; myocardial disorganization ↓ 00:05:58–00:06:05 — Brain protection: inflammatory cellularity ↓ (macrophages/astrocytes) 00:06:05–00:06:29 — Endogenous defenses: catalase activity ↑ (“upgrading the sprinkler system”) 00:06:29–00:07:25 — Takeaway + global sepsis scale + provocative prevention question (daily prophylaxis?) - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

Mitochondria aren’t just your cell’s power plants — they may also contain a built-in kill switch. In this Deep Dive, Dr. Mike unpacks a 2026 Annual Review of Biophysics paper arguing that ATP synthase (the same machine that makes your ATP) can morph into the mitochondrial permeability transition pore (PT pore) under severe stress — especially calcium overload. You’ll learn the “death finger” model (subunit-e pulling a lipid plug), why cyclophilin D and inorganic phosphate help trigger the switch, and why this matters for real-world tissue injury like stroke and heart attack reperfusion damage. Then comes the twist: brine shrimp (sea monkeys) appear to lack this lethal pore — thanks to a tiny structural tweak that may hint at future strategies to “relax the tension” and keep our cellular dams from blowing. (Educational content only, not medical advice.) - Article Discussed in Episode: The Mitochondrial Permeability Transition Pore: Past, Present, and Future - Key Quotes From Dr. Mike: “For decades, the exact molecular identity of the self-destruct mechanism was a huge mystery in biophysics.” “Your mitochondria actually have exactly that — a built-in kill switch.” “When your mitochondria get overwhelmed by too much calcium, they can open up the permeability transition pore.” “You can picture it as a literal finger hooking into a fatty lipid plug... When there’s a massive overload of calcium, that structural finger just pulls the plug.” “We are basically carrying around a vital energy machine that moonlights as an executioner.” - Key Points The PT pore is framed as a mitochondrial kill switch that opens under extreme stress (notably calcium overload). Modern consensus points toward ATP synthase as the structural basis of the PT pore. “Death finger” model: ATP synthase subunit-e acts like a finger pulling a lipid plug — turning an energy machine into a destructive leak. Cyclophilin D (CypD) behaves like a foreman, helping order the pore to open. Inorganic phosphate is the paradoxical accelerator: despite binding calcium, it changes CypD’s binding behavior, promoting pore opening. Some species (e.g., Artemia franciscana / brine shrimp) appear to lack functional PT pore, tolerating huge calcium loads and hypoxia. Brine shrimp subunit-e has ~15 extra amino acids, creating “slack” that prevents the plug from being pulled. If we can mimic that “relaxed tension,” we may reduce reperfusion injury after stroke/heart attack. - Episode timeline 00:00:19–00:00:59 — Setup: mitochondria as power plants… with a surprise self-destruct button 00:01:00–00:01:34 — PT pore basics: calcium overload → swelling, energy collapse, death signaling 00:01:35–00:02:31 — ATP synthase as the likely pore-former: “hydroelectric dam” turning into a floodgate 00:02:32–00:03:20 — “Death finger” model: subunit-e + lipid plug → drain pulled open 00:03:21–00:04:46 — CypD + inorganic phosphate paradox: the “calming” molecule that helps open the gate 00:04:47–00:05:27 — Evolution question: if this kills cells, why wasn’t it removed? 00:05:28–00:05:57 — Brine shrimp (sea monkeys): mitochondria tolerate calcium/hypoxia without PT pore activation 00:05:58–00:06:32 — The structural hack: +15 amino acids on subunit-e = slack that prevents unplugging 00:06:33–00:07:22 — Clinical relevance: reperfusion injury + the hope of mimicking “relaxed tension” in humans 00:07:23–00:07:37 — Wrap + closing thought: maybe the kill switch has a purpose we don’t fully understand (yet) - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

Emergency medicine is built on brute force — shock the heart, slam vasopressors, crank the numbers. But septic shock exposes the flaw in that instinct: the harder you squeeze vessels from the outside, the more you can starve the microcirculation that actually feeds the kidneys, liver, and lungs. In this Deep Dive, we unpack a 2026 Biomedicine & Pharmacotherapy study testing methylene blue as a precision countermeasure for vasoplegic septic shock. The core mechanism: cytokine-driven iNOS overexpression floods nitric oxide, overactivating the NO → sGC → cGMPrelaxation cascade and collapsing vascular tone. Instead of “chemical duct tape” (high-dose catecholamines), methylene blue blocks the pathway at the source—oxidizing sGC’s heme iron to prevent NO binding and inhibiting further NO production—while also acting as a redox-active electron carrier under oxidative stress. In a CLP sepsis model, 10 mg/kg produced the “Goldilocks” effect: improved MAP, protected lungs and kidneys, reduced IL-1β, boosted antioxidant defenses (SOD, GSH), and lowered lipid peroxidation (MDA). But at 100 mg/kg, the pharmacology flipped—pro-oxidant stress, catastrophic liver injury, and early death. The episode closes with the translational bridge: rat-to-human scaling places the effective dose around ~1.6 mg/kg, aligning with real ICU protocols, while highlighting key limitations (12-hour window, lactate lag, female-only cohort and estrogen effects). (Educational content only, not medical advice.) - Article Discussed in Episode: Dose-dependent effects of methylene blue on hemodynamics, cytokines, oxidative stress, and organ dysfunction in a rat model of CLP-induced sepsis: An experimental study - Key Quotes From Dr. Mike: “In emergency medicine, the instinct is always to overpower the crisis with brute force.” Regarding vasoplegia: "The engine driving it is an overproduction of nitric oxide.” “Methylene blue… oxidizes the heme iron… preventing nitric oxide from binding to sGC.” “It (methylene blue) restores normal vascular tone without aggressively squeezing the vessel from the outside.” “At super-therapeutic concentrations, methylene blue stops acting as an efficient electron carrier... Instead of smoothly passing electrons… it begins indiscriminately stealing electrons and auto-oxidizing.” “That is the inherent danger of redox-active compounds.” - Key Points Septic shock punishes “brute force” care: raising MAP can collapse microvascular perfusion and accelerate organ failure. Core driver of vasoplegia: iNOS → excess NO → sGC activation → cGMP surge → vascular smooth muscle relaxation. Standard vasopressors “fight from the outside,” risking regional hypoperfusion, ischemia, and organ injury. Methylene blue “fixes from the inside”: prevents NO binding to sGC (heme oxidation) and reduces NO production. In CLP sepsis (dynamic polymicrobial model), 10 mg/kg improved MAP and organ protection without high-dose pressors. Cellular redox rescue: ↑ SOD/GSH, ↓ MDA (lipid peroxidation), ↓ IL-1β. Dose is everything: at high concentrations methylene blue becomes pro-oxidant, generating ROS and worsening collapse. Translational scaling: 10 mg/kg (rat) ≈ 1.6 mg/kg (human), within the clinical bolus range 1–4 mg/kg. Lactate may lag behind MAP: macro stabilization precedes microcellular recovery. Limitations: 12-hour window, no long-term survival/infusion data, female-only cohort and potential estrogen “buffer.” - Episode timeline 0:19–1:36 — The ICU paradox: brute-force stabilization can starve the microsystem 1:36–3:24 — Paper setup + why a microdose of methylene blue challenges standard critical care 3:24–5:23 — Vasoplegia mechanics: iNOS overexpression, NO flood, sGC/cGMP “relaxation jam” 5:23–7:50 — Why vasopressors backfire: “duct tape” constriction → microvascular hypoperfusion → organ ischemia; “de-catecholaminization” 7:50–9:51 — Why methylene blue is different: redox agent + blocks NO signaling at sGC and suppresses iNOS 9:51–11:26 — Why CLP (cecal ligation & puncture) models real sepsis better than endotoxin injection 11:26–12:16 — Dose-mapping design: 10 vs 50 vs 100 mg/kg and the “razor-thin” window 12:16–15:42 — 10 mg/kg “Goldilocks” outcomes: MAP recovery, lung protection (PF ratio), kidney function (urea), ↓ IL-1β, redox improvements 15:42–17:30 — 100 mg/kg failure: pro-oxidant flip, acid-base collapse, ALT spike, early mortality 17:30–19:17 — Translational math: body-surface-area scaling → ~1.6 mg/kg human; aligns with 1–4 mg/kg ICU range 19:17–22:27 — Limitations: 12-hour snapshot, lactate lag, infusion questions; why you can’t “chase lactate” instantly 22:27–24:35 — Sex-hormone confound: female-only cohort, estrogen’s endothelial/anti-inflammatory buffering; need dual-sex replication 24:35–27:39 — Final synthesis: save microvasculature, not just monitor numbers; broader redox implications for chronic inflammation - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

What if the spinach in your salad, the berries in your smoothie, and the caffeine in your coffee aren’t “fuel” at all — but evolved plant defense chemicals that can directly modify your mitochondria? In this deep dive, we unpack a 2025 paper from the International Journal of Molecular Sciences (“Plant Secondary Metabolites as Modulators of Mitochondrial Health”) and follow the mechanisms step-by-step: how mitochondria maintain themselves through biogenesis, fusion/fission, and mitophagy; how compounds like berberine can trigger a controlled “fake energy crisis” to induce cleanup + rebuilding; how caffeine can interrupt apoptosis signaling under UV stress; why astaxanthin can reducemitophagy during acute oxidative panic to prevent cellular self-cannibalism; and why some “plant” benefits (like urolithin A) depend entirely on your gut microbiome. Finally, we hit the paradox: these same metabolites can become selectively cytotoxic to cancer cells—or become dangerous when isolated into high-dose supplements, with real toxicity and drug-interaction risk. The takeaway: food isn’t just calories — it’s environmental code. (Educational content only, not medical advice.) - Article Discussed in Episode: Plant Secondary Metabolites as Modulators of Mitochondrial Health: An Overview of Their Anti-Oxidant, Anti-Apoptotic, and Mitophagic Mechanisms - Key Quotes From Dr. Mike: “The spinach in your salad… the berries in your smoothie… and even the caffeine in your morning coffee were actually highly evolved chemical weapons.” “We really have to stop thinking of plants just as vitamins and start looking at them as complex chemical defense systems.” “Berberine… creates a fake crisis to force an upgrade.” “Caffeine… effectively jams the self-destruct button.” “Think of the plant compounds you consume as environmental software updates.” - Key Points Mitochondria aren’t static batteries — they’re a dynamic fleet: biogenesis, fusion, fission, mitophagy. Mitophagy failure → exhaust (ROS), DNA damage, and programmed cell death pathways that show up in chronic disease. Plant secondary metabolites evolved as defense chemistry — but “keys fit locks” due to shared ancient biochemical language. Berberine: induces a mild energy dip → triggers mitophagy + biogenesis (cleanup + upgrade loop). Caffeine: can intercept UV-stress death signaling, helping cells survive and repair rather than self-destruct. Astaxanthin: can stabilize membranes and dial back runaway mitophagy during acute oxidative crises. Urolithin A: you can’t “eat it” — your gut bacteria must manufacture it from ellagitannins. Cancer paradox: some compounds become targeted demolition in tumor cells due to their altered mitochondrial state. Dose + context rule everything: isolate + concentrate → membrane damage, ETC disruption, toxicity, interactions. Big frame: plant compounds are “software updates” for mitochondrial stress resilience. - Episode timeline 0:00–1:41 — Hook: food as “chemical weapons” + intro to the 2025 paper + why mitochondria = longevity bedrock 1:41–7:32 — Mitochondrial maintenance 101: biogenesis → fusion/fission → mitophagy “scrapyard” + what failure looks like 7:32–8:56 — Why plant defenses work on us: shared biochemical “locks and keys” across evolution 8:56–11:30 — Alkaloids: berberine (fake crisis → cleanup + rebuild) + caffeine (UV stress apoptosis interception) 11:30–12:55 — Terpenoids: astaxanthin as a membrane stabilizer that prevents panic-mode self-destruction 12:55–16:11 — Polyphenols + the microbiome bottleneck: urolithin A as a bacteria-made mitochondrial “hardware upgrade” 16:11–18:42 — Cancer paradox: same compounds protect healthy cells but can trigger apoptosis in tumor cells (betanin, saponins) 18:42–21:45 — The danger zone: dose escalation, “soap-like” saponin toxicity, high-dose THC/CBD ETC blockade, supplement risks + St. John’s Wort interactions 21:45–24:16 — Synthesis: food as environmental software updates + closing punchline (berries/walnuts/coffee = “security patch”) - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

Photobiomodulation therapy (PBMT) is marketed like universal biology: shine the right wavelength, hit cytochrome c oxidase, boost ATP, accelerate healing. But this Deep Dive unpacks a hidden variable that can make “standard dosing” either ineffective or unsafe: melanin. Using a 2026 narrative review from researchers at the University of São Paulo, we trace the physics of a photon entering the body, how melanin’s absorption overlaps the therapeutic “optical window,” and why simply “turning up the laser” can backfire — creating heat and reactive species in the epidermis while deeper target tissues get little benefit. We also confront a data problem: trials may include darker phototypes, but too often outcomes aren’t analyzed by skin type, creating a misleading “average” that masks risk. Finally, we outline practical fixes — wavelength selection, spot size adjustments, and pigmentation-sensitive, feedback-guided dosimetry — so PBMT can become truly personalized and equitable. (Educational content only, not medical advice.) - Article Discussed in Episode: Is photobiomodulation therapy free from racial bias?: a narrative review of skin pigmentation - Key Quotes From Dr. Mike: Regarding melanin: “It literally absorbs the photons before they can ever reach the deeper tissues.” “For individuals with darker skin tones, this can result in totally subtherapeutic treatments.” “They currently do not differentiate dosing parameters based on skin pigmentation.” “The physics of a photon is constant. But the biological filter it’s passing through is wildly diverse.” “At 660 nm… 21 mm in lighter skin… but in darker skin it drops to 14 mm.” “We need to stop treating light therapy like a one-size-fits-all t-shirt… and treat it like a custom tailored suit.” - Key Points PBMT’s core mechanism: photons → mitochondrial chromophores (cytochrome c oxidase) → ATP support and healing. The optical window (≈600–1100 nm) overlaps with melanin’s strong absorption (≈600–900 nm). Darker skin = more melanin absorption, meaning less light reaches deeper tissue → risk of subtherapeutic dosing. “Just increase power” can be dangerous: melanin absorbs more energy → heat + ROS/RNS → redness, pain, burns. Guideline gap: WALT dosing recommendations don’t meaningfully adjust for pigmentation. Data aggregation problem: studies include darker phototypes but often don’t stratify outcomes, producing “average” conclusions that can hide harm. Fixes the paper argues for: longer wavelengths (e.g., 830–1064 nm), larger spot sizes, gradual ramping + patient sensory monitoring, and pigmentation-sensitive dosimetry models. Bottom line: melanin isn’t a deal-breaker — it’s a dosing variable that must be accounted for. - Episode timeline 0:19–0:58 — Cold open: expensive PBM devices can still burn patients if not calibrated to skin tone 0:58–1:49 — The core question: Is PBMT free from racial bias? Grounding source + paper title 1:49–2:47 — PBMT basics: cytochrome c oxidase, ATP synthesis, “good biology” 2:47–4:29 — The physics: optical window (600–1100 nm) meets endogenous chromophores; melanin’s peak absorption overlaps therapy 4:29–5:27 — Why darker skin can get subtherapeutic dosing: photons absorbed before reaching target tissue 5:27–7:56 — Why “turn it up” is risky: melanin heat + ROS/RNS → pain, redness, superficial thermal injury (cake/oven analogy) 7:56–10:50 — Guideline + research bias: WALT doesn’t differentiate by pigmentation; studies include darker phototypes but don’t analyze by skin type (“mathematical erasure”) 10:50–12:33 — Solution #1: wavelength selection; penetration example (660 nm vs 830 nm) shows gap narrowing for darker skin 12:33–13:39 — Solution #2–3: larger spot size + gradual increments with sensory monitoring (patient feedback as safety gauge) 13:39–15:27 — Big takeaway: pigmentation-sensitive dosimetry is a necessity; closing question + outro - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

Upon Don Bailey's return to the Deep Dive episodes, he and Dr. Mike reframe fatigue, aging, and neurodegeneration through one core process: mitophagy — the cell’s highly selective mitochondrial recycling program. The episode starts with a hard truth: “engineering-style” diagnoses feel comforting, but chronic fatigue and cognitive decline live in a murky zone standard tests rarely capture. From there, the conversation builds a vivid model of mitochondrial energy production (OXPHOS), the unavoidable “exhaust” of ROS, and the multi-tiered quality control stack that keeps your cellular power grid from collapsing: biogenesis (PGC-1α), dynamics (fusion/fission), and mitophagy (the scrapyard). Then it goes deeper — showing how mitophagy failure can turn mitochondrial damage into neuroinflammation (via leaked bacterial-like mtDNA and the NLRP3 inflammasome) and even “cellular rust” (ferroptosis) when iron-driven lipid peroxidation spirals out of control. The episode also tackles the paradox: mitophagy is protective — until extreme stress pushes it into overdrive, potentially tipping into ferroptosis. Finally, it translates the research into real levers: exercise as hormetic signaling (MICT vs HIIT), the AMPK↔mTOR seesaw, and biohacking tools like urolithin A, spermidine, resveratrol, and adaptogens — not as exercise replacements, but as precision amplifiers that help you stay in the “Goldilocks zone.” (Educational content only, not medical advice.) - References From Episode: Mechanistic Modulation of Autophagy by Bioactive Natural Products: Implications for Human Aging and Longevity Early mitophagy activation by Urolithin A prevents, but late activation does not reverse, age-related cognitive impairment Mitophagy as a therapeutic target for exercise-induced fatigue: modulation by natural compounds and mechanistic insights Mitophagy in Alzheimer’s disease and its potential as a therapeutic target - Key Quotes From Episode: “Mitophagy is the scrapyard.” “If the trash isn’t being collected, your cells become crowded with clunker mitochondria.” “We are fundamentally as young as our mitochondrial recycling program.” Regarding Urolithin A: “The supplement isn’t a replacement for the gym. It’s an amplifier.” “You cannot supplement your way out of a sedentary lifestyle.” - Key Points “Clean” diagnoses work for broken bones—not for fatigue/brain fog/aging biology. Energy comes from mitochondria via OXPHOS, but ROS is the inevitable “exhaust.” MQC has tiers: biogenesis (PGC-1α) → fusion/fission → mitophagy. Mitophagy = autophagosome “trash bag” + lysosome “acid vat” → true recycling. Aging = declining mitophagy → accumulation of “clunker” mitochondria → fatigue + ROS. Key QC pathway: PINK1/Parkin (membrane potential loss → PINK1 buildup → Parkin ubiquitin “kiss of death” → autophagosome recruitment). Redundancy matters: receptor routes like FUNDC1 provide rapid hypoxia response. Alzheimer’s reframing: mitochondrial cascade hypothesis—mitochondrial failure may precede plaques/tangles. Broken mitochondria leak mtDNA (bacterial-like) → microglial DAMP sensing → NLRP3 inflammasome → IL-1β inflammation. “Cellular rust”: ferroptosis (iron + lipid peroxidation) via Fenton reaction → hydroxyl radicals → membrane collapse. Paradox: mitophagy protects—until overdrive overwhelms lysosomes → iron flood → GPX4 overwhelmed → ferroptosis. Best lever: exercise (hormesis). Acute ROS/hypoxia = signal to “clean house.” MICT vs HIIT: steady AMPK vs shock AMPK + hypoxia receptors; HIIT higher reward, smaller margin. Overtraining = “cellular chainsaw”: pathological mitophagy → iron spill → ferroptosis. Biohacking layer: compounds that tilt AMPK↑ / mTOR↓ (urolithin A, spermidine, resveratrol/SIRT1). Adaptogens can reduce mitophagy markers in terminal exhaustion by preventing panic-mode autophagy. Supplements ≠ replacement for exercise; they’re precision optimizers for a systemic “earthquake.” Actionable thesis: find your personal mitophagy threshold (stimulate cleanup without tipping into rust/inflammation). - Episode timeline 00:00–03:30 — Why “engineering-style” diagnoses fail for fatigue/aging/brain fog 03:30–09:00 — OXPHOS explained: electron transport chain, proton gradient, ATP + ROS “exhaust” 09:00–15:00 — MQC stack: biogenesis (PGC-1α) → fusion/fission → mitophagy “scrapyard” 15:00–20:30 — Mitophagy mechanics: autophagosome “trash bag” + lysosome “acid vat” → recycling 20:30–27:30 — Aging: mitophagy slows → clunker mitochondria accumulate → fatigue + ROS acceleration 27:30–36:30 — Molecular detectives: PINK1/Parkin ubiquitin system (membrane potential → tagging → clearance) 36:30–40:30 — Redundant pathways: receptor-mediated “panic buttons” (e.g., FUNDC1 under hypoxia) 40:30–49:30 — Alzheimer’s paradigm shift: mitochondrial cascade hypothesis + amyloid/tau sabotage of QC 49:30–54:30 — Inflammatory spillover: mtDNA as DAMP → microglia → NLRP3 inflammasome → IL-1β 54:30–58:30 — Ferroptosis: iron + Fenton reaction → hydroxyl radicals → lipid peroxidation (“cellular rust”) 58:30–62:00 — Control levers: exercise hormesis; MICT vs HIIT; AMPK→ULK1; recovery window; overtraining risk 62:00–64:00 — Biohacking layer: AMPK↔mTOR seesaw; urolithin A/spermidine/polyphenols/adaptogens + closing synthesis - ♻️⚡️  Mitophagy → Urolithin A → BioLithin Lite  ⚡️♻️ BioLithin Lite is a premium, precision-formulated mitochondrial longevity stack designed for those who want targeted cellular renewal without unnecessary complexity. Built around clinically-studied Urolithin A and synergistic taurine, BioLithin Lite supports mitophagy — the body’s natural process of recycling worn-out mitochondria — helping promote cleaner cellular energy, healthier aging, enhanced recovery, and long-term mitochondrial resilience. Minimalist by design yet sophisticated in function, BioLithin Lite delivers foundational mitochondrial support in a streamlined daily formula engineered for sustained performance, vitality, and cellular optimization.   🚨  For the next week, SAVE 20% on your order of BioLithin Lite!  🚨 Discount code: MITOPHAGY20Expires on 5/14, midnight PST*must choose "Single" quantity option and then increase to desired amount   Shop BioLithin Lite! ♻️⚡️ - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

In this Energy Code Deep Dive episode, Dr. Mike breaks down a modern (and slightly unsettling) obesity paper: blue light exposure worsened obesity in high-fat diet–fed mice — not just through “sleep/circadian disruption” in the abstract, but via signals consistent with mitochondrial dysfunction and oxidative stress in subcutaneous white fat. The study compares normal vs high-fat diet mice under white light vs blue light and finds that blue light, in the high-fat context, is associated with more weight/fat gain, worse glucose handling, lower whole-body energy expenditure, and a strong tissue-specific signal in inguinal white adipose tissue (iWAT) — a depot closer to the surface that may be more vulnerable to light penetration. Mechanistically, the paper points toward suppressed oxidative phosphorylation gene expression plus higher ROS/lipid peroxidation and weaker antioxidant defenses in iWAT. The key takeaway: in a high-fat environment, blue light may act like a metabolic amplifier — increasing load while weakening the machinery that should burn fuel cleanly. (Educational content only, not medical advice.) - Article Discussed in Episode: Blue light exposure exacerbates obesity in high-fat diet-fed mice by inducing mitochondrial dysfunction in the white adipose tissue - Key Quotes From Dr. Mike: “Blue light, obesity, fat tissue, and mitochondrial dysfunction… modern and a little unsettling.” “Could the kind of light we are increasingly surrounded by actually make metabolic dysfunction worse… by directly damaging the way fat tissue handles energy?” “In mice eating a high-fat diet, blue light exposure led to more weight gain and more body fat than white light exposure.” “Blue light exposed high-fat mice had lower oxygen consumption, lower carbon dioxide production, and lower heat production.” “Light is not just visual information, it is metabolic information.” - Key Points The paper asks: can blue light worsen obesity beyond circadian/sleep effects — via fat-tissue mitochondria? 4 groups: normal diet vs high-fat diet × white light vs blue light exposure. In high-fat diet mice, blue light → more weight gain + more body fat than white light. Blue light + high-fat diet → worse glucose tolerance and insulin sensitivity. Strongest depot effect: inguinal white adipose tissue (iWAT) (subcutaneous, closer to surface). Visceral depot (e.g., epididymal WAT) showed less pronounced change, supporting “location matters.” Whole-body physiology: blue light high-fat mice had lower O₂ consumption, CO₂ production, and heat output → lower energy expenditure. These changes were not explained by obvious differences in movement or food intake (per the transcript summary). iWAT showed suppressed oxidative phosphorylation-related gene expression. iWAT also showed higher oxidative stress (↑ROS/↑MDA) and lower antioxidant defenses (↓SOD/↓total antioxidant capacity). Brown fat showed some “thermogenic markers up” signals, but whole-body heat output was down → possible failed compensation. - Episode timeline 0:19–0:47 — Intro + why this paper is “modern and unsettling” 0:47–2:20 — Study design: diet (normal vs high-fat) × light (white vs blue) 2:31–3:43 — Reframing: white fat is active metabolic tissue, not passive storage 3:47–5:09 — Headline outcomes: more fat gain + worse glucose/insulin handling under blue light (high-fat context) 5:14–6:10 — Depot specificity: iWAT (subcutaneous “frontline”) vs deeper visceral fat 6:26–7:47 — Metabolic rate findings: ↓O₂/↓CO₂/↓heat → lower energy expenditure (not just behavior) 7:50–10:26 — Mitochondria + oxidative stress: ↓OXPHOS signals + ↑ROS/↑MDA + ↓antioxidant defenses in iWAT 10:56–12:04 — Brown fat paradox: some thermogenic markers ↑, but whole-body heat ↓ → “failed rescue” 12:09–13:47 — Direct vs indirect mechanism: circadian disruption vs local tissue exposure; what’s still unknown 14:14–16:48 — Final synthesis: light as metabolic information; blue light as an “amplifier” under high-fat stress - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

In this Energy Code Deep Dive episode, Dr. Mike unpacks a paper that reframes ALS at a deeper level: ALS may begin as an energy regulation failure, starting in the hypothalamus, before it becomes an obvious motor neuron story.The hypothalamus isn’t just “another brain region”; it’s the body’s metabolic control room — governing hunger, energy expenditure, hormones, and fuel signaling. The paper shows that in ALS mouse models, the hypothalamus develops early mitochondrial bioenergetic impairment (including reduced spare respiratory capacity) alongside neuroimmune activation (astrocytes and microglia) and melanocortin circuit disruption (POMC/AgRP imbalance) that could help explain early hypermetabolism and weight loss seen in ALS. Most provocatively, early metabolic modulation (TMZ) restored hypothalamic bioenergetics, reduced glial activation, normalized aspects of circuit signaling, delayed onset, and extended survival — suggesting the “first domino” may be a failing energy command center, not just downstream motor collapse. (Educational content only, not medical advice.) - Article Discussed in Episode: The hypothalamus is an early site of mitochondrial failure and neuro-immune circuit disruption in amyotrophic lateral sclerosis - Key Quotes From Dr. Mike: “ALS may not begin only as a motor neuron story. It may also begin as an energy regulation story.” “Mitochondrial dysfunction shows up in the hypothalamus before symptoms begin.” “If that is true, then ALS is not just a disease of movement. It is also a disease of failed energy coordination.” “These hypothalamic mitochondrial changes… happened before major motor symptoms.” “…if you intervene early at the level of hypothalamic energy failure, you may be able to change the trajectory of disease.” - Key Points ALS may not start only in motor neurons; it may start with hypothalamic energy-control failure. The hypothalamus is the body’s metabolic thermostat/control room (hunger, weight, hormones, energy use). Hypermetabolism + weight loss are common in ALS and correlate with worse outcomes — this may be upstream, not just secondary. In ALS models, hypothalamus shows early mitochondrial dysfunction before symptom onset. Key mitochondrial finding: reduced maximal respiration + reduced spare respiratory capacity (“backup power” loss). Changes are region-specific: hypothalamus shows the strongest coordinated mitochondrial/inflammatory signature vs hippocampus/cerebellum. Early astrocyte and microglia activation appears alongside metabolic reprogramming toward glycolysis. Melanocortin circuitry disruption: decreased POMC neurons, increased AgRP-related signaling → altered energy balance control. Timing matters: these shifts occur before major motor symptoms, implying causal relevance. TMZ (trimetazidine) given early restored hypothalamic bioenergetics, reduced glial activation, normalized circuit features, delayed onset, extended survival (mouse data). - Episode timeline 0:19–0:34 — Intro + why this paper could change how we think about ALS 0:34–1:55 — The core reframing: ALS as energy coordination failure, not only motor decline 2:02–3:15 — Hypothalamus 101: the body’s metabolic control room + why ALS hypermetabolism matters 3:18–5:43 — Early hypothalamic mitochondrial failure: methods + respiration + spare respiratory capacity explained 5:54–6:50 — Region specificity: why the hypothalamus stands out vs other brain areas 6:55–8:39 — Neuroimmune activation: astrocytes/microglia activation + metabolic shift toward glycolysis 8:41–10:11 — Melanocortin system disruption: POMC/AgRP imbalance as a driver of systemic energy mismanagement 10:15–11:12 — The timing argument: control-system failure may precede visible motor catastrophe 11:23–12:28 — Translational wedge: TMZ restores bioenergetics, calms glia, shifts circuits, delays onset (in mice) 12:48–13:25 — Cross-model relevance: evidence beyond a single ALS model 13:32–16:11 — Final synthesis: ALS as a metabolic command-center disorder plus motor degeneration - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

In this Energy Code Deep Dive episode, Dr. Mike breaks down a provocative neuroprotection review: low-dose methylene blue and near-infrared (NIR) light may look like totally different therapies — one is a molecule, one is photons — but the paper argues they converge on the same core target: mitochondrial respiration. You’ll hear a simple “neurons as cities / mitochondria as power plants” model for neurodegeneration, why methylene blue can function like an alternate electron shuttle in the electron transport chain, how NIR light can energize cytochrome oxidase, and why both approaches may widen the neuron’s “energy margin” during stress. The takeaway isn’t “magic cures.” It’s a disciplined mitochondrial lens: improving the power supply may give repair, plasticity, and survival systems the bandwidth to work. (Educational content only, not medical advice.) - Article Discussed in Episode: Protection against neurodegeneration with low-dose methylene blue and near-infrared light - Key Quotes From Dr. Mike: “Two very different therapies (methylene blue & NIR light) may be helping the brain in basically the same way.” “Methylene blue, at low doses, appears to help by acting like an alternate electron shuttle.” “This paper makes the point that methylene blue has a hormetic dose response…” “…near infrared light is more like directly energizing one of the key turbines in the mitochondrial power plant.” “Different tools, same target, and that target is mitochondrial respiration.” “…if you can stabilize mitochondrial respiration, you may be able to widen that energy margin and make neurons harder to kill.” - Key Points The paper’s thesis: two very different interventions may protect neurons via the same mitochondrial mechanism. Neurodegeneration framed as energy margin collapse (not only plaques/tangles/toxins/inflammation). Low-dose methylene blue: acts as an alternate electron shuttle → supports electron flow, ATP production. Dose matters: methylene blue shows hormesis (low dose supportive; higher dose can backfire). Near-infrared light: photons absorbed by cytochrome oxidase → boosts mitochondrial respiration and ATP. NIR effects may outlast a session via enzyme induction / capacity signaling (not just a short “boost”). Unifying mechanism: both interventions enhance oxidative metabolism and support neuronal survival under stress. Paper reviews multiple model contexts (ischemia, trauma, neurotoxicity, neurodegeneration models, etc.) as “shared bottleneck” evidence. Practical translation emphasis: target access matters (MB crosses BBB; NIR can reach cortical tissue with correct parameters). Key caution: mechanism ≠ guaranteed clinical proof; these are credible mitochondrial-support tools, not universal cures. - Episode timeline 0:19–0:34 — Show open + why this paper matters 0:34–1:20 — Core premise: different tools, same mitochondrial target 1:22–2:24 — “Neuron as a city” model: neurodegeneration as failing power plants 2:24–4:24 — Methylene blue explained: electron transport chain “extra courier” + hormetic dosing 4:24–5:15 — Cytochrome oxidase focus: why boosting the “end-of-line turbine” matters 5:15–7:24 — Near-infrared light mechanism: photons → cytochrome oxidase → ATP + longer-lasting effects 7:24–8:55 — The unifying mechanism: respiration support → wider “energy margin” → neurons harder to kill 8:55–10:29 — Evidence across models + “target access” (BBB penetration; transcranial penetration) 10:29–11:43 — Why energy support unlocks repair/plasticity outputs (BDNF, synaptogenesis, etc.) 11:43–12:34 — Hormesis again: the “sweet spot” principle for MB and light 12:34–15:25 — Synthesis + disciplined conclusion (not cures; mitochondrial respiration is the lever) - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

In this Energy Code Deep Dive episode, Dr. Mike breaks down a practical 8-week human study on shilajit and performance where it actually matters: after fatigue sets in. Recreationally active young men took placebo, 250 mg/day, or 500 mg/day, then got pushed through a brutal leg-extension fatigue protocol to see how much strength they lost — not just how strong they were fresh. The standout finding: in the stronger half of subjects, the 500 mg group preserved significantly more maximal isometric strength post-fatigue — and showed a quieter signal on serum hydroxyproline, a marker often used to reflect collagen/connective-tissue turnover. Bottom line: this paper doesn’t claim “instant strength.” It suggests shilajit may be more interesting as a fatigue-resistance + tissue-support tool — at the right dose, in the right population. (Educational content only, not medical advice.) - Article Discussed in Episode: The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels - Key Quotes From Dr. Mike: “In that stronger subgroup, the high dose shilait group lost significantly less maximal isometric strength after the fatiguing protocol…” “So in simple terms, the men taking 500 mg per day of Sheelajit held on to their strength better once fatigue hit.” “This was not a study showing Shilait magically blocks exercise damage… It is more a study suggesting that over time, the higher dose may support the tissue environment…” “The strongest and cleanest finding is this… 500 mg per day… helped preserve maximal strength better after fatigue…” “Sometimes performance support is not about creating more force at the start. Sometimes it is about losing less force when fatigue tries to take it away.” - Key Points The study asks a real-world question: how much strength do you lose when you’re tired? Design: recreationally active young men; placebo vs 250 mg/day vs 500 mg/day for 8 weeks. Test: maximal isometric strength pre-fatigue, then 2×50 maximal concentric isokinetic leg extensions, then post-fatigue testing. Primary performance signal showed up in the upper 50% (stronger subjects): 500 mg/day = less post-fatigue strength loss. The lower dose (250 mg/day) did not clearly separate from placebo in that stronger subgroup. Hydroxyproline (HYP) was used as an indirect marker of collagen/connective-tissue breakdown. In the stronger subgroup, the 500 mg/day group had lower baseline HYP vs low dose and placebo after supplementation. No big claims of “massive strength gain,” “weight change,” or “muscle growth.” The story is fatigue-retention, not “overnight PRs.” Mechanistic framing is suggestive (ATP/mitochondrial support is discussed), but the study itself is performance + serum marker, not deep mitochondrial assays. Limitations: young men only, specific fatigue model (concentric-dominant), and funding/source considerations. - Episode timeline 0:19–0:34 — Show open + setup for a shilajit performance Deep Dive 0:34–1:30 — The question: 8 weeks of shilajit—does it help strength retention under fatigue + connective tissue signals? 1:38–2:14 — What shilajit is (Ayurvedic mineral-rich exudate; fulvic acids, DBPs, minerals) 2:14–2:58 — Study design: placebo vs 250 mg/day vs 500 mg/day; 8-week supplementation 2:40–3:22 — The fatigue protocol + why “strength loss under fatigue” is the real-world metric 3:27–4:14 — Hydroxyproline explained as a collagen/connective-tissue breakdown signal 4:15–5:01 — Main finding: overall modest, but stronger subgroup shows a clearer effect 4:29–5:36 — Headline: 500 mg/day group lost less maximal isometric strength post-fatigue (in stronger half) 5:36–6:09 — Dose specificity: 250 mg/day didn’t separate clearly; possible threshold effect at 500 mg 6:13–7:38 — Hydroxyproline results + why the concentric-only protocol matters for interpretation 7:59–9:04 — Mechanistic framing (ATP/mitochondria discussion as a plausible lens) 9:04–10:31 — What the study did not show + disciplined interpretation 10:35–11:15 — Limitations + conflict-of-interest note 11:19–13:49 — Synthesis: shilajit as “hold the line under fatigue” support + wrap - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

Dr. Mike unveils BioShilajit — a “trio stack” built for mitochondrial performance: shilajit for ionic minerals + fulvic/humic support, PQQ to signal mitochondrial biogenesis (PGC-1α), and pharmaceutical-grade methylene blue as a low-dose electron-cycling “failsafe” for the respiratory chain. Along the way, he breaks down why chronic fatigue and brain fog often evade standard labs, walks through the origin story and chemistry of shilajit, highlights ATP and endurance data, explains PQQ’s unique role in building new “cellular engines,” and tells the bizarre history of methylene blue — from textile dye to essential emergency medicine — before tying it all together as structure + supply + backup mechanics for cellular energy. He closes with launch details, the first-week discount code, and where to find the full resource library on the BioLight product page. (Educational content only, not medical advice.) - Article Discussed in Episode: Fullerenes as Anti-Aging Antioxidants - Key Quotes From Dr. Mike: Regarding BioShilajit: "A mountain resin, a bacterium, and a clothing dye… sounds like quite the trio.” “Shilajit roughly translates to: the conqueror of mountains and destroyer of weakness.” “Shilajit contains over 85 distinct trace minerals — and the key word is bioavailable.” “Shilajit is the pharmacological opposite of a stimulant — it doesn’t tape over the check-engine light; it helps the cell produce more of its own ATP.” “A microscopic picomolar concentration of PQQ can execute thousands — sometimes tens of thousands — of redox cycles without breaking down.” “PQQ triggers this exact same genetic alarm bell (PGC-1α -> mitogenesis) — but without the ten-mile run.” “Inside damaged mitochondria, methylene blue’s mechanism is bypassing the blockade (blockages in the ETC).” - Key Points Two BioLight events + one roadmap: Beyond Conference (Austin, May 27–29), Return to Nature (Franklin, June 11–12), and a tentative A4M plan (December). Core thesis: chronic fatigue/brain fog often reflects micro-level mitochondrial “power grid” failure, not a single broken marker on standard labs. BioShilajit = “unlikely trio”: shilajit + PQQ + methylene blue designed as a closed-loop energy system. Shilajit basics: paleo-humus resin rich in fulvic/humic acids, DBP-like compounds, and ionic trace minerals for high absorption. ATP angle: shilajit framed as ATP preservation + ETC enzyme protection under stress (mouse forced-swim model described). Stimulant vs metabolic: shilajit positioned as the opposite of “masking fatigue” (caffeine analogy). PQQ: framed as a catalytic redox molecule tied to mitochondrial biogenesis via PGC-1α / CREB signaling. Methylene blue: framed as a low-dose electron cycler that can bypass bottlenecks in the ETC, especially relevant to brain energy. Safety/precision: strong emphasis on dose hormesis + USP pharmaceutical grade only (avoid aquarium/industrial impurities). - Episode timeline 00:01:07–00:03:37 — Beyond Conference (Austin, May 27–29): booth location + product teases 00:03:56–00:05:58 — Speaking topics + Return to Nature (Franklin, June 11–12) + vibe contrast 00:06:13–00:06:51 — Tentative A4M (December) + lead-in to minerals line 00:06:51–00:07:59 — Minerals stack → pivot to BioShilajit announcement 00:07:59–00:10:23 — Why “binary medicine” fails fatigue/brain fog; “wrong level” diagnosis 00:10:24–00:12:34 — The “unlikely trio” frame: mountain resin + bacterial cofactor + blue dye 00:12:43–00:16:40 — Shilajit origin stories + sensory reality + what it is (paleo-humus) 00:20:14–00:22:17 — Molecular payload: fulvic/humic acids + trace minerals + safety/purity note 00:22:26–00:29:32 — Evidence + mechanisms: ATP/fatigue model + “not a stimulant” analogy 00:29:32–00:34:02 — Hormones + cognition: testosterone study overview + tau aggregation discussion 00:34:02–00:39:10 — Shilajit “matchmaker” model: fulvic delivery + DBP-style mitochondrial cleanup 00:39:10–00:48:53 — PQQ deep dive: discovery, “vitamin-like” role, redox cycling, biogenesis signaling 00:49:24–01:05:24 — Methylene blue: history → ETC bypass model → brain relevance → dose/sourcing warnings 01:05:24–01:12:25 — Closed-loop synergy: build engines (PQQ) + supply/protect (shilajit) + failsafe (MB) 01:12:25–01:15:48 — Launch details + discount code + deadline (through May 7) 01:15:54–01:18:41 — Product page “mini-library” + shoutout + closing - For the next week, save 20% on your order of BioShilajit!   And for the next week ONLY, you can combine this 20% discount with the Subscribe and Save 10% discount option* (choose on the product page when adding to cart).   This limited-time offer provides you with a 30% discount on BioShilajit and you will retain this exclusive discount of the lifetime of your subscription.   Discount code: BIOSHILAJIT20   Expires on 5/7, midnight PST   *must choose "Single" quantity option and then increase to desired amount   Shop BioShilajit! - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

What if one of the strangest molecules in biology — the carbon “nanoball” known as C60 — could meaningfully influence aging? In this Energy Code Deep Dive, Dr. Mike breaks down the paper “Fullerenes as Anti-Aging Antioxidants” and explores why fullerenes have become a lightning-rod topic in longevity. You’ll learn what fullerenes are, why their electron-handling chemistry makes them different from typical antioxidants, and how the review frames their potential role in oxidative stress and mitochondrial function. We unpack the famous C60-in-olive-oil lifespan study, the proposed mechanisms (from “radical sponge” behavior to a more strategic mitochondrial ROS-reduction hypothesis), and the most important caveat: context and formulation can flip the biology. Preparation, dose, impurities, and even light exposure can shift fullerenes from promising to problematic—so this episode is about the science, the signal, and the safety questions that still need answers. (Educational content only, not medical advice.) - Article Discussed in Episode: Fullerenes as Anti-Aging Antioxidants - Key Quotes From Dr. Mike: “These molecules (Carbon 60) can accept electrons… interact with free radicals… and move through lipid membranes.” “ROS are like sparks coming off a machine… a few sparks are normal, too many sparks start causing damage.” “Fullerenes can accumulate in mitochondria… placing a fire extinguisher inside the power plant itself.” “Now the fullerene is not just cleaning up sparks after they happen, it may be reducing how many sparks the mitochondrial power plant throws off in the first place.” “Sometimes the most interesting ideas in anti-aging science are not the ones that sound familiar.” - Key Points What fullerenes are: spherical carbon cages; C60 = 60 carbon atoms in a “soccer-ball” structure. Why the hype exists: they can accept electrons, interact with free radicals, and move through lipid membranes. Aging framework: ties into the free radical/mitochondrial oxidative stress model of aging. The headline animal finding: C60 dissolved in olive oil was associated with a large lifespan increase in rats (not a human claim). How they may work: not only scavenging ROS, but possibly triggering protective pathways. Mitochondria angle: evidence suggests mitochondrial accumulation, potentially changing ROS “at the source.” Provocative mechanism hypothesis: fullerenes may behave like a mild “pressure release valve” (uncoupler-like behavior) in mitochondria. Critical caution: biology is context-dependent — prep, dose, surface chemistry, impurities, and light can shift effects. Safety reality: mixed findings across studies; the review treats this as a platform with variable outcomes. Bottom line: compelling early signals, but not a validated human anti-aging therapy. - Episode timeline 0:47–1:41 — What fullerenes are: C60, the carbon “soccer ball” 1:41–2:18 — Why longevity cares: electrons, radicals, membranes, mitochondria 2:19–3:35 — Free-radical theory → mitochondria as the “spark source” 3:46–4:16 — The non-simple story: beneficial vs harmful effects 4:23–5:30 — Anti-aging evidence overview + the famous C60/olive-oil rat study (with realism) 5:54–6:33 — “Radical sponge” concept + SOD-mimic derivatives 6:42–7:31 — City analogy + the idea that fullerenes may also trigger endogenous defenses 7:40–9:38 — Mitochondria deep dive: accumulation + mild “uncoupler/pressure-valve” hypothesis 10:03–11:23 — Toxicity + why formulation and context can flip outcomes 11:24–12:11 — Broad application claims + why that’s both exciting and cautionary 12:11–15:21 — The real takeaway: promise, limits, unanswered questions + closing - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

In this Deep Dive episode, Dr. Mike breaks down a landmark first-in-human study on urolithin A — one of the most important translational steps yet in mitochondrial longevity science. The paper asks the question the field has been waiting for: when you target mitophagy (the selective cleanup of damaged mitochondria) in real humans, does it appear safe, does it reach the bloodstream and tissue, and does it actually shift biology in the direction of healthier mitochondrial function? You’ll learn why urolithin A is different from typical “mitochondria boosters,” how the study tested safety, tolerability, and bioavailability, and why it matters that urolithin A was detected in skeletal muscle. Dr. Mike also explains the key biomarker signals—like reductions in plasma acylcarnitines — and the muscle gene-expression changes that suggest a coordinated mitochondrial health signature, including comparisons to patterns seen in healthier, more active older adults. The takeaway: this study doesn’t prove performance gains yet — but it strongly supports that mitochondrial quality control is a targetable human biology, and it opens the door for larger efficacy trials. (Educational content only, not medical advice.) - Article Discussed in Episode: The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans - Key Quotes From Dr. Mike: “Aging is also the progressive failure of mitochondrial quality control.” “Instead of just trying to stimulate mitochondria harder… (with urolithin A) you are trying to improve the quality of the mitochondrial population itself.” “Urolithin A was detectable in skeletal muscle after oral dosing…” “This is not just a paper saying urolithin A is present in blood… the muscle is responding with a transcriptional program consistent with improved mitochondrial health.” “The molecular signature induced by urolithin A resembles aspects of what is seen with regular exercise.” - Key Points Why it matters: A “mitophagy-first” intervention is tested in humans, not just cells or animals. Study design: Randomized, double-blind, placebo-controlled Phase 1 in healthy sedentary older adults, with single- and multiple-ascending dose arms (28 days). Safety: Favorable profile, no serious adverse events reported; no major lab/ECG concerns noted in the transcript. Bioavailability: Detectable in plasma across doses; dose-dependent exposure from 250–1000 mg. Tissue access: Detectable in skeletal muscle, which is critical for the aging-muscle thesis. Metabolic signal: Reduced plasma acylcarnitines, consistent with improved mitochondrial fuel handling. Muscle response: Dose-dependent upregulation of mitochondrial/mitophagy-related gene programs; examples mentioned include GABARAPL1 and FABP3. Systems-level finding: Gene-set patterns shift toward a profile more consistent with healthier muscle biology. Exercise resemblance: The molecular signature overlaps with aspects of exercise adaptation — without claiming equivalence. Limitation: No functional endpoints (strength, walking speed) due to short duration — this is a foundational mechanistic/PK/biomarker study. - Episode timeline 0:51–1:34 — Why this paper is a “turning point” (from mice to humans) 1:34–2:38 — What urolithin A is + why mitophagy is the target 2:38–3:47 — Aging as mitochondrial quality-control failure; why muscle is the proving ground 3:47–4:46 — Trial design: randomized, double-blind, placebo-controlled Phase 1; single vs multiple ascending dose 4:46–5:39 — Safety & tolerability overview 5:39–6:57 — Pharmacokinetics: plasma exposure, dose-dependence, conjugates, and skeletal muscle detection 6:57–7:36 — Practical translational detail: minimal food effect (yogurt matrix) 7:36–9:14 — Biomarker signal: acylcarnitines as a window into fatty-acid oxidation efficiency 9:14–10:57 — Muscle biopsy findings: gene expression shifts (mitophagy/mitochondrial programs) 10:57–12:29 — Transcriptomics + “directional rescue” vs pre-frail sedentary signatures 12:29–13:53 — Exercise-like signature (with explicit caveats) 13:53–14:57 — Limitations: no performance outcomes yet; why that’s expected in 4 weeks 14:57–16:25 — Evidence hierarchy: safety → PK → biomarkers → then larger trials 16:25–17:07 — Why supplementation matters: microbiome variability makes food-derived production inconsistent 17:07–19:31 — Final synthesis: mitophagy/quality control as a targetable human pathway + closing - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

In this Energy Code Deep Dive, Dr. Mike unpacks Mitochondria at the Heart of Aging: Structure, Function, and Failure — a sweeping review arguing that aging isn’t just random damage over time, but a progressive loss of mitochondrial adaptability. The episode walks through the core failure loops that accelerate aging across tissues: mtDNA instability → impaired oxidative phosphorylation → rising ROS → more mtDNA damage, plus breakdowns in fusion/fission architecture, mitophagy and quality control, NAD⁺ metabolism and sirtuin resilience, and the inflammatory spillover that turns mitochondrial stress into inflammaging. The key takeaway: mitochondria aren’t background “powerhouses” — they’re a systems-level coordinator of redox, metabolism, cleanup, and stress responses, and aging may be the gradual loss of that mitochondrial “intelligence.” (Educational content only, not medical advice.) - Article Discussed in Episode: Mitochondria at the heart of aging: structure, function, and failure - Key Quotes From Dr. Mike: “Aging is not just reducing mitochondrial quantity, it is degrading mitochondrial architecture.” “Mitochondrial aging is a network problem, not a single molecule problem.” “Aging is in part the loss of mitochondrial intelligence.” “Not all tissues age the same way mitochondrially.” “We are not just trying to stimulate energy. We are trying to restore mitochondrial adaptability.” - Key Points Central thesis: Aging = loss of mitochondrial adaptability, not just lower ATP. Mitochondria as aging hub: redox control, apoptosis, inflammation coordination, metabolic flexibility, QC. Hallmarks link: mitochondrial dysfunction interacts with genomic instability, senescence, inflammaging, proteostasis loss, stem cell exhaustion. mtDNA vicious cycle: mtDNA mutations/deletions → weaker OXPHOS → more ROS → more mtDNA damage. Tissue vulnerability: post-mitotic, high-demand tissues (brain, heart, skeletal muscle) are hit hardest. Dynamics failure: imbalance in fusion (MFN1/2, OPA1) and fission (DRP1) → fragmentation + crista disruption + reduced stress tolerance. Mitophagy decline: PINK1/Parkin + BNIP3/NIX/FUNDC1 pathways weaken → damaged mitochondria accumulate. Inflammaging bridge: mtDNA/ROS/cardiolipin danger signals activate cGAS–STING and NLRP3. NAD⁺ collapse loop: NAD⁺ decline → weaker SIRT1/SIRT3 → lower resilience; dysfunction also worsens NAD⁺ regeneration. MIDAS concept: mitochondrial dysfunction can directly drive senescence (not just nuclear DNA damage). Intervention framing: reduce damage + improve clearance + restore function (but calibration matters: mitohormesis, too much/too little mitophagy). Translation realism: biomarkers, delivery, long-term safety, and tissue-specific effects remain limiting factors. - Episode timeline 0:33 — Paper setup + thesis: aging as loss of mitochondrial adaptability 1:32 — Mitochondria as more than ATP: redox, stress signaling, apoptosis, inflammation, flexibility, QC 2:28 — Mitochondria woven into hallmarks of aging (senescence, proteostasis, inflammaging, etc.) 3:23 — mtDNA damage + the core vicious cycle (OXPHOS decline → ROS → more damage) 4:18 — Why post-mitotic tissues (brain/heart/muscle) are uniquely vulnerable 4:59 — Mitochondrial dynamics: fusion/fission balance and aging-related fragmentation 6:35 — Quality control failure: why the cell can’t just “clean it up” forever 7:00 — Mitophagy pathways (PINK1/Parkin; BNIP3/NIX/FUNDC1) + consequences of decline 8:08 — Mitophagy failure → danger signals → cGAS–STING / NLRP3 → inflammaging 9:13 — NAD⁺ metabolism: SIRT1/SIRT3 dependence and feed-forward decline loops 11:32 — MIDAS: mitochondrial dysfunction–associated senescence as a distinct route 13:01 — Interventions framework: reduce damage / enhance clearance / restore function 13:49 — Nuance: mitohormesis + “calibrated restoration” (no one-way levers) 14:59 — Urolithin A + combination logic (clearance + biogenesis; coordinated restoration) 16:01 — Barriers: biomarkers, delivery, tissue heterogeneity, translation into older humans 16:50 — Final synthesis: aging as loss of mitochondrial “intelligence” and adaptive coordination - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

In this Energy Code Deep Dive, Dr. Mike breaks down a preclinical paper testing methylene blue in a classic ovalbumin (OVA)–induced allergic asthma mouse model. The core question: if allergic asthma is driven by a self-reinforcing loop of TH2 cytokines (IL-4, IL-13), IgE signaling, eosinophilic airway infiltration, and oxidative stress, can a redox-active compound interrupt the cycle? The study reports dose-dependent improvements across airway inflammation (BALF immune cells), immune programming (IL-4/IL-13 + OVA-specific IgE), oxidative damage (MDA), antioxidant defenses (GSH/GPx), and lung histology — while emphasizing the key caveat: this is not human clinical asthma, and safety/translation questions remain open. (Educational content only, not medical advice.) - Article Discussed in Episode: Methylene blue attenuates ovalbumin-induced airway inflammation and oxidative stress in mouse model of asthma - Key Quotes From Dr. Mike: “Oxidative stress is not a side issue in asthma, it is part of the disease mechanism.” “Eosinophilia is one of the hallmarks of allergic asthma.” “Methylene blue significantly reduced those IgE levels… in a dose-dependent manner.” “Both cytokines were significantly elevated… and methylene blue… significantly lowered both of them.” “This is a proof of concept study, and as a proof of concept, it is strong.” - Key Points Model: OVA + alum sensitization, then inhaled OVA challenge (TH2-driven allergic asthma in mice). Intervention: methylene blue 10 vs 20 mg/kg. Inflammation: reduced BALF leukocytes, especially eosinophils (dose-dependent). Immune signaling: lowered IL-4 and IL-13 (TH2 axis), dose-dependent. Allergy amplifier: lowered OVA-specific IgE (dose-dependent). Oxidative stress: decreased MDA (lipid peroxidation marker). Antioxidant defenses: increased GSH and GPx. Tissue-level confirmation: histology showed less peribronchial/perivascular inflammatory infiltration. Translation caution: murine acute allergic model ≠ clinical asthma outcomes (AHR, symptoms, remodeling). Safety realism: methylene blue has side effects + drug interactions that matter in humans. - Episode timeline 0:34 — Paper setup: asthma + oxidative stress + why methylene blue is interesting 1:49 — Model overview: OVA-induced allergic asthma (TH2 inflammation) 2:13 — Study design: 10 vs 20 mg/kg MB + endpoints (BALF, cytokines, oxidative markers, histology, IgE) 3:14 — Why MB could matter: redox, anti-inflammatory, mitochondria-adjacent logic 4:14 — TH2 biology refresher: IL-4 → IgE; IL-13 → mucus/remodeling/hyperreactivity 5:17 — BALF results: reduced leukocytes/eosinophils/lymphocytes/neutrophils (dose response) 7:06 — IgE results: OVA-specific IgE drops with MB (dose response) 8:01 — Cytokines: IL-4 and IL-13 reduced (dose response) 9:19 — Oxidative stress panel: MDA down; GSH + GPx up 11:53 — Histology: less inflammatory infiltration; scores improve (dose response) 13:15 — Translation + safety cautions: mouse model, not clinical asthma; side effects/interactions 14:22 — Broader synthesis: asthma as an inflammation–redox loop; MB as a “clue” for redox therapies 15:35 — Closing summary + take-home message - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

What if some of the hardest brain disorders aren’t just “neurotransmitter problems” or “protein problems,” but redox problems — where the NAD⁺/NADH balance drifts, mitochondrial performance declines, oxidative stress rises, and inflammation becomes self-reinforcing? In this Deep Dive, Dr. Mike breaks down a review arguing that bioenergetic failure may be a shared organizing principle across neurodegenerative disease (Alzheimer’s, Parkinson’s, ALS) andpsychiatric illness (schizophrenia, bipolar disorder). We cover why raising NAD in blood isn’t the same as fixing compartmentalized brain redox, why clinical results have been mixed, and why the future of “redox therapy” hinges on biomarker-guided, mechanism-driven trials — not hype. (Educational content only, not medical advice.) - Article Discussed in Episode: Redox therapy for neuropsychiatric disorders: Molecular mechanisms and biomarker development - Key Quotes From Dr. Mike: “The redox system is not peripheral to brain function. It is central to it.” “We still do not fully understand NAD subcellular cycling.” “We lack robust in vivo biomarkers that can really tell us whether a redox-based therapy is engaging its intended target in the brain.” “Raising a precursor in blood is not the same as fixing a dynamic, compartmentalized, disease-specific, energetic failure inside the brain.” “Ketogenic interventions do not just supply alternative fuel. They also appear to influence the NAD plus to NADH ratio.” - Key Points   Redox ≠ generic antioxidants: the paper centers on the NAD⁺/NADH ratio as a core metabolic control variable. Shared energetic bottleneck: different diagnoses may share overlapping mitochondrial dysfunction + oxidative stress + inflammation. Why outcomes are mixed: the field still lacks clarity on subcellular NAD cycling (cytosol vs mitochondria vs nucleus). Biomarkers are the bottleneck: without in vivo target engagement measures in the brain, trials are hard to interpret. Therapy categories discussed: NAD-targeted strategies and ketogenic therapy as redox-modulating interventions. Ketogenic angle: not just alternate fuel — potentially shifts redox state and metabolic flexibility. Precision matters: heterogeneity across patients/stages means treatment should follow mechanism, not label. - Episode timeline 0:34 — Paper framing: brain energy, mitochondria, oxidative stress, treatment future 2:22 — Core concept: redox as NAD⁺/NADH ratio (not vague antioxidant talk) 3:44 — Neurodegeneration: Alzheimer’s, Parkinson’s, ALS through an energetic lens 5:09 — Psychiatry: schizophrenia/bipolar as potential bioenergetic + redox disorders 6:11 — Why NAD is central: respiration, stress signaling, survival programs 7:12 — Reality check: promising preclinical data, mixed clinical outcomes 7:35 — Key limitation: compartmentalized NAD pools + unclear subcellular cycling 8:22 — The measurement problem: lack of robust in vivo brain redox biomarkers 9:35 — Strategy 1: NAD-targeted supplementation (promise vs translation gap) 10:41 — Strategy 2: ketogenic therapy as a redox-shifting metabolic intervention 11:47 — The unifying loop: redox imbalance → mitochondrial dysfunction → ROS → inflammation → worse mitochondria 13:24 — Why neuroimaging/biomarkers are essential for precision redox therapy 14:48 — Cross-diagnostic mechanism: treatment may follow mechanism, not diagnoses 15:50 — What’s needed next: mechanism-first trials + target engagement + better biomarkers 16:34 — Final synthesis + takeaway - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

In this episode of The Energy Code, Dr. Mike connects two papers into one cohesive story: skin aging is largely an energy and mitochondrial quality-control problem, not just a surface-level cosmetic issue. First, a 2025  Experimental Dermatology review explains how UVA and UVB converge on mitochondrial dysfunction — mtROS amplification, mtDNA mutations, membrane potential loss, impaired respiration, inflammatory signaling, senescence, and extracellular matrix breakdown that shows up as wrinkles, thinning, pigment disruption, slower healing, and (at extremes) greater cancer permissiveness. Then a Scientific Reports study puts an intervention on that map: methylene blue in human fibroblasts and 3D skin models appears to reduce mitochondrial ROS, improve proliferation and senescence markers, activate Nrf2-linked antioxidant defenses, and improve tissue-level metrics like viability, dermal thickness, hydration, and elastin-related signals — with clear dose-dependent tradeoffs. The takeaway isn’t hype: it’s a cleaner framework for “skin longevity” built on mitochondrial resilience + redox control + turnover. (Educational content only, not medical advice.) - Articles Discussed in Episode: Role of Mitochondrial Dysfunction in UV-Induced Photoaging and Skin Cancers Anti-Aging Potentials of Methylene Blue for Human Skin Longevity - Key Quotes From Dr. Mike: “Skin aging is not just a surface problem. It is, to a large extent, an energy problem, an oxidative stress problem, and a mitochondrial quality problem.” “UVA penetrates deeper… and tends to cause indirect damage largely through reactive oxygen species.” “UVB is higher energy… and directly damages DNA through lesions like cyclobutane pyrimidine dimers and six-four photoproducts.” “More ROS damages mitochondrial DNA, and damaged mitochondrial DNA tends to worsen mitochondrial function, which then produces more ROS. That is the vicious cycle.” “It (methylene blue) reduced mitochondrial ROS… increased Nrf2-related antioxidant signaling… increased dermal thickness… improved hydration… increased elastin expression.” - Key Points Both papers converge on one thesis: photoaging is a mitochondrial + oxidative stress disorder expressed through skin. UVA vs UVB: UVA = deeper, ROS-heavy “slow burn”; UVB = higher-energy, direct DNA lesions—both end up stressing mitochondria. Vicious cycle: mtROS damages mtDNA → mtDNA damage worsens function → more mtROS → escalating dysfunction. Downstream signature of photoaging: lower membrane potential, impaired respiration/ATP, permeability transition, apoptosis, inflammation, senescence, SASP, and ECM degradation. Mitophagy is central: aging isn’t only damage—it’s failing cleanup and turnover of damaged mitochondria. Real-world aging is compounded by environmental synergy (UV + pollutants) increasing mitochondrial strain. Skin cancer link: mitochondrial dysfunction and ROS can support mutation burden, apoptosis resistance, metabolic adaptation in malignant progression. The methylene blue study is experimental (cells + 3D tissue), not a long-term clinical outcomes paper. In those models, methylene blue appears mitochondria-facing (not a generic antioxidant): ↓ mtROS, ↑ proliferation, ↓ senescence markers, ↑ Nrf2 signaling. 3D tissue findings emphasize dose window: lower concentrations look supportive; higher concentrations introduce coloration/viability tradeoffs. - Episode timeline 02:30 — Episode roadmap: two papers + the “through-line” you’re connecting 04:30 — Paper #1 setup: UV photoaging as a systems problem (not just cosmetic) 07:00 — UVA vs UVB: deep oxidative stress vs direct DNA injury (two routes, same mitochondrial endpoint) 11:00 — Why mitochondria sit at the center: ATP + ROS + apoptosis + inflammation + senescence + repair capacity 15:30 — The vicious cycle: mtROS ↔ mtDNA damage → membrane potential loss → respiration/ATP decline 20:00 — Tissue-level photoaging: collagen/elastin degradation, pigmentation shifts, barrier decline, slower healing 24:30 — Senescence + SASP: why dysfunctional survival accelerates structural aging 28:00 — Mitophagy + MQC: why aging is “failed cleanup,” not just accumulated damage 31:30 — Environmental synergy: UV + pollution/oxidative burden compounding mitochondrial strain 34:30 — Skin cancer angle: mitochondrial dysfunction as part of carcinogenic permissiveness/adaptation 38:00 — Transition to Paper #2: why methylene blue is a compelling “fit” for the mitochondrial model 40:00 — Experimental findings in fibroblasts: mtROS ↓, proliferation ↑, senescence markers ↓ (old vs young cells) 43:30 — Comparator antioxidants: what MB did differently (and why that matters conceptually) 46:00 — Nrf2 bridge: how MB aligns with UV-protection mechanisms from Paper #1 48:00 — 3D skin model results: viability, dermal thickness, hydration, elastin/collagen-related signaling 50:30 — Dose-window realism + translation caveats (preclinical ≠ clinical) 51:30 — Final synthesis: “skin aging = loss of energetic coherence” + mitochondrial resilience as the lever - ⚡️ Upgrade your skincare routine with the Mist Ritual Bundle and SAVE 20%! ⚡️ Elevate your skincare routine with the Mist Ritual Bundle — a curated pairing of the Mystic Nano Mister plus your choice of the Blue Mist or Gold Mist — and SAVE 20%!   First, choose the color of your Mystic nano-mister: White, Rose Gold, or Magenta   And then choose between the two premium skin serums: Blue Mist or Gold Mist   The Mystic Nano Mister helps disperse a fine, consistent mist for a more elevated application experience, while Blue Mist and Gold Mist offer two distinct ways to upgrade your routine. Together, they create a versatile system that fits seamlessly into morning, evening, or anytime your skin needs a refreshing reset.   Whether you are looking to support hydration, enhance your skincare ritual, or simply enjoy a more luxurious way to apply your mist, this bundle offers a complete experience at a better value than purchasing each product individually.   Check out the Mist Ritual Bundle! - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

In this Energy Code Deep Dive, Dr. Mike breaks down a mini-review asking a provocative question: could urolithin A support sleep health, indirectly, by improving the biology that makes sleep restorative? The authors don’t claim urolithin A “improves sleep,” and they emphasize a key limitation: there are no direct sleep-outcome studies using EEG, polysomnography, or actigraphy. Instead, they map the pathways that connect urolithin A to sleep-relevant physiology: central circadian clock genes in the SCN, protection against sleep-deprivation–induced neuroinflammation, support for brain mitochondrial integrity and dynamics, and stabilization of the gut microbiota / gut barrier — all systems tightly linked to sleep quality, recovery, and aging. The takeaway isn’t “take urolithin A for sleep.” It’s that the mechanistic groundwork may now be strong enough to justify real sleep trials that measure sleep architecture and circadian markers directly. (Educational content only, not medical advice.) - Article Discussed in Episode: Potential impact of urolithin A on pathways relevant to sleep health: a mini review - Key Quotes From Dr. Mike: “They map out the biological pathways through which urolithin A might influence sleep.” “Urolithin A is not a plant polyphenol in the direct sense. It is a gut microbial metabolite.” “Urolithin A can influence core clock-related genes in the suprachiasmatic nucleus.” “Not because it (urolithin a) is a sedative… but because it may support the deeper biology that makes sleep restorative.” “Sometime in the future — sleep health may not come from forcing the brain to sleep, but from restoring the biology that allows sleep to heal.” - Key Points The paper is hypothesis-building, not a sleep-claims paper. Urolithin A is a gut-derived metabolite from ellagitannins/ellagic acid (pomegranate, berries, nuts). No direct urolithin A sleep studies using EEG / polysomnography / actigraphy were found. Preclinical evidence clusters into 4 domains: SCN clock modulation, sleep-deprivation neuroprotection, mitochondrial integrity, microbiome support. Urolithin A may influence SCN clock genes (e.g., Clock, Cry1, Bmal1) in inflammatory conditions. Sleep deprivation models: urolithin A linked to improved fatigue resistance, lower inflammatory/oxidative markers. Brain resilience: reduced glial activation, lower hippocampal cytokines, preserved mitochondrial morphology/dynamics, better memory task performance post–sleep deprivation. Gut-brain-sleep axis: sleep disruption associates with dysbiosis; urolithin A may help microbiome compositionand barrier function, especially under sleep stress. Serotonin and SIRT1 pathways are more speculative and dose-context dependent. Future direction: controlled trials with objective sleep metrics + circadian markers, and mechanistic studies using physiologic concentrations. - Episode timeline 0:19–1:38 — The premise: a careful question, not a claim (why this paper matters) 1:54–2:53 — What urolithin A is: gut metabolite + why that intersects with sleep systems 2:58–4:32 — Human context + the key limitation: no direct sleep-outcome studies 4:32–5:13 — The “pathway buckets”: clock, brain inflammation, mitochondria, gut microbiota 5:13–6:46 — Circadian angle: SCN genes and rhythm markers (relevance vs proof) 6:46–8:53 — Sleep deprivation models: fatigue, inflammation/oxidative stress, hippocampal protection 8:53–9:55 — The Energy Code frame: restorative sleep depends on mitochondrial + inflammatory resilience 10:03–11:32 — Gut-brain-sleep axis: dysbiosis links + urolithin A as a stabilizer (indirect support) 11:50–13:34 — Speculative pathways: serotonin + SIRT1 as hypothesis generators 14:03–15:20 — What we don’t know + what studies should be done next 15:26–17:04 — Synthesis: sleep support via “restoration biology,” not sedation - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

In this Energy Code Deep Dive, Dr. Mike breaks down a core idea in modern immunology: immune behavior is metabolically gated — and mitochondria sit at the center of that gate. This review reframes mitochondria as active organizers of immune fate, not just “powerhouses,” showing how mitochondrial fusion/fission balance, ROS tone, mtDNA containment vs leakage, trafficking, mitophagy, and even mitochondria-derived extracellular vesicles (mito-EVs) shape whether immune cells become inflammatory, regulatory, resolving, or stuck in chronic dysfunction. You’ll hear how activation often involves a shift toward glycolysis + anabolic metabolism, while resolution leans back into more stable oxidative metabolism, and how “execution hubs” like mTOR/HIF-1α (pro-inflammatory) and AMPK/SIRT1 (restorative/containment) translate metabolic state into inflammatory output. The episode closes with the translational take: the future isn’t blanket immune suppression — it’s context-aware immunomodulation by targeting mitochondrial architecture, quality control, and metabolic checkpoints. (Educational content only, not medical advice.) - Article Discussed in Episode: Metabolic control of immunity and inflammation: Mitochondrial dynamics, pharmacological targets, and therapeutic opportunities - Key Quotes From Dr. Mike: “The immune system is not just responding to receptors… it is responding through metabolism.” “Metabolism does not just correlate with inflammation, metabolism gates inflammation.” “Mitochondrial integrity becomes the point where upstream immune and metabolic signals are converted into irreversible inflammatory cell death.” “Resolution of inflammation is not only about removing the initial trigger, it is also about reconstituting the mitochondrial architecture that supports homeostasis.” “Immune regulation is not only a matter of what the immune system sees, it is also a matter of what the mitochondria allow.” - Key Points Immune activation isn’t just signaling → it’s metabolic state–dependent, centered on mitochondria. Mitochondria act as decision platforms: ATP, ROS, intermediates, membrane potential, mtDNA integrity. Metabolic inflammatory checkpoints: metabolism doesn’t just correlate with inflammation — it gates it. Activation often shifts toward glycolysis; resolution often favors OXPHOS and resilient mitochondrial networks. mTOR/HIF-1α reinforce glycolysis and inflammatory programming (e.g., IL-1β axis). AMPK/SIRT1 support restraint: homeostasis, antioxidant defense, autophagy/mitophagy, resolution. mtDNA leakage (via pores/VDAC oligomers) can trigger cGAS-STING and inflammasome signaling. Fusion vs fission is a tuning dial: short-term fission can be adaptive; chronic fission can sustain pathology. Mito-EVs can spread mitochondrial state between cells — either supportive or inflammatory, depending on cargo/context. Therapeutic angle: shift immune outcomes by targeting mitochondrial dynamics + MQC, not just cytokines. - Episode timeline 0:19–2:22 — The thesis: immunity is metabolically organized; mitochondria as immune “organizers” 2:24–4:44 — Immunometabolism basics: activation = metabolic rewiring (OXPHOS ↔ glycolysis) 5:34–7:13 — “Metabolic inflammatory checkpoints”: metabolism gates inflammatory permission 7:20–9:47 — Execution hubs: mTOR/HIF-1α vs AMPK/SIRT1 and chronicity vs resolution 10:32–11:30 — Mitoxyperiosis: mitochondrial rupture as a terminal inflammatory death event 11:41–13:49 — Trafficking + spatial immune geometry; mtDNA containment vs escape (cGAS-STING) 13:58–16:10 — ROS nuance + dynamics centerpiece: fission/fusion as intensity and duration control 17:21–19:51 — Mito-EVs: intercellular mitochondrial messaging; QC decisions include export 20:00–22:16 — Pharmacologic opportunities: context-aware immunomodulation via mitochondrial targets 22:23–24:48 — Synthesis: mitochondria “decide” what inflammation becomes - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

In this Deep Dive, Dr. Mike breaks down a frontier idea in mitochondrial medicine: ocular mitochondrial transplantation — isolating healthy mitochondria and delivering them into specific eye compartments to support bioenergetics in tissues like the retina, retinal pigment epithelium (RPE), and optic nerve head. The promise is obvious: mitochondrial dysfunction shows up across major blinding diseases (AMD, glaucoma/optic neuropathies, diabetic retinopathy), and these tissues are some of the most energy-demanding in the body. But the real focus of this paper is not hype, it’s delivery. The episode walks through what the evidence suggests so far about route-dependent targeting: intravitreal delivery trending toward inner retina/optic nerve head exposure, subretinal delivery aligning with outer retina/RPE exposure, and suprachoroidal delivery looking technically feasible but still biologically unproven for true retinal/RPE uptake. You’ll also hear the key unanswered questions that determine whether this becomes clinical reality: uptake vs signaling effects, persistence/durability, dosing, and immune safety in a tissue with minimal tolerance for inflammation. (Educational content only, not medical advice.) - Article Discussed in Episode: Mitochondrial Transplantation in the Eye: A Review and Evaluation of Surgical Approaches - Key Quotes From Dr. Mike: “Therapeutic mitochondrial transplantation is, in a sense, taking an existing biological logic and trying to harness it intentionally.” “That means the mitochondria are not some side note in ophthalmology, they are central players.” “You cannot just say put mitochondria into the eye and assume they will reach the right place.” “Intravitrial delivery is probably the most relevant route if your therapeutic target is retinal ganglion cells… or the proximal optic nerve.” “Suprachoroidal delivery appears technically promising, but still biologically uncertain with respect to actual retinal or RPE uptake.” “The concept is biologically plausible, surgically approachable, and anatomically root-dependent.” - Key Points The eye is an extreme bioenergetic environment; mitochondrial failure can map directly onto vision failure. Mitochondrial dysfunction is implicated across AMD, glaucoma/optic neuropathies, diabetic retinopathy, and age-related retinal decline. Horizontal mitochondrial transfer is a real biological phenomenon (TNTs, EVs, free mitochondria), not just theory. Therapeutic effect appears context-dependent: stressed/injured cells may benefit more than “healthy” cells. The central translational problem is delivery + target engagement (getting mitochondria to the right compartment). Intravitreal → mostly inner retina; optic nerve head–directed technique may increase ONH/RNFL exposure. Subretinal → strongest outer retina/RPE exposure but more invasive and less repeat-friendly. Suprachoroidal → technically feasible delivery route; biologic uptake into retina/RPE still uncertain. Mechanism remains unresolved: integration vs paracrine-like signaling vs triggering host repair/mitophagy. Safety is non-negotiable: mitochondria can behave like DAMPs depending on source, purity, mtDNA debris, dose, and repeat exposure. - Episode timeline 0:19–1:15 — The premise: can we deliver healthy mitochondria to the eye clinically? 1:17–2:21 — Why mitochondria matter in vision + the disease landscape (AMD, glaucoma, LHON/DOA, DR) 2:39–4:36 — What “mitochondrial transplantation” means + natural horizontal mitochondrial transfer 4:52–6:59 — Why the eye is uniquely hard: compartments, barriers, and precision targeting 7:24–9:37 — AMD focus: RPE mitochondrial dysfunction + metabolic coupling with photoreceptors 9:37–11:08 — Diabetic retinopathy: mitochondrial oxidative stress + “mitochondrial memory” 11:08–12:28 — Glaucoma/optic neuropathy: RGC energy dependence + early transport bottlenecks 12:28–16:17 — Evidence so far: in vitro uptake; animal intravitreal signals; durability questions 16:22–21:16 — Delivery routes compared: intravitreal vs subretinal vs suprachoroidal (pros/limits) 21:19–23:21 — Safety and immune risk: DAMP biology, purity, source, and repeat dosing concerns 23:25–25:37 — Synthesis: feasibility vs efficacy; “delivery is everything” conclusion - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook